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Lipoprotein metabolism and antioxidant status in diabetic glomerular
and tubular dysfunction. S.F. O'Brien and G.F. Watts, Department of
Medicine, University of Western Australia, Australia. Serum cholesterol and
apolipoprotein B concentrations have been reported to be positively
associated with urinary albumin excretion in insulin-dependent diabetes
mellitus, but their relationship with renal tubular function remains un-
clear. The relationship between serum antioxidant status and glomerular
and tubular function in diabetes mellitus has not yet been described. We
aimed to examine the relationship of serum lipids, lipoproteins, apoli-
poproteins and antioxidants with renal dysfunction as measured by urinary
excretion of albumin and of retinol binding protein (RBP) in insulin-
dependent diabetes mellitus (IDDM). We studied 123 patients with
IDDM. Glomerular function was assessed as the urinary albumin/creati-
nine ratio (UA/Uc), and tubular function as the urinary retinal-binding
protein/creatinine ratio (UR/UC), both measured in three early morning
spot urine samples. The mean (range) UA/UC was 1.95 mg/mmol (0.3 to
476.5) and UR/UC was 17.5 gImmol (1.0 to 1853.8). Seventeen percent of
the patients had a UA/UC > 3 mg/mmol and 33% had a U/U > 20
j.rg/mmol. Significant positive correlations were observed between both
UA/UC and UR/Uc and the following: serum total cholesterol (P < 0.002);
triglycerides (P < 0.001); apolipoproteins Al (P < 0.05), All (P < 0.01)
and B (P < 0.001); glycated hemoglobin (P < 0.01). No significant
associations were found with serum vitamine E, a-carotene or total
antioxidant activity. In multiple regression, only UA/UC was independently
associated with serum apo B and cholesterol concentrations. In conclu-
sion, in IDDM glomerular dysfunction, as measured by UA/Uc, is
associated with elevated serum cholesterol, triglycerides, apo B and apo A,
but not with HDL cholesterol or antioxidant status. Tubular dysfunction
tends to occur with increasing albuminuria, but it is not independently
associated with serum lipid, lipoprotein, apolipoprotein or antioxidant
levels.
Hyperapobetalipoproteinemia as a predictor of microalbuminuria in
insulin-dependent diabetes mellitus. S.F. O'Brien and G.F. Watts, Depart-
ment of Medicine, University of Western Australia, Australia. The purpose of
this study was to examine the role of lipoprotein metabolism in the
development of microalbuminuria in insulin-dependent diabetes mellitus.
We measured serum lipids, lipoproteins and apolipoproteins in 53 nor-
moalbuminurie insulin-dependent diabetic patients who were re-studied
after 10 years. Albuminuria was assessed as the urinary albumin:creatinine
ratio in repeated early morning samples. The incidence of microalbumin-
uria was 9.4%. The increase in albuminuria was significantly and positively
related to baseline serum concentrations of total cholesterol (P < 0.05),
non-high-density-lipoprotein cholesterol (P < 0.05) and apolipoprotein(apo) B (<0.001), but there were no significant associations with triglyc-
erides, low-density-lipoprotein cholesterol, apo Al or lipoprotein(a). The
association with serum apo B remained significant after adjusting for sex,
smoking, duration of diabetes, glycated hemoglobin, blood pressure, and
family history of cardiovascular disease. The findings suggest that elevated
serum apo B may independently contribute to the development of early
nephropathy in insulin-dependent diabetes mellitus.
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Outbreak of HUS associated with verotoxigenic E. coli and dry fer-
mented sausage. KF. Jureidini, PH. Henning, A. Al-A bbad, S. Keeley, J.C.
Paton, A. W Paton, Renal, Intensive Care & Microbiology Units and Dept. of
Nephrology, Women c & Children's Hospital, North Adelaide, South Austra-
lia, Australia. During a period of 30 days, 20 children aged from 4 months
to 12 years were admitted to the Women's & Children's Hospital with
HUS. Consumption of, or household contact with a locally produced
semi-dry unpasteurized fermented sausage (mettwurst) was documented
in 18 who presented in the first 24 days. Fecal samples from all but one of
these were positive for Shiga-like toxin types I and II (SLT-I and SLT-lI)
by polymerase chain reaction (PCR) assay. SLT producing E. coIl belong-
ing to serotype 0111 was isolated from 14 of the cases, two of which also
yielded a type 0157 isolate. Eight of the 10 mettwurst samples from the
patient's homes were PCR positive for SLT-1 and II genes, and E. coli
0111 was isolated from 4 of these. Three children presenting late in the
epidemic (all positive for 0111) had no history of ingestion or contact with
mettwurst. The typical presentation was extremely painful, bloody diar-
rhea a mean 5 days after ingestion followed by the rapid onset of HUS a
mean 4 days later. Eighteen required dialysis within 2 days of onset of
HUS. All children had daily hemodialysis. Three required a period of
CVVHD. Parenteral nutrition was introduced at onset of dialysis. No
other specific treatment was instituted. The mean period of dialysis was 14
days (7—45 days). One child aged 4 died on day 3 of HUS with multiple
cerebral infarcts. Ten had a bizarre neurological syndrome with halluci-
nations for a mean of 4 days. Four had seizures, one of whom developed
reversible dense hemiplegia, four had prolonged hyperglycemia, five had
severe bowel ischemia and two of these required bowel surgery. Five
children have significant residual renal impairment. Fifteen appear to
have made a complete recovery.
Real (renal) outcomes for children one-year after urinary tract infec-
tion. J.C. Craig, J.F. Knight, L.P. Roy, Department of Nephrology, Royal
Alexandra Hospitalfor Children, Sydney, Australia. As part of a prospective
cohort study of children under 5 years of age with first-time urinary tract
infection, 159 children have been assessed 1 year after entry to determine
the frequency of and risk factors for important adverse outcomes of
chronic renal damage and impaired GFR. Renal damage was defined as
cortical abnormality on DMSA sean. GFR was estimated using DTPA
clearance curves (mI/mm/i .73 m2). Potential risk factors such as demo-
graphic variables, acute treatment options, UTI recurrence, and renal
imaging at entry were assessed by univariate and multivariate methods,
and expressed in terms of relative risks (RR) with 95% confidence
intervals (95% CI). A total of 45.9% (73/159) had abnormal DMSA
seintigraphy at entry. Complete healing occurred in 56.2% (41/73). New
defects developed in 4.6% (4/86), all of whom had at least one further
symptomatic UTI. 23.9% (38/159) showed persistent renal damage. This
was more likely to occur in children with abnormal sonography (RR 2.1,
95% CI 1.3 to 3.4), vesicoureteric refiux (RR 4.2, 95% Cl 1.9 to 9.2), or
abnormal DMSA at presentation (RR 14.9, 95% CI 4.9 to 45.2). Mean
GFR was 116 (range 43 to 177, N = 141). One child had a GFR <70 and
was the only subject with proteinuria. GFR was significantly associated
with grade of renal cortical abnormality (F4135 = 3.59; P = 0.008), and
grade of VUR (F(,134 = 2.96; P = 0.009) at entry. No child had
hypertension. UT! recurred in 17.6% (28/159). After adjusting for all
potential covariates, only DMSA at entry was significantly associated with
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renal cortical abnormality (Wald's test g 37.7; P = 0.0001) and GFR at
1 year (t18 = 2.74; P = 0.007). RR for cortical abnormality at 1 year was
5.6, 20.5 and 153.8 for children with a single small defect, multiple
unilateral defects and bilateral or diffuse unilateral damage at ently,
respectively (x2 trend = 61.8; P = 0.001). Children with the most severe
grade abnormality had a mean GFR of 100, 17 lower than children who
had normal or mild cortical abnormality at entry (P < 0.05, Newman-Kids
correction). Although persistent cortical abnormality at 1 year after UTI
is common in children, new defects are unusual. Initial DMSA appearance
is the best predictor of adverse outcome at 1 year and cortical defects do
have a severity dependent effect on GFR.
Does treating children with vesicoureteric reflux prevent end-stage
renal failure from reflux nephropathy? J.C. Craig, J.F. Knight, L.P. Roy,
Department of Nephrology, Royal Alexandra Hospital for Children, Sydney,
Australia. It was in 1960 that the association between vesicoureteric refiux
(VUR) and the scarred kidney was first recognized. Since then, it has
become almost universal practice to treat children with VUR with
long-term antibiotics and/or surgical reimplantation. To test the hypoth-
esis that treatment of children with VUR prevents end-stage renal disease
(ESRD), we analyzed the age-standardized incidence of ESRD due to
refiux nephropathy (RN) from 1964—1994 in the ANZDATA Registry
(Australian subjects only). We also analyzed the median ages of patients
with RN at entry into the Registry to test a secondary hypothesis, that
intervention delays the onset of ESRD from RN. Of 16,542 patients with
ESRD, 1142 (6.9%) had RN. This proportion has varied little over the
past 30 years [median proportion = 7.1 (range 2.7—16.7, interquartile
range 6.0—8.1)1. The number of patients with ESRD due to RN has
increased steadily at a rate of 2.3 patients per year, from 1 to 73 per year.
The population adjusted incidence of RN has also steadily increased, from
0.09 per million total population in 1964—1966 to the present day figure of
4.3 per million, an increase of 0.13 patients per million total population
per year. After adjusting for differences in the age distribution over time
there was evidence of a linear increase in ESRD secondary to RN, with an
increase of 0.12 patients per million population per year. Over the 31 year
period the median ages at entry for males and females with RN-related
ESRD has increased, from 27 to 36 years and 31 to 48 years, respectively.
This represents an increase of 0.35 age-years per year for males and 0.55
age-years per year for females. However, this increase is significantly lower
than for males and females with non-RN ESRD (0.84 and 0.90 age-years
per year, respectively). These data indicate that the hoped-for reduction in
ESRD due to RN has not occurred, despite vigorous treatment of children
with VUR. On the contrary, the age-standardized incidence of RN-related
ESRD is increasing. Although the median age of patients with RN
entering ESRD programmes is also increasing, this is not occurring as
rapidly as for non-RN ESRD. (We acknowledge the kind assistance of
ANZDATA staff-particularly Brian Livingston.)
Spot urine protein-to-creatinine ratio for assessing proteinuria in
hypertensive pregnancies. P. Saudan, M. Brown and T Fa,rell, Depart-
ments of Renal Medicine and Obstetrics, St George Hospital, University of
NSW Kogarah, Australia. Twenty-four-hour urine collection for protein
measurement is mandatory for an accurate diagnosis of proteinuria in
hypertensive pregnant women. Many problems are encountered with 24
hr-urine collections including inaccurate timing, cumbersome collection
for pregnant patients and difficult laboratory sample handling. Use of a
spot urine protein-to-creatinine ratio (P:C ratio) instead of 24 hr-urine
protein measurement could overcome these problems in pregnancy. This
is an important clinical issue as proteinuria is a cardinal feature of
preeclampsia and is associated with higher maternal and neonatal mor-
bidity and mortality than hypertension alone. We therefore compared the
random urine P:C ratio with 24 hr-urine protein excretion in our hyper-
tensive pregnant patients. Forty-five pregnant women admitted with de
novo hypertension whose dipstick urinalysis was positive for protein were
enrolled prospectively over a 6 month period. Fifty-two random urine P:C
ratios were compared with subsequent 24 hour proteinuria. The correla-
tion coefficient between methods was 0.94 (P < 0.0001) and the limits of
agreement for the methods were —0.06 to 0.06 g protein/mmol creatinine
for samples less than 1 g proteinuria/24 hr, the area when it is most difficult
to know whether true proteinuria is present from urinalysis alone. A spot
urine P:C ratio of 0.025 g prot/mmol creatinine gave a positive predictive
value of 89% and a negative predictive value of 93% for proteinuria 300
mg/day. The urine P:C ratio may replace 24 hr-urine collection to assess
protein excretion in hypertensive pregnant women.
Transport characteristics of human proximal tubule cells (PTC) in
primary culture. D. W. Johnson, BK. Brew, P. Poronnik, DI. Cook, M.J.
Field, CA. Pollock. Department of Medicine, University of Sydney at Royal
North Shore Hospital, Sydney, Australia. Primary cultures of PTC provide a
potentially invaluable in vitro model for studying the regulation of
epithelial polarity and transport in the human kidney, since in vivo
experiments are not possible and extrapolation from animal data may be
misleading. However, previous attempts to culture human PTC have
suffered the problems of significant heterocellular contamination, poor
yields of viable cells and lack of characterisation of PTC functional
polarity and transcellular transport capacities. To overcome these possible
pitfalls, a new method for primary culture of human PTC was developed,
in which a combination of proteolytic digestion, mechanical sieving,
isopycnic ultracentrifugation and selective media was used to isolate large
numbers of highly purified populations of PTC from histologically normal
regions of 12 human nephrectomy specimens. PTC were grown on porous
membrane inserts and reached tight confluence within 6—8 days, as
evidenced by relative impermeability to inulin. Cells displayed typical
morphology, including well-developed apical microvilli and tight junction
formation. Alkaline phosphatase (27.2 0.8 U/g protein) and y-glutamyl-
transpeptidase activities (319.1 45.9 U/g protein) were expressed at
levels comparable to that found in vivo. cAMP production was stimulated
by parathyroid hormone (PTH), but not by vasopressin. A number of
polarised transport systems were demonstrated, including: (i) Natdepen
dent, phlorizin-inhibitable apical glucose uptake; (ii) Na-dependent,
PTH-inhibitahle apical phosphate uptake; (iii) probenecid-inhibitable,
vectorial organic anion (p-aminohippurate) transport; (iv) vectorial or-
ganic cation (tetraethylammonium) transport; and (v) pharmacologically
distinct apical and basolateral sodium-hydrogen exchangers. The results
suggest that the described method for primary human PTC culture will
provide a useful model for the study of highly polarized transport
processes in the human proximal tubule.
Calcium channel blockers and skeletal muscle metabolism. C.H.
Thompson, G.J. Kemp, G.K Radda, MRC NMR Unit, Oxford Radcliffe
Hospital, Oxford, England, United Kingdom. There have been concerns
expressed recently about the safety of calcium (Ca) channel blockers in the
treatment of hypertension. The dihydropyridine group of Ca channel
blockers affect Ca movement across muscle cell membranes and mito-
chondrial enzyme activity can be altered by intra-mitochondrial Ca levels,
which in turn can be affected by cytosolic Ca. Nifedipine's effect on aerobic
and anaerobic ATP synthesis was studied using 31P magnetic resonance
spcctroscopy (MRS) of Wistar rat skeletal muscle before, during and after
sciatic nerve stimulation at 2 Hz and 10 Hz. Before stimulation, either 0.8
mg/kg (N = 5) or 12.5 pg/kg (N = 5) nifedipine or 0.2 ml dimethyl
sulfoxide (control) (N 4), the diluent vehicle, was injected intra-
arterially. There was significant hypotension at 0.8 mg/kg nifedipine (76
mm Hg) but not at 12.5 rg/kg (95 mm Hg). Compared to control rats,
there was no difference in metabolism during exercise or at the end of
exercise at either stimulation rate or at either dose of nifedipine. The
maximal rate of oxidative ATP synthesis was 50% lower (P < 0.05) at both
doses of nifedipine (22—24 mM/mm) compared to the control animals (48
mM/mm). Six normotensive adult subjects were given slow release nifed-
ipine, 10mg p.o. twice daily. Before and after one week of nifedipine, their
calf muscle was studied by 31P MRS and near infra-red spectroscopy
before, during and after voluntary plantar flexion to exhaustion. Nifedi-
pine did not alter blood pressure, resting or exercising muscle metabolism.
Nifedipine did not change the muscle re-oxygenation rate hut did reduce
the oxidative ATP synthesis rate by 20% (25 cf .32 mM/mm; P < 0.05)
during recovery from exercise. Hence, nifedipine caused a reduction in the
oxidative ATP synthesis rate in the muscle of initially normotensive
humans and rats. This may have been due to a direct effect on the
mitochondria by the calcium channel blocker or an indirect effect on
calcium fluxes within the muscle cell. The production of this oxidative
defect may contribute to exercise intolerance of patients receiving this
drug and may also contribute to the adverse clinical outcome of some
patients prescribed these Ca channel blockers.
Tubulointerstitial processes in glomerulonephritis. AN. Stein-Oakley,
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Medicine, Monash Medical School, Department of Pathology and Renal
Services, Alfred Hospital, Prahan, 318/, Victoria, Australia. It is generally
accepted that the degree of tubulointerstitial pathology correlates most
closely with declining renal function. In this study we have investigated
tubulointerstitial changes in biopsies from patients with IgA nephropathy
(IgAN) and focal and segmental glomerulosclerosis and hyalinosis
(FSGS), the latter displaying more severe vascular and interstitial changes.
The expression of adhesion molecules, fibrogenic growth factors, collagens
and a smooth muscle actin (aSMA) was assessed by immunohistochem-
istry, and the extent and phenotypic profile of infiltrating leukocytes was
analyzed. Up-regulated expression of ICAM- 1 and VCAM-1 was observed
in 60% of IgAN and 90% of FSGS patients. ICAM-1 expression was
largely interstitial and endothelial, and was prominent in areas of inflam-
matory cell infiltrate. VCAM-1 up-regulation was apparent in the distal
convoluted tubules as well as in areas of peritubular or focally distributed
infiltrating leukocytes. ELAM was detected on endotheliuni in 11% of
IgAN and 30% of FSGS patients while P-selectin was expressed in 50% of
IgAN and 77% of FSGS biopsies. The proportion of FSGS patients with
up-regulated basic fibroblast growth factor in the interstitium was signif-
icantly higher than in IgAN (86% vs. 33%, P < 0.01) and a similar trend
was evident for platelet-derived growth factor (PDGF). We have previ-
ously reported significantly increased expression of PDGF receptors in
expanded intertubular areas, correlated with monocyte/macrophage infil-
trate. Cells expressing PDGF receptors were also shown to express a
SMA, and increased expression of collagens I, III, V and VI was detected
in serial sections. Occasional interstitial collagen IV was also observed.
There was a higher proportion of FSGS patients expressing the interstitial
collagens type I and V, compared to IgAN (P < 0.05). The chemoattrac-
tant properties of fibrogenic growth factors and the up-regulation in
adhesion molecules would contribute to the accumulation of infiltrating
leukocytes, in turn releasing fibrogenic growth factors and other cytokines.
This would result in the phenotypic change of fibroblasts to myofibro-
blasts, and extracellular matrix production. The up-regulated expression
of adhesion molecules, growth factors and a SMA in the interstitium
appears to be associated with the increased severity of tubulointerstitial
injury seen in patients with FSGS.
Evidence for a paracrine growth-regulatory loop involving proximal
tubule epithelial cells and cortical fibroblasts in the human kidney. D. W.
Johnson, BK. Brew, M.J. Field, AZ. Gyo,'y, CA. Pollock, Department of
Medicine, University of Sydney, NSW Sydney, Australia. The potential role
of paracrine interactions in the regulation of tubulointerstitial growth was
examined by coculturing confluent populations of human renal cortical
fibroblasts (CF) and human proximal tubule cells (PTC) (N 24),
obtained from histologically normal sections of 9 adult human kidneys. In
additional experiments, human PTC and CF were also separately incu-
bated for 24 hours in CF-conditioned media (N = 30) and PTC-
conditioned media (N = 24), respectively. Cellular protein content and
thymidine incorporation were then measured as indices of cell hypertro-
phy and DNA synthesis respectively. PTC cocultured with CF or exposed
to CF-conditioned media exhibited increased cellular protein content
(150% 18%, P = 0.01 & 119% 7%, P < 0.01) and increased
thymidine incorporation (185% 31%, P = 0.01 & 153% 7%, P <
0.0001), respectively, compared with controls. CF incubated in PTC-
conditioned media showed a reduction in protein content (83% 6%,
P = 0.01) and an augmentation of thymidine incorporation (155% 15%,P = 0.0005). Coculture of PTC with CF resulted in a significant increase
in CF numbers (140% 8%, P < 0.0001) and a decrease in thymidine
incorporation (84% 8%, P < 0.05) compared with controls. Immuno-
neutralization studies suggested a role for IGF-1 in mediating the
observed paracrine stimulation of CF and PTC growth. A trend existed for
IGF binding protein-3 secretion by CF to be stimulated in the presence of
PTC-conditioned media (178.8 25.1 to 256.7 46.0 ng/ml; P = 0.13).
IGF-1 secretion from both PTC and CF did not change in the presence of
conditioned media, indicating mechanisms additional to that of the IGF-1
axis are involved. The results suggest the presence of paracrine growth-
regulatory interactions between PTC and CF in the normal human kidney.
Elucidating the signals in this simple in vitro model may provide insight
into the pathogenesis of disordered PTC growth and tubulointerstitial
fibrosis in human renal disease states.
Acute on chronic volume expansion natriuresis and the role of ANP. N.
Salipan-Moore, S. Mildenberger, N. Willis, S. Reddy, and AZ. GyO,y, Depts
of Medicine University of Sydney and Renal Medicine Royal North Shore
Hospital and St Leonards 2065, and RPAH Camperdown, NSW, Australia.
Previous experiments have shown that during acute volume expansion
(AcVE), infusion of atrial natriuretic peptide (ANP) causes a synergistic
increase in Na excretion. In 32 rats we have now studied the characteristics
of the natriuresis of AcVE when superadded onto a chronic salt loaded
and volume expanded rat model (ChVE). Rats on the high salt (HS) diet
had significantly higher Na excretion in the control period (P = 0.0031),
but the response to AcVE was equal (compare "3-i", P = 0.1322). The
response to ANP was not different in the two groups (P = 0.0842), nor was
the combined effect of ANP and AcVE (total final natriuresis) different in
the two groups (P = 0.1228). However, the response to ANP in the
presence of AcVE showed synergism but only in the NS group ("2-1" vs.
"4-3", P = 0.0442, HS P = 0.6403). In conscious rats arterial ANP was
significantly lower in the HS than in the NS rats (P = 0.0011), but during
superadded AcVE the effect of HS disappeared (P = 0.0650), although
AcVE itself caused an increase in ANP (P = 0.0010) to comparable levels.
In conclusion, (1) ChVE did not alter the natriuretic response to AcVE or
to ANP separately. (2) ChVE abolished the synergistic interaction be-
tween AcVE and ANP present in the NS rats. (3) ChVE reduced baseline
levels of ANP. (4) ANP levels increased equally to AcVE in both groups.
(5) Therefore, ANP seems to be of more importance in the natriuretic
response to acute VE than to ChVE.
The isolated kidney function of DOCA-salt hypertensive rats. CR.
Dallemagne, L. Brown, Z.H. Endre, and S. -Y Oor, School of Life Science,
Queensland University of Technology, Brisbane, and Department of Physiol-
ogy and Pharmacology, and Medicine, The University of Queensland, St
Lucia, Queensland, Australia. The objectives were to investigate the extent
of and contributing factors to renal impairment in the hypertrophied
kidneys from DOCA-salt hypertensive rats. Rats 8—10 weeks of age were
uninephrectomized under ketamine-zylazine anaesthesia. They were di-
vided into four groups: uninephrectomized only (UNX, N = 6); UNX rats
with 1% sodium chloride in drinking water (UNX-Na, N = 4); UNX rats
treated with deoxycorticosterone with 1% NaCI in their drinking water
(DOCA-salt, N = 6), DOCA-salt rats given 1% CaCl2 in the drinking
water (DOCA-Ca, N = 5). After four weeks rats were anesthetized with
Nembutal (78 mg/kg). The right renal artery was cannulated via the
superior mesenteric and the kidney suspended over a reservoir of recir-
culating modified Krebs-Henseleit solution with 6% albumin. Urine and
perfusate were collected and glomerular filtration rate (GFR) measured
by 14C-inulin clearance, renal blood flow (RBF) by in-flow ultrasonic
transducer, sodium, potassium and chloride concentrations by ion-selec-
tive electrode analyser. Renal hypertrophy was present in all four groups.
CaC12 treatment attenuated the systolic blood pressure increase (DOCA-
salt 180 10, DOCA-Ca 146 5 mm Hg). Between 90 and 135 mm Hg
kidneys from UNX and UNX-Na had similar function (both uncorrected
and corrected for kidney weight, kw) whereas kidneys from DOCA-salt
and DOCA-Ca rats had lower GFR, urine flow rate (UV), renal blood
flow, filtration fraction (FF), Na excretion (U,,aV) and fractional Na
excretion (FENa) and higher renal vascular resistance (RVR). Corrected
values at 90 mm Hg perfusion pressure were, in the order UNX, UNX-Na,
DOCA-salt, DOCA-Ca (*P < .05 vs. UNX): kidney weight (mg/g body
wt), 4.82 0.14, 5.79 0.21, 8.79 0.51 (*), 9.4 0.49 (*); UV (pJ/min/g
kw): 77 34, 125 12, 9.3 3.4 (*), 18 12 (*); GFR (.rl/min/g kw)
600 62, 518 56, 128 67 (*), 92 41 (*); RBF (ml/min/g kw) 3
2,28 1.4,25 4(*), 24 4(*); FF1.71 0.23, 1.86 0.18; 0.61 0.38
(*), 0.32 0.10 (*); RVR 2.55 0.13, 3.24 0.18, 3.89 0.57, 4.29 ±
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0.86 (*); U,,,V (mmol/min/g kw) 6910 3395, 9495 2301, 452 78,
968 793; FEN 6.7 2.7, 12 1.9, 1.7 0.4 (*), 5.8 2.6. In conclusion,
there are intrinsic changes in the kidneys from DOCA-salt rats after four
weeks of treatment not due to an increased load from the high salt diet
and not corrected by calcium supplementation. Possible effectors of the
changes are growth factors: kidneys from DOCA-salt rats have increased
insulin-like growth factor-I immunostaining in proximal tubules at day 14
(N = 3).
Comparison of the effects of ouabain and brain natriuretic peptide in
saline-loaded sheep. GB. Pidgeon, A.M. Richards, MG. Nicholls, L.K
Lewis, TG. Yandle, M Rademaker, C.i Charles, R.R. Bailey and K.L. Lynn,
Departments of Nephrology and Medicine, Christchurch Hospital,
Chnstchurch, New Zealand. It has been claimed that ouabain is an
endogenous hormone that may be pivotal in the pathogenesis of some
forms of hypertension and may exaggerate natriuresis in situations char-
acterized by volume overload. Brain natriuretic peptide (BNP) is a
natriuretic peptide of cardiac origin which circulates at increased plasma
concentrations in conditions characterized by pressure and/or volume
overload including hypertension and heart failure. We compared the
hemodynamic, renal and endocrine effects of ouabain with those of (BNP)
in nine saline-loaded sheep in a balanced, randomised, single-blind,
placebo-controlled, crossover study. BNP infusion reduced mean arterial
pressure, whereas neither ouabain nor placebo infusions affected blood
pressure. Hematocrit rose steadily during BNP infusion but fell during
placebo and ouabain infusions. Neither ouabain nor BNP affected urine
volume, sodium, potassium or creatinine excretion. Mean heart rate
declined during the ouabain and placebo infusions, more so during
ouabain, but was not altered during BNP infusion. Endogenous ouabain
concentrations were not detectable at baseline or during BNP or placebo
infusions, but rose to concentrations of 11 1.3 nmol/Iiter during the
ouabain infusion. Plasma renin activity, atrial natriuretic peptide, angio-
tensin II and aldosterone concentrations did not differ from matched
control values. These studies suggest that ouabain is not an endogenous
hormone present at physiologically relevant concentrations. It does not
cause natriuresis during saline-loading in sheep and is therefore unlikely
to be responsible for the exaggerated natriuresis seen in some forms of
hypertension.
Large, rapid increases in bone mineraJ density after paratbyroidectomy
occur and are predominantly at the axial skeleton. MS. Stein, D.K
Packham, P.R. Ebeling, iD. Work and G.J. Becker, Departments of Medicine
and Nephrology, The Royal Melbourne Hospital, Parkville, Victoria, Austra-
lia. We report longitudinal data of changes in bone mineral density
(BMD) post-parathyroidectomy in 12 consecutive patients (9 women and
3 men) treated after May 1994. Their median (range) age, height and
weight were: 62 years (33—72), 163 cm (148—170) and 72 kg (52—96) for the
women and 49 years (32—60), 159 cm (155—173) and 63 kg (32—60) for the
men. Seven received hemodialysis and 2 peritoneal dialysis, 2 had chronic
renal failure, and 1 patient was newly transplanted. Median duration of
renal replacement therapy was 15 months. One had had a previous
parathyroidectomy. Median preoperative PTH, calcium, albumin, phos-
phate, and alkaline phosphatase were 74 pmol/liter, 2.51 mmol/liter, 37
glliter, 1.65 mmol/liter and 233 lU/liter, respectively. BMD was measured
in g/cm2 by dual energy x-ray absorptiometry using Hologic QDR1000W
and QDR2000 plus scanners with in vitro coefficients of variation at the
lumbar spine (LS) of 0.37% and 0.6% and at the femoral neck (FN) of
2.1% and 2.2%, for each machine, respectively. BMD was recorded at
baseline which was a median (range) 2 weeks (—26 to + 1) preop and at a
median of 7 weeks (4 to 12) and 6 complete calendar months (5 to 8)
postop. Each patient was always measured on the same scanner. BMD was
expressed as g/cm2 and as Z-scores. Median change (baseline to first
postop measurement) in absolute (and %) BMD, at the LS, FN and
ultradistal radius (UD) (N = 12) was: 0.04 (3.6%), P = 0.04; 0.03 (4.5%),P = 0.006; and 0.001 (0.3%), P = NS, respectively. Median change
(baseline to second postop measurement) in absolute (and %) BMD, at
the LS, FN and (UD) (N = 9) was: 0.098 (9.1%), P = 0.004; 0.067 (9.4%),P = 0.0.004; and 0.010 (3.1%), P = NS; respectively. The % change in
BMD at UD (baseline to first postop measure) ranged from —6.0% to
4.3% raising the possibility that in some patients a redistribution of bone
mineral content occurred. We conclude that changes in BMD after
parathyroidectomy may be large and rapid and increases are predomi-
nantly restricted to the axial skeleton.
Effect of calcitriol on tubular reabsorption of calcium in moderate CRF.
P. TH. Coates and M. Cochran, Flinders Medical Centre, Bedfbrd Park, SA,
Australia. We administered calcitriol 0.5 Lg daily to twenty patients with
stable moderate CRF who were not taking diuretics and measured
calcium-related variables, obtained after an overnight fast, before and
after 7 days' supplementation. Calcium excretion (CaE) relative to GFR
was calculated using creatinine as the marker and related to calculated
ultrafiltrable calcium (UFCa).
Results before calcitriol P
Plasma UFCa v —CaE <0.05
Plasma UFCa v —PTH <0.05
Plasma UFCa v +Calcitriol —0.05
CaE v +PTH <0.05
Calcitriol v + Ca/Cr —0.05
PTH v Calcitriol Not related
After calcitriol, these relationships lost their significance, and UFCa
tended to be positively related to CaE (P — 0.05). In 15 subjects, CaE fell
following calcitriol, but UFCa increased, denoting greater tubular reab-
sorption. Therefore, in these cases a tubular leak had been contributing to
the hypocalcemia and was corrected by calcitriol. Among those cases
where CaE increased, there was a non-significant tendency to higher
absolute urinary calcium excretion (Ca/Cr) and higher plasma calcium
levels, suggesting an initially more normal physiological state though the
degree of CRF was not different. Thus, a reduced tubular reabsorption of
calcium commonly contributes to the hypocalcemic tendency in CRF, is
not controlled by PTH, but is reversible with calcitriol.
Immunolocalization of fibroblast growth factor-i and -2 in the embry-
onic rat kidney. B. Cancilla, J. Cauchi, B. Key, V. Nurcombe, D. Alconi, and
J.F. Bertram, Department of Anatomy and Cell Biology, University of
Melbourne, Parkville, Victoria, Australia. Fibroblast growth factors (FGF5)
regulate cell proliferation, migration, differentiation and angiogenesis
during morphogenesis in many tissues. The aim of the present investiga-
tion was to determine the in vivo distribution of FGF-1 and FGF-2 in
developing rat metanephroi at embryonic days 14, 15, 16, 18 and 20.
Avidin-biotin enhanced indirect immunohistochemistry demonstrated
that FGF-1 and FGF-2 were co-localized in metanephroi at all ages
studied. Strong immunostaining for FGF-1 and FGF-2 was observed in
ureteric bud branches and in developing distal tubules. FGF-1 and FGF-2
were also present in developing nephron elements, from vesicles to
S-shaped bodies, and in the mesangium of capillary loop and maturing
stage glomeruli. Both growth factors were present in the mesenchyme of
the nephrogenic zone and in the interstitium of the developing cortex.
However, immunostaining for the FGFs was not observed in mesenchymal
condensates, endothelial cells, medullary interstitial cells, or in the thin
undifferentiated epithelium of the immature loop of Henle. These findings
indicate that the expression of both FGF-1 and FGF-2 is regulated in the
embryonic kidney, suggesting a role for these molecules in kidney
development.
Expression of FGF-i and FGF-2 and their high affinity receptors in
glomeruli. J. Cauchi, M.D. Ford, and J. F. Bertram, Department of Anatomy
and Cell Biology, University of Melbourne, Parkville, Victoria, Australia.
Fibroblast growth factors (FGFs) regulate cell proliferation and differen-
tiation, and are also important regulators of extracellular matrix and
wound repair. They are among the most potent angiogenic factors known.
As such, the FGFs are thought to be involved in the maintenance of
normal renal structure and function and have been implicated in the
pathogenesis of renal disease. The aim of the present study was to
determine whether FGF-1 (acidic FGF) and FGF-2 (basic FGF) and their
high affinity receptors (FGFRs) were expressed in normal adult rat
glomcruli. The kidneys of 200 g female Sprague-Dawley rats were
perfused with buffer and glomeruli isolated using conventional sieving
techniques followed by micropipetting. Expression of the two FGFs and
six FGFR isoforms were determined within samples of whole cortex, ten
glomeruli and single glomeruli using reverse transcriptase-polymerase
chain reaction. We found mRNA for both FGF-1 and FGF-2 in cortex as
well as in glomeruli. All six FGFR isoforms assayed (FGFR1 Tub and Tile,
FGFR2 Tub and Tile, FGFR3 Tile and FGFR4) were expressed in whole
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cortex. However, only three of the FGFR isoforms were expressed in
glomeruli, these being FGFR1 lIIc, FGFR2 lIIb and FGFR4. No mRNA
was detected in glomeruli for FGFR1 11th, FGFR2 111c or FGFR3. These
results indicate that glomeruli express several high affinity receptors for
FGF-1 and FGF-2. The differential expression pattern of FGFR isoforms
between glomeruli and cortex has important implications for the roles of
the FGFs in the normal kidney, and suggests that the FGFs may have
different effects in different regions of the kidney. Moreover, perturbation
of glomerular FGFR isoform expression may alter the binding of specific
FGFs to glomerular cells and thereby mediate pathogenic changes.
Perindopril is more effective than enalapril in experimental diabetic
nephropathy. K.A. Duggan, G. Hodge, M.M. Makarious, and J.A. Charles-
worth, Hypertension Service, The Liveipool Hospital and Renal Unit, Prince
1-Jenty Hospital, Sydney, Australia. Treatment with ACE inhibitors amelio-
rates human and experimental diabetic nephropathy, possibly due to
changes in angiotensin 11 (Ang II) and/or bradykinin concentrations.
However, ACE hydrolyzes numerous vasoactive peptides at two catalytic
sites that are thought to be substrate specific. Ang I is cleaved at the
C-terminal site, bradykinin at both the C and N-terminal sites, while other
substrates (eg, LHRH, CCK-8) are preferentially cleaved at the N-
terminal site. Some ACE inhibitors (eg, perindopril) bind preferentially to
the C-terminal site while others (eg, enalapril) bind to both. The efficacy
of perindopril and enalapril were compared in the diabetic SHR to
determine whether all of the benefits of ACE inhibition derive from
changes in the concentrations of C-terminal related substrates and/or
products or alternately whether N-terminal substrates and/or products
might also be involved. Diabetes was induced by injection of streptozoto-
cm 60 mg/kg in 14-week-old SHR. Blood glucose was maintained at 4—8
m by daily ultralente insulin. The rats were randomized to Control (C),
enalapril (E; 10 mg/kg/day) or perindopril (P; 4 mg/kg/day). Blood
pressure in both treatment groups was lower than control (C) (P vs. C P <
0.0001, E vs. BC P < 0.0001). Levels were marginally higher in the
perindopril than the enalapril group. This difference was significant only in
the second month (P < 0.025). Creatinine clearance was lower in the
perindopril group (0.44 0.05 mI/mm) than either control (0.85 0.11
mI/mm, P < 0.005) or enalaprit (0.66 0.05 mI/mm, P < 0.005) groups.
Proteinuria was also lower in this group (4.25 0.85 mg/24 hr) than
enalapril (15.30 5.77 rng/24 hr, P < 0.05) or control (32.13 4.51 mg/24
hr, P < 0.0001) groups. Plasma ACE activity was less in perindopril
(36.4 2.8 nmol/min) than enalapril (47.0 3.5, P < 0.025) and control
(53.0 2.2, P < 0.0005) groups. The difference in efficacy between
perindopril and enalapril we observed suggests that the benefits of ACE
inhibition derive from changes in the concentrations of peptides catalyzed
by the C-terminal rather than the N-terminal site.
Intravenous sodium loading is associated with changes in both the
synthesis and metabolism of angiotensin II. V.Z.C. Ye and KA. Duggan,
Hypertension Service, The Liverpool Hospital, Sydney, Australia. The admin-
istration of an acute sodium load intravenously results in increased urinary
sodium excretion as well as a rapid decrease in the plasma concentration
of angiotensin II (Ang II). This reduction in the concentration of Ang II
could occur as a result of a decrease in its rate of synthesis either from
changes in plasma renin concentration or changes in serum angiotensin
converting enzyme (ACE) activity. Alternately, it may result from an
increase in the rate at which Ang II is metabolized. In these studies we
investigated the effect of administration of an intravenous sodium load of
1.5 mmol/kg as 3 N saline on the plasma renin concentration and the
serum ACE activity. In a separate series of studies we measured the
steady-state metabolic clearance rate of Ang II before and after adminis-
tration of a sodium load as above. All studies were performed in male New
White Rabbits which had been maintained on a low sodium diet for 7 days
prior to study. Serum ACE activity decreased from 82.1 5.0 nmol/min
before the sodium load to 68.8 6.9 nmol/min at 60 minutes (P < 0.025)
after sodium administration. The steady-state metabolic clearance rate of
Ang II increased from 42.2 9.0 mI/kg/mm to 191.3 1.7 mI/kg/mm (P <
0.05) in response to administration of the sodium load. Plasma renin
concentration did not change significantly. We conclude that an increase
in Ang II metabolism and a decrease in its rate of synthesis by ACE both
contribute to the decrease in the plasma concentration of Ang 11 that
occurs with sodium loading.
Correlation of renal ['2511-amylin binding and blood pressure in a rat
model of renal ablation and hypertension. Z. Gao, ME. Cooper, P.1
Wookey, Department of Medicine, Austin and Repatriation Medical Centre,
Repatriation Campus, Heidelberg West, Victoria, Australia. The aim of this
study was to explore the underlying changes in cellular binding sites that
might explain the relationship between the increase in the density of
amylin binding in the rat renal cortex and systolic blood pressure (SBP) in
a rat model of renal ablation and hypertension. Male Sprague-Dawley rats
(8 weeks old) were anesthetized and subtotal nephrectomy performed
(5/6th Nx model). In the sham controls only a midline incision was made
before suturing. SBP was monitored by tail cuff plethysmography. Two
weeks later, either the kidneys were prepared for in vitro autoradiography
to study the binding in the renal cortex of ['251]-amylin and the amylin
antagonist, [1251j-AC512, or the animals were anesthetized for infusion of
['251]-amylmn in an in vivo model. This latter preparation allowed the
cellular localization of the ['251]-amylin binding sites to be explored and
correlated with SBP. Two groups of animals could he defined, which we
referred to as hypertensives (SBP > 170 mm Hg, mean = 189 6, N =
5) and normotensives (SBP < 150 mm Hg, mean = 132 4, N = 5); the
latter group had a similar mean SBP to the sham-operated group (126
4mm Hg, N = 5). On the one hand, there was a significant correlation (r =
0.67, P = 0.04, N = 10) between the density of L'2511-amylmn binding and
SBP, hut on the other, the density of [125l]-AC512 binding was indepen-
dent of SBP. Novel binding sites for ['2511-amylin were found associated
with interstitial fibroblasts in the hypertensives.
Effect of propionyl L-carnitine on skeletal muscle metabolism in
chronic renal failure. C.H. Thompson, A.B. Irish, G.J. Kemp, D.1 Taylor,
and G.K Radda, MRC NMR Unit, Oxford Radcliffe Hospital, Oxford,
England, United Kingdom. Carnitine deficiency has been implicated in the
myopathy of patients with ehronic renal failure (CRF) resulting in
defective mitochondrial oxidation of fatty acids. Using 31P magnetic
resonance spectroscopy and near infra-red spectroscopy, we examined calf
muscle metabolism in 10 patients with CRF (5 haemodialysis, 5 continu-
ous ambulatory peritoneal dialysis) before and after 8 weeks of propionyl
L-earnitine (PLC) (2g p.o. daily). Prior to PLC treatment, resting phos-
phocreatine/ATP was significantly elevated (4.41 0.20 (SEM) cf 4.00
0.06 in control subjects; p < 0.05) but normalised on PLC (3.98 0.14;
p < 0.05 cf pre-treatment). Thus, in resting muscle, where fatty acid
oxidation provides the small amount of ATP necessary for cell function,
PLC supplementation normalised metabolism. In Contrast, there was no
effect of PLC on mixed aerobic and anaerobic metabolism of muscle
during or following an incremental exercise protocol until fatigue (<10
mm). The maximal calculated oxidative capacity remained low: 28 3
mM/mm before PLC and 24 3 mM/mm after PLC (normal was 49 3
mM/mm; p < 0.05 cf either pre- or post-PLC value). The maximal
calculated oxidative Capacity of the skeletal muscle did not correlate with
[Hbj prior to PLC but a significant positive correlation existed after PLC
(p < 0.03). Moreover, the half-time of phosphocreatine recovery (another
index of oxidative capacity) significantly improved in those patients (n =
6) with [Hbl > 10 g/dl (0.93 0.1 mm to 0.74 0.08 mm) although, even
after PLC, it was still significantly lower than normal (0.49 0.04 mm).
Thus, following brief exercise (2—10 mm), PLC administration did not
alter muscle oxidative metabolism. Oxygen delivery appeared to be rate
limiting to oxidative metabolism in CRF but only in PLC-treated subjects.
PLC administration may be of benefit to exercising skeletal muscle
metabolism in CRF if [Hh] is over 10 g/dl. Oxidative metabolism did not
normalise on PLC suggesting that anaemia and carnitine deficiency are
not the only causes of mitochondrial dysfunction in CRF.
Elevated plasma total renin precedes microalbuminuria and diabetic
nephropathy in IDDM. T.1 Allen, M. Cooper, I Winikoff A. Akdeniz, S.
Skinner, G. Jerums, Endocrine Unit, Austin & Repatriation Medical Centre,
Heidelberg, Victoria, Australia. Plasma prorenin is increased in patients
with insulin-dependent diabetes mellitus (IDDM) with microvascular
complications. There are no previous longitudinal studies to establish
whether increases in plasma total renin can predict the development of
microalbuminuria or retinopathy in IDDM patients over a 10 year period.
Plasma total renin concentration (TRC) and albumin excretion rates
(AER) were determined in 78 JDDM patients who were followed
longitudinally for 10.4 0.2 (mean SE) years. Patients were classified as
progressors if at least 2 out of 3 consecutive measurements of AER were
greater than 20 rg/min (microalbuminuria) and there was a significant
positive regression of log transformed AER versus time. This yielded 12
progressors and 66 non-progressors. The two groups had similar duration
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of diabetes, age, follow-up, glycemic control and blood pressure at the
start of the study. Plasma TRC was assayed using a sensitive, direct
two-site immuno-radiometric assay (IRMA) with epitope specific mono-
clonal antibodies. A normal level of 149 (131—170) mIU/liter (geometric
mean and 95% confidence levels) was derived from 29 healthy, non-
diabetic subjects. The interassay CV was 6.7% and the detection limit was
20 mIU/liter. Inactive prorenin comprises approximately 90% of TRC.
Plasma TRC was increased in progressors [350 (1.1)1 mlU/liter, geometric
mean (tolerance factor)1 compared to non-progressors [189 (1.2)1 after 5
to 10 years duration of diabetes, and continued to rise in this group,
reaching a mean of 923 mIU/liter after 20 years of diabetes. When serial
measurements of TRC and AER were compared in individual progres-
sors, a significant increase in TRC was apparent up to 5 years before the
onset of microalbuminuria. As a predictor of persistent microalbuminuria,
the sensitivity of a plasma TRC level of 270 mIU/liter in a larger cohort of
123 patients was 87%. Microalbuminuria in patients with IDDM is
preceded by a substantial increase in plasma TRC, suggesting that plasma
TRC may be an excellent predictor of the subsequent development of
diabetic microvascular disease.
Nitric oxide synthesis inhibition and renal vascular reactivity in
pregnant and nonpregnant Wistar-Kyoto rats. Z.M. Chu, L.J. Beilin,
Department of Medicine & West Australian Heart Research Institute, Royal
Perth Hospita4 Australia. Both nitric oxide (NO)-dcpendent and -indepen-
dent mechanisms were involved in the blunted vasoconstrictor responses
in the blood perfused mesentery of 18 to 20 day pregnant rats. In the
present study, we have investigated whether NO modulates renal vascular
reactivity and plays a role in pregnancy-related renal vasodilation with the
used of an in situ blood perfused renal preparation in Wistar-Kyoto rats
(WKY). Eighteen to 20 day pregnant and age-matched nonpregnant rats
were used. Animals were anesthetized with a-chloralose (150 mg/kg, s.c.).
Blood was pumped from left carotid to right renal arteries at a constant
flow rate (2 mI/mm). Noradrenaline (NA) and angiotensin II (Ang II)
were given by bolus injection locally into the renal circulation. Change in
perfusion pressure indicated alteration in vascular resistance in this
constant flow perfusion system. Basal renal perfusion pressure was slightly
decreased in pregnant rats. Vasoconstrictor responses to Ang II were
reduced (P < 0.05) in the pregnant group but responses to NA were
unchanged. NO inhibition by nitro-L-arginine (L-NOARG) (5 mg/kg, iv.)
or nitro-L-arginine methyl ester (L-NAME) (100 mg/kg, iv.) increased
basal renal perfusion pressure and renal vasoconstrictor responses to NA
and Ang II, but the increase in basal renal perfusion pressure was
significantly less in pregnant rats (P < 0.05) and renal Ang II responses
were still decreased (P < 0.05) in pregnant compared with nonpregnant
animals after NO synthesis inhibition. We conclude that endogenous NO
plays an important role in modulating renal vascular tone in both pregnant
and nonpregnant animals. However, the reduced renal vasoconstrictor
responses to Ang II in pregnant WKY appear to be independent of NO.
Preserved expression of 11j3-hydroxysteroid dehydrogenase type II in
biopsies from patients with renal disease. A.N Stein-Oakley, J.A. Maguire,
J. Dowling, Z. Krosowski, and NM. Thomson, Department of Medicine,
Monash Medical Schoo4 Baker Institute and Department of Anatomical
Pathology, Alfred Hospita4 Prahran, Victoria, Australia. The enzyme 11/3
hydroxysteroid dehydrogenase type II (11/3HSD2) unidirectionally con-
verts glucocorticoids to their receptor-inactive I 1-keto metabolites. There
is considerable evidence which suggests that this is an obligatory step in
the kidney, permitting binding of aldosterone to the non-selective miner-
alocorticoid receptor. Deficiencies in 1If3HSD2 result in excess cortisol
binding to the mineralocorticoid receptor, causing salt and water reten-
tion, hypokalemia, hypertension and suppression of the renin-angiotensin
system. Recent studies have suggested that 1 1J3HSD deficiency may be
implicated in essential hypertension. Using an antibody, HUH23, raised
against a peptide deduced from the eDNA sequence, we have recently
described the expression of 11 /3HSD2 in normal human kidney. 1 1/3HSD2
was strongly expressed on the distal convoluted tubule (DCT), cortical and
medullary collecting duct (CD), and variably on the thick ascending loop
of Henle (TAL) and in the visceral epithelial cells of the outer capillary
loops of the glomerulus. In this study we have used the HUH23 antibody
to examine the expression of 1 1/3HSD2 in renal biopsies from patients
with renal disease secondary to hypertension, and patients with primary
renal disease, with or without hypertension. Despite variable degrees of
tubulointerstitial damage, strong expression of 1 1f3HSD2 was observed in
DCT and CD in all patient groups, in preserved as well as in collapsed or
dilated tubules. The expression on TAL was generally low or absent,
although the integrity of the TAL was confirmed by staining with an
antibody directed to Tamm-Horsfall protein. The glomerular expression
of 11/3HSD2 was variable, but it did not appear to be associated with a
particular patient group. Our results therefore suggest that lack of renal
11/3HSD2 is not a prominent feature of essential hypertension, or
hypertension secondary to primary renal disease.
Increased circulating lipid peroxidation products in pre-eclampsia. A.
Borden, L.J. Beilin, K.D. Croft, J. Ritchie, B.N. Walters, and CA. Michael,
University Depts of Medicine & Obstetrics & Gynaecology & Heart Research
Institute, Perth, Australia. Endothelial dysfunction occurs in pre-eclampsia
but the primary insult remains unknown. Free radical-mediated lipid
peroxidation can potentially affect endothelial function, however, the
methodology to assess it has to date has been non-specific. Recently, a
series of bioactivc prostaglandin F2-like compounds (iso-prostanes) have
been discovered. Iso-prostanes are renal vasoconstrictors that affect
platelet function and are produced independently of the cyclooxygenase
enzyme by the peroxidation of arachidonic acid, catalyzed by free radicals.
The aim of this study was to examine plasma free and total (free and
phospholipid bound) 8-iso-prostane, and urinary 8-iso-prostane as indices
of lipid peroxidation, in 21 women with pre-eclampsia and 19 normal
pregnant women. The women were seen before delivery and at 6 weeks
post-partum when blood pressure was measured, blood collected for
routine biochemistry and hematology, and a 24 hr urine collected for
urinary protein levels. Plasma and urinary 8-iso-prostane were measured
by EIA after extraction. Plasma free 8-iso-prostane was elevated in the
pre-eclamptic women before delivery, 72.2 16 compared to 33.5 7.2
pglml in normal pregnancy (P < 0.05). Total plasma 8-iso-prostane was
not different in the two groups. Urinary excretion of 8-iso-prostane was
lower in the pre-eclamptic group 1011 130 compared to 1691 130
ng/24 hr in normal pregnancy (P < 0.01). Six weeks after delivery, the
groups were not different with respect to plasma or urinary 8-iso-prostane.
This study shows that plasma free 8-iso-prostane is elevated in pre-
eclampsia; this may be due to increased release by phospholipase A2
and/or due to decreased renal clearance by the kidney. Increased levels of
free 8-iso-prostane may contribute to endothelial dysfunction and vaso-
constriction in pre-eclampsia.
Expression of transforming growth factor-fl! and ALK-5 in the devel-
oping rat metanephros. A. T Clark, M. Ford, V Nurcombe, and iF.
Bertram, Department of Anatomy and Cell Biology, University of Melbourne,
Parkville, Victoria, Australia. Transforming growth factor-/31 (TGF-/31) has
been implicated in a number of developmental events, including embry-
onic pattern formation, conversion of mesenchyme to epithelium, changes
in extracellular matrix, tubulogenesis, cellular proliferation and differen-
tiation. TGF-/31 signal transduction is mediated by type I and type II
receptors. Only one functional type I receptor (activin-like receptor
kinase-5, ALK-5) has been described. Signal transduction occurs when
TGF-/31 is presented to ALK-5 at the cell surface by a membrane bound
TGF-J3 type II receptor. We recently described the distribution of TGF-/3
type II receptor mRNA in the developing rat metanephros. The present
study sought to localize TGF-)31 mRNA in the developing rat metane-
phros using in situ hybridization and to assess the expression of ALK-5
mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
Metanephroi for in situ hybridization were removed at embryonic days 15
(E15) to E20. Intense TGF-f31 expression was observed in the nephro-
genie zone mesoderm as reported by others, but in addition, TGF-131
mRNA was found in branching ureteric duct epithelium and the mesen-
chyme surrounding vesicles, comma-shaped bodies and S-shaped bodies.
Expression was also observed within these vesicles, comma-shaped bodies
and S-shaped bodies. Some glomeruli contained TGF-f31 mRNA in the
mesangial region, however, the majority of glomeruli did not contain
detectable levels of TGF-f31 mRNA. Expression was not observed in
proximal tubules, collecting ducts or the interstitial cells of the developing
medulla. RT-PCR demonstrated that ALK-5 is expressed in metanephroi
from E18 to E21, but not at E15. These results, considered together with
our earlier findings, demonstrate that all the components required for
TGF-131 signal transduction are transcribed during development of the
metanephros.
Inhibition of tissue factor (TF) reduces renal injury and glomerular
fibrin deposition in crescentic glomerulonephritis (GN). J. Erlich, P.
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Tipping, and S. Holdsworth, Centre for Inflammatoiy Diseases, Department
of Medicine, Monash University, Clayton, Victoria, Australia. Glomerular
fibrin deposition is a important mediator of renal failure in crescentic
glomerulonephritis (GN). Increased expression of glomerular tissue factor
(TF) activity and protein are prominent features of human and experi-
mental crescentic GN. Increased glomerular TF activity is likely to be the
major determinant of the net glomerular procoagulant activity. The role of
TF in the development of glomerular fibrin deposition, renal injury and
renal failure in of crescentic GN was investigated by in vivo inhibition
using a polyclonal anti-rabbit TF antibody. GN was initiated in presensi-
tized NZ white rabbits by an i.v. injection of a subnephritogenic dose (25
mg/kg) of horse anti-rabbit glomerular basement membrane globulin.
Rabbits were treated with 100 mg/kg sheep anti-rabbit TF globulin or
normal sheep globulin (control) 30 minutes prior to induction of GN.
Rabbits received two further doses of anti-TF or NSG and renal injury was
assessed 72 hours after initiation of disease. Rabbits receiving anti-TF
globulin had a 95% reduction in glomerular TF activity (P < 0.0039) with
no change in glomerular macrophage infiltration. Plasma fibrinogen was
higher in rabbits receiving anti-TF globulin 3.16 mglml vs. 2.37 mg/ml (P <
0.025). The coagulation profile did not differ between the two groups.
Glomerular fibrin deposition (GFD) (scored 0 to 3+ by immunofluores-
cence in a blinded protocol) (anti-CD5 treated 0.79 vs. control 1.5; P <
0.0 18) and proteinuria (anti-CD5 treated 1275 277 mg/24 hrs vs. control
2249 336; P < 0.037) were both significantly reduced in the anti-TF
treated animals. Glomerular macrophage infiltration assessed by esterase
staining demonstrated no difference between anti-TF treated and controls.
Rabbits receiving anti-TF globulin had a trend to higher creatinine
clearance than controls, but the increase did not reach statistical signifi-
cance. This study demonstrates, using a polyclonal anti-TF antibody, that
it was possible to produce 95% inhibition of glomerular TF activity with a
significant reduction of glomerular fibrin deposition, but without reduc-
tion of glomerular macrophage accumulation. The relatively modest
reduction in GFD suggests that a greater than 95% inhibition of TF
activity will be required to block GFD. The reduction in proteinuria in the
rabbits receiving anti-TF globulin suggests a role for TF as an important
mediator of renal injury either via the generation of thrombin and
fibrinogen or by some as yet undefined signalling mechanism.
Basic fibroblast growth factor in puromycin aminonucleoside-induced
nephrosis. A. Tzanidis and N.M. Thomson, Department of Medicine,
Monash University Medical Schoo4 Alfred Hospital, Melbourne, Australia.
Chronic renal injury is characterized by progressive pathological changes
within glomeruli and the tubulointerstitium, associated with an accumu-
lation of extracellular matrix proteins. These changes are consistent with
the involvement of fibrogenic growth factors. This study investigates the
expression of basic fibroblast growth factor (bFGF) in an experimental
model of puromycin aminonucleoside (PAN)-induced chronic renal dam-
age. Disease was induced in male Sprague-Dawley rats using 2 i.v. doses of
PAN after uninephrectomy, controls receiving sham laparotomy and
vehicle. Animals were killed at regular intervals over a 12 week period.
The tissue expression of bFGF protein was determined by immunohisto-
chemistry on snap-frozen tissue sections. bFGF messenger RNA was
measured by semiquantitative RT-PCR and results expressed as the ratio
of bFGF to GAPDH gene products. PAN animals demonstrated glomer-
ular hypertrophy, glomerulosclerosis, tubular dilation and interstitial
fibrosis from week 6, which gradually increased in severity by week 12. In
shams, bFGF protein was detected in discrete cells within glomeruli. In
the interstitium, vascular expression was noted with some outer medullary
vessels showing nuclear bFGF staining. Strong bFGF expression was also
demonstrated on intertubular cells within the inner medulla. By week 6,
PAN animals demonstrated a marked increase in diffuse glomerular bFGF
staining within the mesangium and de nova expression within glomerular
parietal epithelial cells. There was a generalized increase in interstitial
cellular bFGF throughout the cortex and medulla, in areas of tubular
dilation and fibrosis. These changes were more prominent by week 12.
bFGF protein was also colocalized with a-smooth muscle actin expression,
indicative of fibroblast/myofibroblast involvement. In contrast to the
increase in bFGF protein expression seen in this model, semiquantitative
RT-PCR demonstrated no significant difference in bFGF mRNA levels
from whole kidney in PAN animals compared to sham controls at weeks
6 and 12 (week 12, PAN 0.32 0.03, sham 0.36 0.03). The inconsistancy
of these findings may be due to the dilution effect of using whole kidney
RNA samples, given the relatively high constitutive expression of this
growth factor in normal and sham animals. Further studies utilizing
isolated glomerular and tubulointerstitial RNA samples may demonstrate
increased bFGF mRNA levels in this model. Alternatively, the increase in
bFGF protein in the absence of increased mRNA may be the result of
intracellularly stored bFGF being released upon sublethal injury, as bFGF
lacks the signal for a classical secretory pathway.
Glomerular capillary growth in rats administered puromycin amino-
nucleoside. M.M. Cahill and J.F. Bertram, Department of Anatomy and Cell
Biology, University of Melbourne, Parkville, Victoria, Australia. Recent
evidence suggests that glomerular hypertrophy is a key event in the
development of focal and segmental glomerulosclerosis (FSGS). We have
previously shown that glomerular hypertrophy precedes FSGS in rats
administered multiple doses of puromycin aminonucleoside (PAN). This
glomerular hypertrophy involved a 50% increase in the total length of
capillaries per glomerulus. The aim of the present study was to determine
whether this increase in capillary length per glomerulus was due to an
increase in the length of existing capillaries and/or sprouting of new
capillary loops (angiogenesis). Female Sprague-Dawley rats (200g) re-
ceived seven subcutaneous injections of PAN (2 mg/100 g body weight) at
weeks 0, 1, 2, 4, 6, 8 and 10. Kidneys were perfusion-fixed with 4%
paraformaldehyde at weeks 7 and 13 and small cubes of cortex were
embedded in epon-araldite. Adjacent 0.5 m epon-araldite sections
stained with methylene blue were obtained from 10 glomeruli from each
rat. To estimate the number of capillary loops per glomerulus, pairs of
sections were viewed at —1,500x and capillary events were counted.
Values were (mean SD; 5—6 rats per group):
Week 7 Week 13
Wvcap, corpWvcap, corp
x106 pm3 neap x106 Lm ncap
Saline 139 30 133 51 129 38 142 50
PAN 89 27 114 7 98 50 140 40
Data were analyzed using two-way analysis of variance. There were no
significant effects of either PAN or time on the number of capillary loops
per glomerulus (noap). However, there was a significant effect of PAN (P <
0.05) on the number of capillary loops per unit volume of renal corpuscle
(Wvcap. corp). These results suggest that glomerular capillary growth in this
PAN model of FSGS occurs primarily via lengthening of existing capillar-
ies, rather than angiogenesis. In previous reports of glomerular capillary
growth in other models of glomerular injury (unilateral nephrectomy,
lithium treatment, diabetes) capillary growth was shown to be due to
angiogenesis. Glomerular capillaries thus appear to grow via a different
process in this model.
Analysis of the expression of multiple cytokines in individual human
renal biopsies. Q. Hasan, B.M. Ruger, P.F. Davis, N.S. Greenhil4 P.R.
Dunbar, R. Murray-McIntosh, and Ti Neale, Department of Medicine,
Wellington School of Medicine, Wellington South, New Zealand. The
molecular basis of most forms of human glomerulonephritis (GN) is still
poorly understood. Previous studies indicate the involvement of cytokines
in the initiation and progression of many nephropathies. However, studies
of individual cytokines are of limited value, as they are known to interact
in a complex manner. We therefore investigated the expression of a
number of relevant cytokines: basic fibroblast growth factor (bFGF),
interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), isoforms of trans-
forming growth factor-13 (TGF-13) and platelet derived growth factor(PDGF). A strategy to quantitate the expression of these cytokines in
small (-1 mg) human renal biopsy samples was developed. RNA was
isolated from 30 biopsies from patients with GN [8 IgA nephropathy
(IgA), 7 membranous nephropathy (MN), 4 focal glomerular sclerosis
(FGS), 5 diabetic nephropathy (DN), 2 minimal change nephritis (MCN)
and 4 membranoproliferative GN (MPGN)]. Competitive RT-PCR was
performed and a constitutively expressed gene, hypoxanthine-guanine
phosphoribosyltransferase (HPRT) to equalize RNA concentration and
then for the quantitation of cytokines. Although no strong correlation
between gene expression and diagnosis was established, several interesting
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observations were made: mRNA transcripts of bFGF, TGF- (3 iso-
forms), PDGF-A, -B and the receptor (PDGF-R) were seen in most
biopsies including the normal human kidney sample; TGF-f31 and -p3
were reduced in four cases of MN; TGF-133 was elevated in most cases of
DN; IL-6 expression was not universally observed but was present in all
cases of FGS; TNF-a was detected in most MN cases: Immunohistochem-
istry and in situ hybridization demonstrated that TNF-a was synthesized by
glomerular epithelial cells in MN. From this study we conclude that
although differences in cytokine transcript expression are demonstrable,
no distinct patterns characteristic of disease type were observed.
Effects of ramipril and valsartan on progression of renal damage in rat
remnant kidney. L. Wu, R. Gilbert, M. Cooper, and C. Roe, Department of
Medicine, Austin & Repatriation Medical Centre, Victoria, Australia. The
renin-angiotensin system is implicated in the progressive renal injury that
follows subtotal nephrectomy (STNx). Whether this is due to angiotensin
II (Ang It) alone or other vasoactive substances produced by the action of
angiotensin converting enzyme (ACE) is uncertain. The aim of the present
study was to examine the effects of ACE inhibition with ramipril on renal
injury following STNx in comparison with the effect of Ang II receptor
blockade alone (valsartan). Thirty male Sprague-Dawley rats underwent
STNx and received either ramipril (STNxR, 3 mg/liter in drinking water,
N = 10), valsartan (STNxV, 30 mg/kg/day by gavage feeding, N = 10) or
no treatment (STNx, N = 10). Three animals from STNx died of renal
failure during the course of study. The animals were sacrificed at 12 weeks
for functional and histological examination.
Groups BP mmHg Cr mmol/liter Upr mg GS IF %
STNx 185 8 0.12 0.OP' 156 36 0.9 0.1k' 6.3 1.8
STNxR 122 4 0.076 0.03 58 21 0.3 0.1 1.4 0.5
STNxV 135 8 0.078 0.03 65 17 0.3 0.1 1.5 0.6
Data were expressed as mean SEM. P < 0.01 (ANOVA). Abbrevia-
tions are: BP, systolic blood pressure; Cr, plasma creatinine; Upr, 24 hour
urine protein; GS, glomeruloselerosis score; and IF, interstitial fibrosis.
Both ACE inhibition and Ang TI receptor blockade reduce proteinuria
preserve renal function and attenuate both glomerular and tubulointer-
stitial damage in this animal model. We suggest that the predominant
renoprotective action of ACE inhibition is achieved by reduced Ang II
production.
Apoptosis and resolution of experimental tubulointerstitial nephritis.
TD. Hewitson, KG. C. Smith, and G.J. Becker, Department of Nephrology,
Royal Melbourne Hospital and Walter & Eliza Hall Institute, Victoria,
Australia. Resolution of tubulointerstitial nephritis is an important step in
limiting renal fibrogenesis. However, the mechanism of this resolution
remains poorly understood. To determine if apoptosis has a role, we
studied its presence in renal infection and scarring, produced by direct
inoculation of F. coli into the renal cortex of Sprague-Dawley rats.
Animals were sacrificed at day (D) 0, 3, 12, 24 and 100 (N = 5 each
interval). Apoptosis was identified by electron microscopy (EM) and in
situ labelling of fragmented DNA using terminal transferase mediated
UTP nick end labelling (TUNEL). Results were assessed with respect to
tubulointerstitial cellularity and macrophage localization. TUNEL local-
ized apoptosis to interstitial cells, occasional tubular cells and tubular casts
within a focal lesion. The morphological features of apoptosis were
confirmed by EM. Interstitial cellularity was maximum at D3 (1754
435/0.1 mm2 cf. 231 34 DO, P < 0.01), decreasing to 807 ill by Dl00
(P < 0.01). Correspondingly, the proportion of interstitial cells that were
apoptotic increased from 0.17 0.33% DO to 1.61 0.83% D3 (P < 0.05)
and remained significantly higher than DO animals throughout. Cells were
commonly found within intratubular casts at 3, 12 and 24 days but only
rarely at 100 days. Of these cells, up to 52% were apoptotic. Tubular
cellularity was reduced at D3, remaining less than DO controls throughout,
although there was a transient rise in cellularity at D24. Apoptosis was
increased in the tubular epithelium although this did not differ signifi-
cantly from DO. Macrophage phagocytosis of apoptotic bodies was ob-
served. Conclusions: Apoptosis may he an important mechanism in
resolution of infective renal inflammation. Apoptotic cells can be removed
by tubular cast drainage.
Artificial activation of matrix metalloproteinases. C. I. Jones, f.M.
Forbes, R. G. Walker, and G.J. Becker, Departments of Nephrology, The
Royal Children's Hospital and The Royal Melbourne Hospital, Parkville,
Victoria, Australia. Renal extracellular matrix (ECM) accumulation is the
hallmark of progressive renal disease and results from a combination of
excessive ECM formation and decreased degradation. Matrix degradation
primarily occurs through the activation of two enzyme systems: the matrix
metalloproteinases (MMP's) and the plasmin/plasminogen system. Much
of the degradative effect of the latter system is through activation of the
MMP's. The two most abundant MMP's in the kidney are MMP-2 and
MMP-9 (type IV collagenases). The effects of plasmin, trypsin, urokinase,
streptokinase and prostaglandin E1 (PGE1) on the activation of renal
MMP's-2 and 9 were studied in vivo. A unilateral nephrectomy was
performed on Sprague Dawley rats. Then the following drugs were
administered: plasmin 2 U intraarterially; streptokinase 12000 U, 25000 U,
50000 U tail vein; urokinase 10000 U intraarterially, trypsin 0.5 mg
intraarterially, and PGEJ 50—250 jrg subcutaneously. Controls were given
an injection of neutral salt buffer vehicle after nephrectomy. The kidneys
were harvested and homogenized. An aliquot of this suspension was
analyzed by zymography to determine activation of MMP-2 and MMP-9
by the administered agents. Decreasing concentrations of each of the
agents were incubated with rhabdosarcoma cell culture supernatant
(CCSN) to determine the in vitro effects on the collagenases. The results
were analyzed by zymography. When administered in vivo, plasmin,
urokinase and streptokinase had no effect on the gelatinases. Trypsin and
PGE1 in vivo produced a band of degradation at 66 kDa corresponding to
the activated form of the MMP-2. Control experiments showed that
nephreetomy produced no activation of the matrix metalloproteinases.
Incubation of plasmin and PGE1 with the rhabdosarcoma CCSN produced
activated forms of both MMP-2 and MMP-9, respectively, at molecular
weights of 63 and 83 kDa respectively. Trypsin, in vitro, produced
numerous activated bands for both getatinases, with two corresponding to
those seen in vivo. Streptokinase and urokinase had no effect in vitro.
Trypsin and PGE1 were the most efficient activators of gelatinase when
administered in vivo to the experimental rats. The use of parenteral trypsin
was associated with high mortality in the experimental rats. In contrast,
PGEJ was tolerated. In conclusion, activation of MMP's 2 and 9 was
achievable using trypsin, plasmin and PGE1.
Tissue distribution of TGF-131 and SPARC in rat subtotal nephrec-
tomy. L. Wu, A. Cox, C. Roe, M. Dziadek, M Cooper, and R. Gilbert,
Department of Medicine, Austin & Repatriation Medical Centre, Victoria,
Australia. Mechanisms underlying the accumulation of extracellular matrix
(ECM) in the chronically diseased kidney are not well-understood.
Transforming growth factor-n (TGF-p) stimulates ECM production and
reduces its degradation while secreted protein acidic and rich in cysteine
(SPARC) has the opposite effect. We have previously demonstrated
increased TGF-131 and SPARC mRNA were associated with renal damage
in rat subtotal nephrectomy (STNx). To further investigate the gene and
protein distribution, we performed in situ hybridization using an antisense
probe for TGF-pl and SPARC and immunofluorescence using a poly-
clonal rabbit anti-mouse SPARC antibody. Thirty rats receiving STNx
were compared with 30 rats having partial nephrectomy (PNx). At 16
weeks, STNx developed functional and morphological damage. In Situ
hybridization revealed increased TGF-pl mRNA within sclerotic glomer-
uli and abundantly in damaged tubulointerstitium in STNx. SPARC
mRNA, in addition to its abundant expression in glomeruli and intersti-
tium, was aberrantly expressed in tubular epithelial cells together with
augmented immunotluorescence staining for its protein. Progressive renal
damage in STNx is accompanied by increases in both the proscierotic
cytokine TGF-f31 and SPARC, an inhibitor of ECM accumulation and
growth factor activity. We speculate that the degree of renal injury reflects
the balance between various factors that increase and reduce ECM
accumulation.
Oxidative status of low density lipoprotein (LDL) in hemodialysis (HD)
patients: Effect of dialysis and comparison with matched controls. J.
Westhuyzen, C. Morgan, D. Saltissi, and H. Healy, Departments of Renal
Medicine and Pathology, Royal Brisbane Hospital, Herston, Queensland,
Australia. End-stage renal failure is associated with a high prevalence of
premature atherosclerosis (AS). The hallmark of AS lesions is foam cells
formed from maerophages by the uptake of biochemically modified LDL.
In this study we examined oxidatively modified LDL in plasma of fasting
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HD subjects (N = 10) and controls of the same sex and age without
significant renal disease (N = 19). Concentrations of moieties susceptible
to oxidation, viz, polyunsaturated fatty acids (PUFA; %) and reactive
amino groups on apoprotein B (mol lysine/mg protein) were determined.
LDL susceptibility to copper-induced oxidation was characterized by the
lag time (mm), the level of conjugated dienes (CD; smol/g protein) before
and after oxidation and the maximal rate during the propagation phase
(jrmol/min/mg protein). HD subjects were studied before and after a
routine dialysis treatment (3—4 hours).
Parameter Control Pre-HD Post-HD
PUFA
C18:2 33.6 3.4 33.2 4.9 33.4 5.2
C20:4 8.2 1.2 7.7 1.1 7.8 1.3
C22:6 2.2 0.6 1.9 0.5 2.0 0.6
Lysine
initial 0.58 0.54—0.62 0.57 0.55—0.65 0.57 0.55—0.68
after Cu2 0.39a 0.35—0.49 0.45 0.37—0.49 0.45 0.4—0.56
Lag time
CD
91.4 82.7—101.0 105.2 90.2—112.0 102.0 89.7—137.6
initial 211 191—224 205 200—231 205 195—222
peak
Maximum
803 758—842 806 749—892 845 777—934
9.5 2.6 8.8 2.9 9.5 2.3
oxidation
rate
Parametric data: means SD; nonparametric: medians (25—75 percen-
tiles).
After incubation with 50 smol/liter CuCl2 for 1 hour at 37°C, P <
0.001 vs. baseline.
There were no significant differences in PUFA composition or concentra-
tion of reactive amino groups. Exposure to Cu2 did not result in
reduction in lysine reactivity in HD subjects as was seen in controls. The
susceptibility of LDL tp in vitro oxidation was similar in all groups. This
study provides no evidence that LDL from HD subjects is more extensively
modified or more susceptible to peroxidative modification in vitro than
controls without renal failure. Paradoxically apoprotein from HD subjects
was resistant to Cu2 initiated oxidation in contrast to controls.
Enhanced uptake by U937 cells of intermediate and low density
lipoproteins from nephrotic children. M.P. Dixit, M.E.C. Richardson, S.K
Sobecki, PH. Henning, KF. Jureidini, A.A. Martin, D. W. Thomas, Depart-
ments of Nephrology and Chemical Pathology, Women's and Children's
Hospital, North Adelaide, South Australia 5006, and Institute of Medical and
Veterinaiy Science, Adelaide, Australia. The nephrotic syndrome is often
associated with abnormalities of plasma lipoproteins, with cholesterol-
enrichment of intermediate density lipoproteins (IDL) and increased
levels of low density lipoproteins (LDL). A possible role of IDL and LDL
in the development of focal and segmental glomeruloscierosis (FSGS) in
the nephrotic syndrome, due to abnormal glomerular cell uptake of
cholesterol, has been suggested. To test for altered cellular uptake of
lipoproteins from ncphrotic syndrome patients, we examined the uptake
by U937 cells of IDL and LDL obtained from nephrotic sera. U937 is a
monocytic cell line that lacks the capacity for endogenous cholesterol
synthesis. Growth of these cells in vitro is dependent on the presence of
lipoproteins in the medium, and the rate of growth can be used as a
convenient measure of cholesterol uptake. The sera from five nephrotic
children (3 FSGS and 2 minimal change nephrotic syndrome) were
collected on initial presentation and before treatment with steroids. Five
age- and sex-matched healthy children with normal lipid profiles were
used as controls. The IDL and LDL in the sera were separated by
fractional ultracentrifugation. The IDL, at 0, 5 and 10 smol/liter, and
LDL, at 0, 50, 100 jsmol/liter, cholesterol concentrations were added to
the culture medium of U937 cells, and the numbers of cells were measured
by electronic cell counter 48, 72, and 96 hours later. The growth rate of
U937 cells was found to be significantly greater in the presence of IDL or
LDL from nephrotic children, compared to growth in the presence of
normal lipoproteins. Since equal concentrations of cholesterol were added
from the nephrotic and control samples, these data suggest that the
lipoprotein particles from nephrotic children are taken up by U937 cells
more avidly than those from normal children. Studies of the possible
mechanisms of this altered avidity of cellular uptake of lipoproteins from
nephrotic children, and the pathways by which this uptake occurs, are
currently in progress.
Interleukin-lO is a growth factor for rat mesangial cells in vitro. S.f.
Chadban, R.C. Atkins, and D.J. Nikolic-Paterson, Department of Nephrol-
ogy, Monash Medical Centre, Clayton Road, Victoria, Australia. Interleu-
kin-I 0 (IL-b) is a recently characterized cytokine which serves as an
important regulator of macrophage and T cell function, being capable of
suppressing delayed type hypersensitivity responses. Hence, IL-b is a
potential therapeutic candidate for the treatment of macrophage and T
cell-mediated renal diseases, although little is known of the role of IL-b
in regulating the function of intrinsic kidney cells. Therefore, the effect of
IL-lO on the growth of a well-characterized rat mesangial cell line (1097)
was studied. Recombinant murine IL-b was administered to mesangial
cells cultured in RPMI/2% fetal calf serum in 5% C02, at 37°C. Prolifer-
ation was assessed by 3H-thymidine uptake after 48 hours of culture. IL-lO
was found to exert a biphasic pattern of growth modulation on mesangial
cells. Picogram doses of IL-bO inhibited proliferation, with maximal
. 18—20% seen at 300 pg/mI (P < 0.01 vs. control). At higher concentra-
tions, however, IL-b augmented proliferation in a dose-dependent man-
ner, reaching a plateau of t 23—70% at 80 ng/ml (P < 0.001). By
comparison, IL-b inhibited the proliferation of the P388D1 murine
monocytic cell line in a dose-dependent fashion, with a 44% growth
inhibition seen at 20 ng/ml IL-b (P < 0.01). In addition, mesangial cells
were brought to a state of minimal proliferation by 3 days of culture in
0.5% FCS. Administration of IL-lO to the starved cells induced a
dose-dependent increase in cell proliferation which was comparable to
that obtained with the addition of PDGF, although a 5-fold higher
concentration of IL-lO was required. Thus, it is concluded that IL-b is a
mesangial cell growth factor which exerts differential effects in a dose-
dependent fashion. This has implications for the regulation of mesangial
cell proliferation in both the normal and inflamed kidney.
Inhibition of tissue factor pathway inhibitor (TFPI) exacerbates fibrin
deposition in crescentic glomerulonephritis (GN). J.H. Erlich, S.R. Holds-
worth, and P. G. Tipping, Centre for Inflammato,y Diseases, Monash Uni-
versiy Department of Medicine, Monash Medical Centre, Clayton, Victoria,
Australia. TFPI is an endothelial-derived protein which inhibits coagula-
tion by binding and inhibiting the activity of tissue factor/factor VIIa/Xa
complexes. TFPI is expressed in normal glomeruli and is down-regulated
in the initial stages of crescentic, fibrin-dependent GN in rabbits. An
antibody with high titer inhibitory activity was raised to recombinant rabbit
TFPI in sheep. In vivo treatment with a globulin fraction of this anti-TFPI
serum was used to investigate the functional contribution of TFPI to
protection against fibrin dependent glomerular injury in rabbits. Presen-
sitized rabbits (N = 5) were treated with anti-TFPI globulin (40 mg/kg), 30
minutes prior to initiation of GN with a subnephritogenic dose of horse
anti-rabbit GBM antibody and were further treated with 3 doses of
anti-TFPI (20 mg/kg) at 12 hourly intervals. Control treatment was with
similar doses of normal sheep globulin. Glomerular fibrin deposition
(scored 0 to 3-i- by immunofluorescence in a blinded protocol) and
creatinine clearance were assessed 48 hours after initiation of GN. Rabbits
treated with anti-TFPI globulin exhibited significant enhancement of
glomerular fibrin deposition [score 1.5 0.3 (mean sEM)1 compared to
control treated rabbits (score 0.5 0.1, P < 0.04). TFPI treatment
significantly reduced creatinine clearance (treated 2.4 0.5 mI/mm,
control 17.7 8.3 ml/min, P > 0.01). Circulating platelet counts and
plasma fibrinogen concentrations were not significantly altered by anti-
TFPI treatment. These studies demonstrate that blocking TFPI increases
glomerular fibrin deposition and suggests the TFPI significantly protects
renal function in crescentic GN by inhibiting fibrin deposition.
Macrophage migration inhibitory factor (MIF)—A previously unrecog-
nized kidney-derived cytokine which participates in local macrophage
accumulation and proliferation in the progression of rat anti-GBM
glomerulonephritis. H Y. Lan, W. Mu, N. Yang, A. Meinhardt, D. Ni/colic-
Paterson, M. Bacher, R. C. Atkins, and R. Bucala, Department of Nephrology,
Monash Medical Centre, Clayton, Victoria, Australia; and The Picower
Institute for Medical Research, Manhasset, New York USA. For many years
MIF was thought to be exclusively a T cell product associated with
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delayed-type hypersensitivity reactions. Using double immunohistochem-
istry, in situ hybridization and Northern blotting, we have demonstrated
constitutive expression of MIF protein and mRNA in tubular cells of
normal rat kidney. However, there was a marked increase in MIF
expression in accelerated anti-GBM glomerulonephritis. MIF expression
was detected in glomerular cells, including endothelial, mesangial, visceral
and parietal epithelial cells. Importantly, MIF expression correlated
significantly with the increasing number of total (EDI +) and proliferating
(EDI+PCNA+) macrophages within glomeruli (P < 0.001) and the
tuhulointerstitium (P < 0.001). Furthermore, local macrophage aeeumu-
latior and proliferation were restricted to areas of focal up-regulation of
MIF txpression, which contributed to the development of severe glomer-
ular hypereellularity, glomerular focal segmental proliferative/sclerotic
lcsiorLs, focal tubulitis, and interstitial fibrosis. A most interesting finding
was that MIF expression was markedly up-regulated in ED1+PCNA+
proliferating macrophages and multinueleated giant cells. In conclusion,
this is the first demonstration that MIF is constitutively expressed in the
normal kidney. Up-regulation of renal MIF expression may play a key role
in the pathogenesis of macrophage-mediated renal injury in glomerulo-
nephritis.
Unique signal transduction of monocyte chemoattractant protein-i
(MCP-1) mRNA in rat cultured proximal tubule cells (PTCC) exposed to
protein. D. C.H. Harris, and J. Chen, Department of Renal Medicine,
Westmead Hospital and University of Sydney, New South Wales, Australia.
MCP-1 production has been demonstrated in proximal tubule cells in vivo
in a variety of proteinuric renal diseases, and in vitro in response to a
number of cytokines such as interleukin-l (IL-i). Previously, we have
shown that various proteins, including bovine serum albumin (BSA),
delipidated BSA and holo- and apo-transferrin (Tf), also induce MCP-1
mRNA in PTCC. To examine the mechanisms of induction of MCP-1
mRNA by protein, tubules were isolated from normal male Wistar rats by
collagenase digestion and Percoll-gradient centrifugation, and grown to
confluence on rat tail collagen matrix in DMEM/F-12 Ham (1:1). Media
were changed on day 3 and proteins and inhibitors added on day 5. BSA
(3.7—30 mg/ml) and Tf (1—8 mg/mI) induction of MCP-1 mRNA was rapid
(<2 hours), stable with continued exposure, absent within 4 hours of
stimulus withdrawal, and time- and dose-dependent. No effect was seen
with dextran or glucose, discounting an effect of osmolality or oncotie
pressure. MCP-1 mRNA was also induced by human serum albumin,
lipopolysaccharide, PMA and IL-I, and with the latter was inhibited by
genistein, an inhibitor of protein tyrosine kinase (PTK). In contrast,
protein-induced MCP-1 expression was unaffected by effeetors of PTK, or
protein kinase C. Unlike protein-induced proximal tubule cytotoxicity
which was specific to holotransferrin (at pH 6.0), MCP-1 expression was
not protein-specific, nor dependent on pH or iron. MCP-1 expression
induced by protein, IL-i and PMA was abrogated by actinomyein D, but
unaffected by cycloheximide, and with protein was inhibited by lysine (an
inhibitor of protein uptake) but not cytochalasin (an inhibitor of pinocy-
tosis). When tubules were grown on filter paper (to more closely retain
tubular morphology), similar effects were seen, suggesting that phenotypic
modulation by culture matrix was not a prerequisite. In conclusion, MCP-1
mRNA was induced in proximal tubule cells by proteins in concentrations
found in protcinuric urine, and appeared to involve unique pathways of
signal transduction. These effects may explain how proteinuria could cause
interstitial inflammation.
Myofibroblasts correlate with fibrotic markers in diabetic nephropathy.
E. Pedagogos, I. Fraser, T Hewitson, K. Nicholls, and G. Becker, Department
of Nephrology, The Royal Melbourne Hospital, Victoria, Australia. Scarring
of the kidney in diabetic nephropathy consists of glomerulosclerosis,
tubulointerstitial fibrosis and arterioloselerosis. The myofibroblast (MF)
expresses a smooth muscle actin (uSMA), has phenotypic features of both
fibroblast and smooth muscle cells, and secretes collagen, which is
important in fibrosis. We examined the biopsies of 62 patients with
diabetic nephropathy to establish whether the MF has a role in progressive
interstitial fibrosis and to ascertain whether a relationship existed between
MF activity and severity of arteriosclerosis. MF were identified by
morphology and aSMA immunostaining and quantitated by the fractional
area of aSMA staining. Blood vessel surface area estimates were made
using a computer aided image analyzer (MD2O). The ratio of blood vessel
wall surface area to total vessel surface area was used as an index of
arterioloselerosis (IA). Interstitial fractional area (IFA), uSMA and
collagen III (Coll3) were quantitated by point counting. Results were
related to structural and functional parameters using rank correlation
coefficients. There was a strong correlation between IFA and Coll3
staining (r = 0.83, P < 0.001), and there were significant correlations
between uSMA and total urinary protein (r = 0.47, P < 0.001), renal
function (serum creatinine) at time of biopsy (r 0.51, P < 0.001), and the
percent change in renal function after 4 years (Cr) (r = 0.37, P = 0.01).
The IA correlated significantly with Co113 (r = 0.29, P = 0.02), GFR (r =
0.39, P = 0.008) and creatinine (r = 0.33,P = 0.01), but no correlation was
observed between aSMA and IA (r 0.16, P = 0.23) or IA and Cr (r =
—0.04, P = 0.8). In conclusion, the MF appears to have a significant role
in the progression of diabetic nephropathy. Ischemia secondary to arte-
riosclerosis may contribute to interstitial fibrosis through fibroblast acti-
vation into MF.
Oxidant stress in the kidney in experimental diabetes mellitus. A.R.
Kitching, B.M. ROger, P.F. Davis, Department of Medicine, Wellington
School of Medicine, Wellington, New Zealand. The effects of hyperglycemia
at the cellular level are considered to be important in the pathogenesis of
diabetic nephropathy. Oxidant damage is a possible mediator of renal
injury in this situation. Mediators and indicators of oxidant stress were
studied in the hypoinsulinemic streptozotocin-induced diabetic rat
(STZR) model at 12 weeks, before development of conventional indica-
tors of renal damage (changes in histology or proteinuria). In vitro
production of H202 in isolated glomeruli (5 animals per group) was
measured. The rate of H2O2 production was about 3.5 times higher for
STZR than for control (CON) rats (52.3 vs 15.0 nmol/g glomeruli 10
minutes after isolation). Total lipid peroxides (LPO) and malondialde-
hyde (MDA) were increased in whole kidney homogenates by 66% (P <
0.05 for both LPO and MDA). This change was reversed by insulin
treatment (INS). Levels of LPO and MDA measured in glomerular lysates
(pooled from cortices of 5 animals) were increased in STZR compared to
controls (LPO 69.6 vs. 37.1, MDA 46.6 vs. 21.3 nmol/mg protein). Levels
of the antioxidant enzyme, superoxide dismutase (SOD) were assessed.
There was a four-fold increase in the inducible form of SOD, Mn-SOD, in
STZR glomerular lysates (pooled glomeruli of 5 animals), reversed by
insulin treatment (STZR 93.3, CON 22.6, INS 36.4 U/mg protein). In
contrast, there was only a 33% increase in glomerular Cu,Zn-SOD, and no
change in whole kidney levels of either form of SOD. Immunostaining
showed Cu,Zn-SOD to be present in the cytoplasm of glomerular epithe-
hal cells. There was no increase in Cu,Zn-SOD staining on semi-
quantitative assessment. Glomeruli from STZR have increased capacity to
produce H2O2, a damaging reactive oxygen species. In glomeruli of STZR,
the levels of products of lipid peroxidation (LPO and MDA) are in-
creased. In addition, there is increased activity of Mn-SOD, an oxidant
enzyme induced by reactive oxygen species. These results provide evi-
dence that oxidant stress is increased within the glomerulus in experimen-
tal diabetes melhitus prior to development of proteinuria or change in
histological appearance.
Binding and quantitation of advanced glycation end-products (AGEs)
and receptor for AGEs (RAGE) in the diabetic rat kidney. T. Soulis, S.
Youssef V Thallas, and M.E. Cooper, Department of Medicine, University of
Melbourne, Austin and Repatriation Medical Centre, Banksia St. West
Heidelberg, Victoria, Australia. Advanced glycation end-products (AGEs),
which accumulate in long-lived proteins and at an accelerated rate in
diabetes, have been implicated in the development of diabetic nephrop-
athy (DN). Aminoguanidine (AG) has been shown to decrease the
accumulation of AGEs in the diabetic kidney. Several different binding
proteins specific for AGEs have been isolated, including the receptor for
AGEs (RAGE), a 35 kDa IgG like binding protein. AGEs have been
previously shown to be present in the collecting duets, distal tubules and
glomerulus of the rat kidney. This study has investigated the changes in
AGE binding associated with diabetes in the rat kidney using in vitro
autoradiography. Immunostaining of AGEs and RAGE in rat glomeruli, a
site of DN, was also assessed. Male Sprague Dawley rats were randomized
into control (C, N = 7), diabetic (D, N = 7) (streptozotocin 50 mg/kg) and
diabetic with AG, (1 g/liter in drinking water), (D + AG, N 7). Rats
were sacrificed at 3 weeks for binding studies and 32 weeks for immuno-
histochemical studies. Formahin-fixed paraffin embedded kidney sections
were stained for AGE using a polyclonal anti-AGE-BSA antibody, and
RAGE using a polyclonal anti-RAGE antibody. For in vitro binding,
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frozen sections (20 m) were incubated with [12511-AGE-RNase. Compet-
itive binding was performed with increasing concentrations of unlabelled
AGE-RNase (NSB = 1 X iO M). There was an increase in 1251-AGE
binding in the renal Cortex and medulla after 3 weeks of experimental
diabetes (cortex; C, 257 3 vs. D, 372 16, dpm/mm2, P < 0.01) which
was prevented by aminoguanidine treatment (D + AG, 262 7, P < 0.01
vs. D). Emulsion autoradiography revealed widespread distribution of
1251-AGE binding in the kidneys, including distal tubules and collecting
ducts. Immunohistochemistry using an antibody to RAGE revealed stain-
ing in similar sites as well as the glomerulus. Studies are now in progress
to determine if the 1251-AGE binding in the kidney is primarily due to
RAGE. After 32 weeks of diabetes, there was an increase in AGE levels
in glomeruli as assessed by immunohistochemistry (C 21 3, D 44 3%,
P < 0.01) which was ameliorated by AG treatment (D + AG 26 3%,
P < 0.01 vs. D). AGE levels, as measured in glomerular and tubular
homogenates by radioimmunoassay revealed a similar pattern (glomeruli;
C, 70 10, D, 250 20, D + AG, 55 10, ng AGE-RNase >< l03/mol
hydroxyproline). In summary, experimental diabetes results in AGE
accumulation in the kidney and this is associated with an early increase in
251-AGE binding. The inhibitor of advanced glycation, aminoguanidine, is
able to prevent these changes. These findings provide further evidence for
a role for advanced glycation and their receptors in the genesis of
experimental diabetic nephropathy.
A thermodynamic equilibrium model for calcium salt urolithiasis:
Clinical application, AZ. Gyoty, and R. Ashby, Department of Medicine
and Renal Medicine, Royal North Shore Hospital and University of Sydney,
and Department of Chemistry, University of Technology, Sydney, New South
Wales, Australia. Conventional calculations using chemical analysis of
urine samples and known complex ion equilibria based on the theory that
urine of calcium stone forming patients is supersaturated and in a
metastable state does not separate these patients from normal controls
adequately and does not correlate well with severity of Stone disease. We
describe an adaptation of such calculations based on the hypothesis that
urine is in a true equilibrium state, the free citrate3 ion playing a major
role in maintaining dispersion of the solid particles (reduced agglomera-
tion). The computer modeling program (SEQUIL) allows calculation of
the quantity of solid Ca oxalate and phosphate in relation to the free
citrate3 activity for individual urines and patients. Using data points
obtained from the existing published literature on Ca stone-forming
urines, a prediction can be made for each patient as to the likelihood of
stone forming propensity of their urines. In 30 calcium stone-forming
patients where such comparisons could be made, Sequil predicted 87% to
be abnormal in at least one urine sample. Using the Ca/Cr (Ca to
creatinine ratio) or Ca excretion rates normally obtained from "routine"
investigations, we would have missed 71% of patients, respectively.
Oxalate/Cr ratio and oxalate excretion rates missed 64% of patients,
whereas using total citrate/Cr ratios and total citrate excretion rates 63%
of patients were missed. Four patients had normal urines by SEQUIL and
are thus truly "idiopathic". Whether more than 3 urine collections would
have resulted in abnormal values in these patients is unknown, but it is a
distinct possibility due to the variability in the three collections. Clinically
there have been no recurrences in 24 months. In conclusion, this computer
program has a high positive predictive value for calcium stone patients and
allows individualization of therapy which may, but not necessarily does,
include changing Ca, citrate or urine volume. It also tends to support
strongly the hypothesis that the equilibrium theory is more appropriate
than the metastable one, as would be expected if agglomeration, and not
just crystal formation, is of major significance in Ca stone formation.
Distinctive renal ultrasound findings in progressive focal and segmen-
tal glomeruloscierosis. PH. Henning, G. LeQuesne, and KF. Jureidini,
Renal Unit and Ultrasound Department, Women's & Children's Hospital,
North Adelaide, South Australia. The ultrasonic appearance of kidneys with
severe or progressive forms of chronic glomerulonephritis is usually
non-specific. The features include a diffuse increase in echogenicity of
renal cortex with eventual loss of cortico-medullary differentiation. There
may be generalized swelling of the kidneys early in the disease which then
evolves to an echodense contracted appearance with advanced renal
failure. The subject of this report is the description of a distinctive
ultrasonic appearance associated with a progressive form of focal and
segmental glomerulosclerosis (FSGS). A four and half year old boy with
nephrotic syndrome, hypertension and mild renal failure was biopsied and
found to have mesangial proliferation and FSGS. Segmental sclerosis was
prominent chiefly in juxta-medullary glomeruli and associated with early
interstitial fibrosis. The condition was unresponsive to standard steroid
and cytotoxic therapy and progression to end-stage renal failure occurred
over 2 years. During the same period serial renal ultrasound examination
demonstrated the emergence of an accentuated abnormal echogenicity in
all pen-pyramidal regions. These zones of strikingly increased echos
widened until they became confluent. At this point repeat renal biopsy
demonstrated marked interstitial fibrosis in the medullary and juxta-
medullary regions. Ultimately, a uniform appearance of increased echo-
genicity was demonstrated throughout a contracted renal cortex in asso-
ciation with some distortion of the pyramids. Ultrasound examination of 4
other children with FSGS and nephrotic syndrome has revealed the same
pen-pyramidal abnormality in one with progressive renal failure but has
been absent in 3 with non-progressive or resolving disease (follow up: 2—11
years). It was also absent in other chronic progressive renal diseases where
FSGS is a feature of the histology (such as reflux nephropathy). We
conclude that this pattern of pen-pyramidal hyperechogenicity is associ-
ated with progressive sclerosis involving predominantly juxta-medullary
cortical tissues in an early phase of the disease. It appears to indicate a
poor prognosis in FSGS with nephrotic syndrome.
Calciphylaxis in renal failure. P. T.H. Coates, G.S. Kirkland, RB.
Dymoclç, B.F. Miaphy, and A.P.S. Disney, Departments of Nephrology and
Histopathology, The Queen Elizabeth Hospital, Woodville, SA and Depart-
ment of Nephrology, St. Vincents J-Iospital, Melbourne, Victoria, Australia.
Calciphylaxis is a commonly fatal syndrome of cutaneous necrosis associ-
ated with soft tissue calcium deposition that occurs in end-stage renal
failure, dialysis and transplant patients. Fourteen individuals (12 female
and 2 male, age range 45—70) were identified with this syndrome since
1985. Three patients had long-standing chronic renal failure (Cr > 300
mmol/liter), 8 patients were dialysis dependent (6 HD and 2 CAPD), and
3 patients developed calciphylaxis in association with a failing renal
transplant. In all cases skin lesions began as painful violaceous livedo
reticularis and progressed to cutaneous necrosis. The most commonly
involved site was the skin of the thighs and buttocks. All patients had a
high calcium phosphate product. Thirteen patients were hyperparathyroid
when the lesions developed. Histopathology of the skin was available in 10
of the patients and showed panniculitis (10/10), small vessel calcification
(10/10), thrombosis of affected vessels (5/10), epidermal necrosis (4/10),
and cutaneous ulceration (4/10). Electron microanalysis of the calcified
vessels showed only calcium and phosphate in 5/5 cases examined.
Treatment consisted of control of calcium-phosphate product (14), surgi-
cal debridement (9), parathyroidectomy (8), and hyperbaric oxygen (1).
Mortality was 11/14 with causes of death sepsis (5), withdrawal from
dialysis (4), and gastrointestinal bleeding (2). Clinical factors identified
included female sex, obesity, use of warfarin (7 patients), and poor calcium
phosphate control. Fluctuating levels of protein C have been implicated in
the etiology of calciphylaxis and may provide a mechanism whereby
warfanin may precipitate this syndrome. Seven patients were identified in
the 1993—1995 period, and this rise in the number of cases may reflect
greater calcium-phosphate products consequent upon a reduction in
aluminum use as a phosphate binder and increased use of calcitriol.
Simvastatin efficacy in renal transplant subjects with hyperlipidemia.
F. Lepre, R. Righy, C. Hawley, D. Saltissi, A. Brown, and Z. Walsh,
Department of Medicine, Nephrology and Dietetics, Princess Alexandra
Hospital, and Department of Nephrology, Royal Brisbane Hospital, Brisbane,
Australia. Hyperlipidemia is a common finding in renal transplant subjects
and contributes to accelerated atherosclerosis. The aim of this study was
to investigate efficacy and safety of simvastatin in subjects on cyclosponine
or Imuran post-renal transplantation. Fifty-one subjects (32 females, 19
males; mean age 51 12.5 years) who were at least one year post-
transplant, had creatinine of <2.0 mmol/liter and cholesterol >6 mmol/
liter were enrolled in a prospective study. After an initial 10 week dietary
period, last 4 weeks on placebo, subjects were randomized to receive
simvastatin 5 mg for 6 weeks followed by simvastatin 10 mg for 6 weeks or
matching placebo. Compared to placebo simvastatin 5 mg significantly
decreased total cholesterol by 20% (P < 0.01), LDL by 29% (P < 0.01),
and ApoB by 26% (P < 0.01). Increasing the simvastatin dose to 10mg did
not lead to further significant changes. HDL increased by 9% (P < 0.01)
and Apo Al by 7% (P < 0.01) only on simvastatin 10 mg dose. Renal
1316 Abstracts
function and cyclosporine levels were unchanged. There were 2 withdraw-
als from the study, both on simvastatin: one with muscle pains and one
with abdominal pain. Muscle pain was the major side effect and occurred
more in subjects on cyclosporine/simvastatin. Liver function tests re-
mained unchanged; CPK rise was seen in a few subjects. Simvastatin is an
effective lipid lowering agent in post-renal transplant subjects. Muscular
side effects are uncommon and tend to occur in subjects on cyclosporine.
Audit of the outcome of patients with renal failure presenting to a
regional nephrology service. KL. Lynn, A.H. Smith, iA. Inkzter, A.L.
Buttimore, R.R. Bailey, and R.A. Robson, Department of Wephrology,
Christchurch Hospital, Christchurch, New Zealand. The incidence of un-
treated end-stage renal failure (ESRF) in New Zealand is not known. We
have undertaken a retrospective audit of the outcome of 491 patients (293
males) aged from 5 to 89 years with renal failure (plasma creatinine  0.30
mmol/liter) presenting to, or already under follow-up by, a regional
nephrology unit serving a population of 480,000 (23,800 Mann) in
Canterbury and Westland. The study period was January 1, 1988 to
December 31, 1993 with follow-up to June 30, 1994. Data were obtained
from the departmental computerized clinical database. One hundred
twenty-three patients had ARF and 37 (30%) of these died. Of the 372
patients with chronic renal failure (including 4 who presented with ARF),
139 had started regular dialysis treatment, 77 remained under follow-up,
39 had been transferred to the care of another doctor, and 95 were dead,
including 27 patients (mean age 71 years) who died of untreated ESRF.
These patients were older than those who began dialysis (mean age 47
years) and were more likely to have hypertension, obstructive uropathy or
neoplasia as the cause of their renal failure. The decision not to start
dialysis was made by the patient and/or family in 11(40%) of 27 cases and
by the medical staff in the remainder. During the study period the annual
regional incidence of ESRF was at least 134 pmp; at least 9 pmp died of
untreated ESRF and 43 pmp starting dialysis. Death from untreated
ESRF is uncommon in Canterbury and Westland. The rate of dialysis
treatment of ESRF is lower than for New Zealand as a whole (69 pmp in
1994) and explained in part by the small Maori population in the study
region.
Comparison of percutaneous kidney biopsy using biopty® gun and
needles of different gauge. KL. Lynn, R.A. Robson ', KM. Wong, L. Lawler,
G. Welsh, J. Gardner, R.R. Bailey and TM. Maling, Departments of
Nephrology, Radiology and Pathology, Christchurch Hospital, Christchurch,
New Zealand. Percutaneous renal biopsy has been facilitated by the use of
real-time ultrasound and the semi-automated, spring-loaded biopsy gun.
We have carried out a prospective, randomized study comparing the safety
and tissue adequacy for histopathological diagnosis of renal biopsies
performed under real-time ultrasound guidance using the Biopty® gun and
a 14 or 18 gauge needle on 103 native and 30 transplant kidneys. The
procedure was performed freehand with the operator holding the ultra-
sound probe in one hand and the Biopty® gun in the other. We aimed to
obtain 3 cores of renal tissue from native kidneys and one core from
transplant kidneys. Repeat biopsy was necessary for only one renal
transplant (0.75%) because of inadequate tissue. The biopsy procedure
was well tolerated and complications were uncommon in both groups
(< 5%). Biopsies of native kidneys with the 14 gauge needle required
fewer attempts (3.23 vs. 3.98; P = 0.005) and the cores obtained contained
more glomeruli for light (24.8 vs. 16.0; P = 0.0001) and immunofluores-
cence microscopy (9.5 vs. 7.4; P = 0.01) than with the 18 gauge needle.
Similarly, more glomeruli were obtained from transplant kidneys with the
14 gauge needle (19.5 vs. 12.9; P = 0.004). Renal biopsy using the Biopty®
gun and a 14 gauge needle is safe and provides more tissue for histopatho-
logical assessment than the 18 gauge needle. The 14 gauge needle should
be the preferred needle for renal biopsies using the Biopty® gun in adults,
and two cores should be adequate for histopathology assessment.
Prospective, randomized, controlled study comparing two dosing regi-
mens of gentamicin with oral ciprofloxacin switch therapy for acute
pyelonephritis. R.R. Bailey, E.J. Begg, R.A. Robson, KL. Lynn, A.H. Smith,
S. T Chambers, M.L. Barclay, J. Homibook. Departments of Nephrology,
Clinical Pharmacology & Infectious Diseases, Christchurch Hospita4
Christchurch, New Zealand. Aminoglycosides are drugs of choice for
severe gram-negative urinary tract sepsis. Recent evidence suggests that
they are just as efficacious, but less nephrotoxic and ototoxic, if the same
total daily dose is given as a single dose rather than in divided doses. An
even larger single dose given only once, followed by a different antibiotic
may be safer, and if effective may have cost efficiency advantages. This
study compared the efficacy and toxicity of a single large (L) iv. dose of
gentamicin (10 mg/kg of lean body weight) with a standard (S) regimen of
gentamicin (2.5 mg/kg iv. stat followed by computer generated doses to
achieve peak/trough concentrations of 8.0/1.5 mg/liter respectively) in
patients with suspected acute pyelonephritis requiring hospitalisation.
Patients were randomly allocated to the L or S group. Patients in the L
group were given oral ciprofloxacin 250 mg, 4 hours after the iv.
gentamicin and continued 12 hourly for 5 days, while those in the S group
received iv. gentamicin until clinical improvement enabled a switch to oral
ciprofloxacin 250 mg ql2h and continued for a total treatment duration of
5 days. End-points monitored included clinical and microbiological cure
(efficacy), plasma creatinine (Cr) and high tone audiometiy. Statistical
analysis was by non-parametric methods. Fifty-three patients (48 women;
mean age 32 yr) were enrolled, with 50 being assessable for clinical
efficacy. Of 24 patients in the L group "cure" was achieved in 21 and
"improvement" in 3. Of 26 in the S group, "cure" was achieved in 25 and
"improvement" in 1. Forty-one were assessable for microbiological effi-
cacy; 15 of 16 in the L arm were cured (sterile urine 1 week after
treatment) and 23 of 25 in the S group. Nephrotoxicity (increase in Cr >
0.045 mmol/L) was observed in 2 of 26 patients in the L group (thought
not to be due to gentamicin) and 0 of 26 in the S group. Ototoxicity
( 10 dB loss in a 2 frequencies in both ears) was observed in 3 of 18 in
the L group and 7 of 23 in the S group (NS). In summary, a single large
dose of gentamicin was comparable in efficacy and toxicity to a standard
regimen and was more convenient and cost effective.
Uncomplicated acute pyelonephritis in young men. R.R. Bailey, Depart-
ment of Nephrology, Christchurch Hospital, Christchurch, New Zealand. It is
widely believed that symptomatic urinary tract infections (UTIs) are very
uncommon in males, except in infancy and the "prostatic" age group. Most
men with a UTI have been considered to have a functional or anatomical
abnormality of the urinary tract. Recent reports have suggested that there
is an increasing number of otherwise healthy young men presenting with
uncomplicated acute pyelonephritis with similar clinical features as those
affecting sexually active young women. From 1 January 1988 to 31 July
1995 a total of 42 men were admitted with acute pyelonephritis (fever
>37.8CC, loin pain or tenderness, infected urine). Of the total of 42 men,
23 (55%) were under the age of 40. Five of these 23 young men were
known to have a serious underlying urinary tract abnormality and had
required frequent admissions for symptomatic UTIs. Of the other 18
young men with an isolated episode of acute pyelonephritis, 14 were
infected with Escherichia coli, 2 with Proteus mirabilis and 1 each with
Enterococcusfaecalis and Staphylococcus saprophyticus. All 18 had normal
imaging of the urinary tract, and all were cured (sterile urine 7—10 days
later) with a 5-day course of treatment. In summary, more than half of the
males admitted with acute pyelonephritis were under the age of 40. Men
with an isolated episode of acute pyelonephritis should be treated in the
same way as for women in a similar age group. Not all require extensive
urinary tract investigations.
M.R.I. findings in shoulders of symptomatic chronic hemodialysis
patients. P. TH. Coates5, J.P. Slavotinelç S.P. McDonald andA.P.S. Disney
Renal Unit, The Queen Elizabeth Hospital, Woodville, Renal Unit and
Department of Radiology, Flinders Medical Centre, Bedford Park, South
Australia, Australia. Chronic shoulder pain is a frequently encountered
diagnostic and therapeutic problem in patients on chronic hemodialysis.
We studied the shoulders of 10 symptomatic chronic hemodialysis patients
who had been treated with hemodialysis for greater than 10 years (median
age 59, median duration 15.9 years) with MRI (lOT Siemens Impact
scanner). Ti (12/900) and T2 (17/119/3000) oblique coronal, Ti (12/750)
oblique saggital and FLASH (18/585, flip angle = 25 degrees) axial images
were acquired. Rotator cuff thickening was graded as mild, moderate or
severe. Location and dimension of bone lesions was also recorded.
Tendon thickening almost exclusively involved subscapularis and supraspi-
natus. There was at least moderate thickening of one or more of these
tendons in 7/10 patients. There were 14 intra-osseous bony lesions (2 per
patient) in the seven patients with moderate or greater tendon thickening
and only 2 lesions (0.7 per patient) in the remaining 3 patients. Within the
bone lesions Ti signal was intermediate and T2 signal was variable. There
were no muscle belly changes other than atrophy in association with a
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supraspinatus tear. Decreased signal was present in the humeral metaph-
ysis in 6/10 patients possibly reflecting red marrow reconversion or iron
deposition. In conclusion, MRI demonstrates frequent abnormalities in
the tendons of symptomatic shoulders of chronic hemodialysis patients.
Histological correlation will be sought in order to confirm the nature of
the lesions and further clinical correlation with ultrasound will be re-
ported.
Fingernail creatinine concentration as a marker of the duration of
renal failure. B.J. Shand, MA. Bailey, R.R. Bailey, Department of Nephrol-
ogy, Christchurch Hospital, Christchurch, New Zealand. It has been pro-
posed that fingernail creatinine concentration may differentiate between
acute (ARF) and chronic renal failure (CRF) [Bergamo et al.AmfKidDis
22:814—821, 1993]. This hypothesis was based on the premise that the
creatinine concentration in fingernail clippings reflected the plasma
creatinine concentration several months previously. We studied the effec-
tiveness of fingernail creatinine concentration as an indicator of the
duration of renal failure in 66 subjects grouped according to renal
function. Nail clippings from all fingers were obtained on one occasion
from 18 subjects with normal renal function, 12 patients with a stable renal
transplant >5 month, 26 on hemodialysis (HD) and 10 with CRF not on
dialysis. Repeat nail collections were made from 2 patients with ARF and
2 following renal transplantation. The clippings were frozen in liquid
nitrogen, pulverized to a powder, weighed and eluted in 5 ml of deionized
water for 24 hr at 45°C using a shaking water bath. The crcatinine
concentration in the eluate was determined using the Sakaguchi color
reaction for substituted guanidines. Data analysis was carried out using a
two-tailed Mann Whitney test and is summarized in the table.
Renal
Normal transplant HD CRF




Median 19 23 56 46
Range 7—125 10—46 21—195 22—90
P compared to normal 0.31 0.004 0.07
Serial measurement of fingernail creatinine followed the expected trends
of decreasing concentration in patients after a renal transplant and
increasing concentration in one of the patients with ARF. The results
indicated that, while grouped data may differentiate between CRF and
normal kidney function or ARF, the method lacked specificity in individ-
ual cases. Approximately one third of normal subjects had a raised
fingernail creatinine concentration (>50 sg/g nail) and a similar propor-
tion of I-ID and CRF patients had less than this concentration in their
nails. We conclude that in individual cases estimating creatinine concen-
tration in fingernails is too unreliable for routine clinical use.
Hemorheological investigations in patients with polycystic kidney dis-
ease. B.!. Shand, R.R. Bailey, KL. Lynn, R.A. Robson. Department of
Nephrology, Christchurch Hospital, Christchurch, New Zealand. Polycystic
kidney disease (PKD) is associated with an increased incidence of
hypertension and cardiovascular abnormalities. As the flow properties of
blood (hemorheology) are an important hemodynamic determinant we
measured the incidence of rheological abnormalities in 39 patients with
PKD (14 males; mean age 47/year, range 20—78). Venous blood samples
were used to measure hematocrit, blood viscosity at the patient's hemat-
ocrit over a range of shear rates, blood viscosity at a standardized
hematocrit of 0.45 (derived value), plasma viscosity, plasma fibrinogen
concentration and platelet hematology (total count and mean platelet
volume). Renal function was assessed by plasma creatinine concentration.
The rheological indices were compared with analyses of blood from
healthy controls (blood donors and patients prior to minor surgery) using
the Mann-Whitney test. Relationships between hemorheology and renal
function were investigated using Spearman's rank correlation. Patients
with PKD had significant decreases in median hematocrit (P < 0.001) and
median blood viscosity at all shear rates (P = 0.05) and significant
increases (P < 0.001) in median plasma viscosity and plasma fibrinogen
concentration. Standardization of the viscosity data to a constant hemat-
ocrit showed an insignificant increase in median values at all shear rates in
patients compared to controls. The most likely cause of this difference was
the raised plasma viscosity. Platelet numbers were significantly lower in
patients with PKD (P = 0.01). This reduction was associated with a
significant increase in mean platelet volume (P = 0.05; mean increase 0.32
fi). Plasma creatinine concentration did not correlate significantly with any
rheological index. We conclude that PKD is associated with mild abnor-
malities in plasma rheology that are offset by a reduction in hematocrit.
Our findings of a small increase in mean platelet volume in PKD confirm
an earlier report and raise the possibility that these larger, hyperfunctional
platelets may contribute to vascular and thrombotic changes in the
disorder.
Plasmapheresis in postpartum hemolytic uremic syndrome. P. TH.
Coates, G. Patrick, A.E. Seymour, Di. Pugsley, W Hague, A.P.S. Disney,
and L.J. Barratt, Renal Unit and Department of Obstetric Medicine, The
Queen Elizabeth Hospita4 Woodville, and Renal Unit, Flinders Medical
Centre, Bedford Park, Adelaide, South Australia, Australia. Hemolytic
uremic syndrome (HUS) is a recognized complication of the postpartum
period. We describe 8 patients (age range 18—35 years) over a 5 year
period with postpartum HUS who were treated with plasmapheresis. All
of the patients developed acute renal failure in association with throm-
botic microangiopathy within 48 hours of delivering healthy live infants.
Four patients developed postpartum HUS in association with preeclamp-
sia. All patients and all infants survived. Daily plasmapheresis (3—9
procedures) consisting of a plasma volume exchange with fresh frozen
plasma (FFP) was performed in all cases until platelet count rose above
150,000 x 10°. Two patients also received prostacyclin infusions from the
time of commencement of plasmapheresis. Five patients had complete
recovery of renal function (functional recovery between 1 and 4 weeks
post-delivery and with a serum creatinine of <120 rmol/liter at 6 months),
one patient developed chronic renal failure and two patients had no
recovery of renal function and have commenced maintenance hemodial-
ysis. There were no clear differences with respect to degree of thrombo-
cytopenia, lactate dehydrogenase value or degree of anemia, hut those
patients in whom renal function did not recover were anuric at the time of
commencement of plasmapheresis. Current literature supports a role for
plasmapheresis in the treatment of some forms of HUS. The results of this
small retrospective analysis suggest that early plasmapheresis with FFP
replacement should also be considered in the management of postpartum
HUS.
Accidental exposure to arsine gas resulting in massive intravascular
hemolysis, adult respiratory distress syndrome and acute renal failure:
management with continuous veno-veno hemodialysis (CVVHD) and
exchange transfusion. M. Lonergan, P. Warburton, i. MacDonald, Depart-
ment of Medicine, L. Harvey. Intensive Care Unit, Wollongong Hospital,
Australia. Arsine gas is a colorless gas that is used in a variety of
manufacturing processes and as a military poison gas. Arsine can be
generated as a by-product of a chemical reaction involving a base metal, an
arsenic impurity and an acid. We report the case of a previously well
21-year-old man who presented acutely unwell with nausea, vomiting,
generalized myalgia, fever, headache and red urine. His examination was
entirely normal except for red urine. His initial hemoglobin was 136 g/liter,
however, the specimen was noted to be grossly hemolyzed as were all
repeat specimens. Screens for immunological causes of intravascular
hemolysis and for glucose-6-phosphate dehydrogenase deficiency were
negative. He developed the adult respiratory distress syndrome. He was
anuric from the time of admission. A single four-hour hemodialysis was
commenced within 17 hours of admission. CVVHD was commenced
immediately after completion of the hemodialysis. When a work history
was taken, the diagnosis of arsine or antimony gas exposure was suspected.
A heavy metal screen confirmed a significant exposure to arsenic with a
blood level of 20.7 jsmol/liter (normal range 0—0.3 jsmol/liter). Exchange
transfusion of ten units of red blood cells using an apheresis machine was
performed on days five and six after exposure. The blood level of arsenic
prior to the first exchange was 7.8 jsmol/liter and following the second
exchange was 3.07 smol/liter. We conclude that a work history is essential.
Notification of his suspected exposure to arsine gas resulted in an
alteration in the order of the chemical reactions utilized to purify the
copper core and also necessitated the screening of all the personnel for
heavy metal exposure. CVVHD and exchange transfusion are effective in
the management of arsine exposure.
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Low birth weight and albuminuria in an Australian Aboriginal com-
munity with high rates of renal disease and renal failure. W. Hoy, M. Rees,
E. Kile, B. Hayhurst, R. McFarlane and iD. Mathews, Menzies School of
Health Research, Clinical Laboratories, Royal Danvin Hospital, Casuarina,
Australia. The influence of birth weight on albuminuria (albumin/creati-
nine ratio, ACR) was evaluated in a NT Aboriginal community with
extraordinarily high rates of renal failure. This community, like many
others, has a high proportion of low birth weight (LBW) babies (<2.5 kg),
and of underweight children, and a progressive increase in weight, with
predominantly abdominal fat distribution, during adult life. All 611
subjects with birth weights recorded from 1958 to 1990, who participated
in a community screening program from 1992 to 1994 were included. The
average BW was 2.7 kg with 25% of <2.5 kg, with 42% at less than the
standard third percentile for weight. More girls were of lower birth weight
than boys. In multivariate analysis, level of ACR at screening was
positively correlated with female sex, age, body weight, blood pressure,
fasting insulin levels, and markers of current and past streptococeal
infection. Birth weight predicted current weight in children and adoles-
cents, who were on average at the 25th percentile of standard weight for
age. After controlling for age and sex, ACR was inversely correlated with
current weight in children and adolescents, with the most malnourished
children having the highest ACR levels. In adults (18 and over), an inverse
relationship of birth weight with ACR was apparent after controlling for
age, sex and current weight, the last being the most powerful determinant.
ACR levels ranked from highest to lowest in subjects grouped as follows:
low birth weight, high body mass index, BMI (25 kg/rn2); normal birth
weight, high BMI; low birth weight, normal BMI; normal birth weight,
normal BMI. After controlling for current weight, there was an 2.6-fold
increase in risk for Overt albuminuria (ACR 34 g/mol) for every kg
reduction in birth weight. Fasting insulin levels showed the same inverse
relationship to birth weight. This is the first demonstration of the
relationship of low birth weight to renal disease. It might be mediated
through defective nephronogenesis or the accompaniments of the "met-
abolic syndrome" to which, according to the Barker hypothesis, LBW
contributes. Hyperinsulinemia/insulin resistance appears to mark this high
risk state. Public health interventions to improve birth weight and early
infant nutrition, and to promote healthy eating and exercise patterns for
everyone should reduce renal disease susceptibility as well as diabetes and
cardiovascular risk in these populations.
Morphologic correlates of renal disease in a high risk Aboriginal
community. D. Howard, J.S. Davis, D. Pugsley, T Seymour and W. Hoy,
Royal Darwin Hospital, Darwin, NT; Queen Elizabeth Hospital, Woodville,
SA; and Menzies School of Health Research, Casuarina, NT, Australia. We
describe the findings of the renal biopsies performed from 1982—1995 in 54
members of an NT Aboriginal community, population about 1600. This
community has rates of renal failure 60 times the NT non-Aboriginal rate,
and 4 times that of other NT Aboriginal communities. Pathological
albuminuria is present in 55% of adults, and there is marked family
clustering of renal disease. Multivariate analysis shows relationships to
metabolic and hemodynamic factors, low birth weight and streptococcal
infections. In our series, there were 27 males and 27 females, age range 13
to 55, with 17 diabetics (31%) and 33 patients (61%) with hypertension.
Serum creatinine ranged from 59 to 620 j.rmol/liter. Minimum indication
for biopsy was persistent proteinuria. Histological diagnoses showed
significant overlap, and were as follows: glomerulomegaly (up to 3 X
normal size) was present in 41 biopsies (76%). Twenty of these had no
additional diagnosis ("glomerulomegaly in isolation"). Fifteen of these 20
had significant glomerulosclerosis and/or interstitial scarring. Mesangio-
pathic GN was present in 25 (46%), with IgA dominant in 3 and 1gM in 7,
the remainder being mixed or unspecified. Diabetic changes were present
in 7 (13%), mixed with other diagnoses in 3 cases. In 6 biopsies, other
diagnoses occurred [SLE, amyloid, toxemia, post-infectious GN(2)1. Two
biopsies had no final diagnosis. Glomeruloselerosis was present in 45%,
interstitial fibrosis in 20% and scant (para)rnesangial electron dense
deposits in 33%. Among members of individual high-risk families, gb-
merubomegaly was a usual finding, with other changes varying. Similar
findings have been described in Central Australian and other Top End
Aborigines. These data demonstrate considerable heterogeneity in the
morphology, with an unusually high incidence of both glomerulomegaly
and mesangiopathic GN. Glomerubomegaly may underlie the predisposi-
tion of these groups to renal disease; it might reflect compensatory
hypertrophy secondary to reduced glomerular endowment, which may be
genetically based or due to intrauterine and early childhood malnutrition.
It might also represent a response to hemodynamic, metabolic or infec-
tious factors during life. Glomerulomegaly alone might lead to premature
glomerulosclerosis, or to more aggressive disease with a variety of
nephropathic insults which abound in these communities. Current classi-
fication systems are inadequate to describe or understand renal disease in
these populations, which might be better defined by its epidemiology than
by its morphology.
Renal disease in a remote desert-dwelling Aboriginal community in
Western Australia. M. Gracey, R. Spargo, P. Smith, R.M. Smith, V. Burke,
J. Beilby, L.J. Beilin, C. Chin, Health Department of Western Australia, East
Perth; University Department of Medicine, Royal Perth Hospital; CSIRO
Division of Human Nutrition, Adelaide; and Department of Clinical Bio-
chemistry, Queen Elizabeth II Medical Centre, Perth, Australia. Renal
disease is a major contributor to ill-health in Aborigines and their rate of
participation in end-stage renal disease programs is high. Diabetes,
hypertension and glomerulonephritis may contribute to pathogenesis.
Concerns about the health status of a remote desert-dwelling Aboriginal
community in Western Australia prompted a survey of urinary abnormal-
ities, cardiovascular risk factors, nutritional status, infections and infesta-
tions in all community members (N = 77). Diabetes was present in 10% of
adults and hyperinsulinemia in 46% of males and 69% of females. Fifteen
percent of the population were hypertensive. Urine was positive for blood
in 43% of men and 58% of women, protein in 43% of men and 58% of
women and leukocytes in 36% of men and 52% of women. Samples with
abnormalities on dip-stick testing were sent for microscopy and culture. E.
coli was grown from 35% of these samples, with mixed growth in 19% and
no growth, but antibacterial substances detected in 8%. Blood urea was
higher in men (mean 5.5 mmol/liter, CI 4.8, 6.1) than in women (mean 3.8
mmol/liter, Cl 3.4, 4.3). Proteinuria was associated with higher blood urea
(5.3 mmol/liter, CI 4.5, 6.1 vs. 4.4 mmol/liter, CI 3.8, 4.8) as was urine
positive for blood (mean 5.4 mmol/liter, Cl 5.6, 6.2 vs. 4.2 mmol/liter, CI
3.7, 4.7). Further investigation is needed into the reasons for the high rate
of urinary tract infection in this population who live in a contaminated
environment. Diabetes and poor nutrition are major problems despite
attempts at reversion to a more traditional lifestyle and will also contribute
to the high incidence of end-stage renal disease.
Renal disease and HTLV-I infection in central Australian Aborigines.
P. Burton, V. Soden, M. G. Kirubakaran, Department Of Medicine, Alice
Springs Hospital, NT., Australia. Human T-lymphotropic virus type I(HTLV-I) infection is known to be endemic in Central Australian
Aborigines. Elsewhere in the world infection has been associated with T
cell leukemias, tropical spastic paraparesis, joint and skin disease, al-
though there has been little disease association documented in Central
Australia. There appears to be a high prevalence of HTLV-I infection
among Central Australian Aborigines on dialysis. Seroconversion whilst
on dialysis has not been documented. If this prevalence were significant it
would suggest that HTLV-I is either associated with renal disease or with
worse outcome in terms of progression to end stage. Between January
1994 and May 1995, 173 Aboriginal patients were screened for HTLV-I.
Clinical parameters of renal impairment (creatinine > 0.12, urea > 8.0on
more than one occasion), hypertension, hematuria, proteinuria, diabetes
and abnormal liver function were also documented. We also looked at
seropositivity in the dialysis community. The presence of HTLV-l sero-
positivity is reported as 13.7% in the Central Australian Aboriginal
community (Bastian et al). Of our hospital-based population 17.9% were
seropositive. A total of 106 patients had renal impairment of whom 17
(16%) were HTLV-l positive. Equal numbers of HTLV-l positive and
negative patients had renal impairment (54.8% and 59.9%, respectively).
There was a high incidence of hypertension in HTLV-I positive patients
(71%). Of the dialysis population in March 1995, 10 Out of 34 patients
were seropositive for HTLV-I (31.25%), approximately twice the rate in
the study population with renal disease. These figures represent a trend
which did not, however, reach statistical significance ( = 2.691). Further
prospective studies in this area would include ongoing surveillance of
dialysis patients to detect seroconversion and monitoring of progression of
renal disease where HTLV-I seropositivity is present, to detect any
difference in renal outcome relative to the rest of the community.
Urinary tract infections in children of the Kimberley region 1990 —1992.
S. Alexander, K Murray, P. Richmond, I. Hewitt, Department of Nephrology,
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Princess Margaret Hospital, Subiaco, WA, Australia. Urinary tract infections
in children in the Kimberley region were studied because of the concern
regarding the high incidence of renal disease in the adult Aboriginal
population of the region. We report on a prospective study of Aboriginal
children in the Kimberley region. From January 1990 to December 1992,
83 children with urinary tract infections were identified, some with
multiple infections. The most common organism was E. coli; other
organisms included Kiebsiella, Proteus, Acinobacter and Pseudomonas.
The annual incidence of urinary tract infections was 0.85 infections/1000
children annually for children aged 5 or less. Routine investigation
included renal ultrasound and micturating cystourethrogram. Ten children
had ureteric refiux and 15 children had either renal or bladder stones.
Renal and bladder stones occurred more frequently in young children and
in children from communities in the Fitzroy River and the Western
Desert, with no stones occurring in children from the coastal communities.
Urinary tract infections in this population are associated with significant
pathology including ureteric refiux and calculi. Calculi are associated with
harsh climatic conditions and young age.
DMSA renal scan in adults with acute pyelonephritis. R.R. Bailey, KL.
Lynn, R.A. Robson, A.H. Smith, TM.J. Maling, J. G. Turner, Departments of
Nephrology, Radiology and Nuclear Medicine, Christchurch Hospital,
Christchurch, New Zealand. The Tcs9mDMSA scan is accepted as the most
sensitive imaging modality for detecting renal parenchymal scarring. More
recently, the DMSA scan has been shown to be of value in imaging areas
of renal parenchymal involvement in children, adults and animals with
acute pyelonephritis. In this study we assessed the acute DMSA scan
findings in 81 consecutive patients (mean age 32.7 years; 73 women)
hospitalized with acute pyelonephritis (fever >37.8°C, loin pain or ten-
derness, infected urine). All patients had a blood culture, hematological
and biochemical screen, C-reactive protein (CRP) and urinary tract
ultrasonography. If the initial DMSA scan was abnormal it was repeated
after 3 months and in some after 6 months. If persisting defects were noted
an IVU was done. Of the 81 patients, 37 (46%) had an abnormal scan:
single defect 19, multifocal defects 12, pre-existing scarring 5 (all subse-
quently shown to have refiux nephropathy), shrunken kidney 1. Those
patients with an abnormal scan had a higher CRP than those with a
normal scan. Of the 31 who had either a focal or multifocal defects on
their initial scan there was adequate follow-up on 24. In 18 of these the
defects resolved, 3 had persistent defects and were subsequently shown to
have refiux nephropathy, 1 had a large renal cyst, 1 an area of renal
calcification, and another a persisting defect but declined an IVU. In
adults with acute pyelonephritis, the DMSA scan may prove to be the most
useful renal imaging procedure, and promises to improve our understand-
ing of the natural history of this condition.
Heparin-binding epidermal growth-like growth factor (HB-EGF) ex-
pression in the 5/6 nephrectomy model. G.S. Kirkland, K Paizis, L. Woo,
D.A. Power, Department of Clinical Immunology, St Vincent's Hospital,
Melbourne, and Department of Medicine, Austin and Repatriation Medical
Centre, Heidelberg, Victoria, Australia. The rat 5/6 nephrectomy model is
commonly used to study hyperfiltration injury. In the acute phase, it is
characterized by macrophage infiltration and mesangial cell proliferation
which precede glomeruloscierosis. The growth factors responsible for
these events, however, have not been well defined. HB-EGF is a newly
described member of the EGF family and has been shown to be a potent
mitogen and chemotaxin for smooth muscle cells, and a mitogen for
fibroblasts and keratinocytes. Since HB-EGF mRNA is produced by
cultured rat mesangial cells, we attempted to determine whether HB-EGF
mRNA and protein is present in the 5/6 nephrectomy model. Male
Sprague-Dawley rats underwent 5/6 nephrectomy or sham operation and
were sacrificed at days 3 and 5 and weeks 1, 2 and 4 after operation.
Semiquantitative RT-PCR showed that HB-EGF mRNA was increased in
glomeruli at day 5, peaked at week 1 and remained elevated through to
week 4. In situ hybridization and immunohistochemistry confirmed in-
creased expression of HB-EGF mRNA and protein in glomeruli, mainly in
glomerular epithelial cells. Unexpectedly, striking expression of HB-EGF
mRNA and protein was noted in the infarcted region from day 3 onwards.
Morphologically, the positively staining cells were typical of myofibro-
blasts and this was confirmed by staining with alpha-smooth muscle actin.
These were mainly seen around necrotic tubules and viable arterioles.
Interestingly, pyknotic nuclei typical of apoptosis were seen in some
tubules and whole glomeruli in the pen-infarct region but, in these areas,
very little staining for HB-EGF mRNA or protein was apparent. These
data show that HB-EGF is expressed in GEC in the 5/6 model and is in the
correct location to cause alterations in GEC function. More importantly,
however, the dramatic increase in HB-EGF mRNA and protein seen in
the infarcted areas implies a role in the response of renal tissue to
necrosis, and the process of wound healing in general.
Anti-interferon'y (IFN'y) antibody treatment inhibits cutaneous de-
layed-type hypersensitivity and crescent formation in anti-GBM glomer-
ulonephritis (GN) in mice.XR. Huang, PG. Tipping and SR. Holdsworth,
Centre for Inflammatory Diseases, Monash University Department of Medi-
cine, Monash Medical Centre, Clayton, Victoria, Australia. Mice with
genetic predisposition to Thi T cell subset responses develop delayed-type
hypersensitivity (DTH) following cutaneous antigen challenge and cres-
centic GN when the antigen is presented in the glomerulus. IFNy is a
pivotal cytokine in directing Thi immune effector responses. The role of
IFNy in directing severe crescentic injury in GN was studied by in vivo
inhibition using a functionally inhibitory monoclonal rat anti-mouse IFNy
antibody (R4.6A2). GN was induced by i.v. injection of sheep anti-mouse
GBM globulin in Thi prone C57BL/6 mice sensitised 10 days earlier by s.c.
injection of sheep globulin in Freunds complete adjuvant. Mice were
treated with rat anti-mouse IFN7 antibody (1 mg i.p.) or normal rat
immunoglobulin (control) at the time of sensitization, at the time of
administration of anti-GBM globulin and with 0.5 mg i.p. on days 3, 5 and
7 after anti-GBM globulin. Injury was assessed 10 days after anti-GBM
globulin. Control mice developed crescentic GN with 40 3.0% of
glomeruli affected, proteinuria (6.1 0.6 mg/24 hr, normal 0.8 0.5
mg/24 hr) and glomerular accumulation of CD4 + ye T cells (1.8 0.1
cells/glomerular cross section (c/gcs), normal 0.01 0.001 c/gcs) and
macrophages (5.0 0.1 c/gcs, normal 0.01 0.001 c/gcs). These mice also
developed a pronounced DTH response to intradermal challenge with
sheep globulin (footpad thickness 2.9 0.03 mm, normal 1.6 0.01 mm).
Treatment with anti-IFNy antibody significantly reduced glomerular
crescent formation (4 1.4%, P < 0.001) and proteinuria (2.5 mg/24 hrP < 0.01) and prevented glomerular accumulation of CD4 + ye T cells
(0.1 0.01 c/gcs, P < 0.001) and macrophages (0.5 0.01 c/gcs, P <
0.001) compared to control treatment. Cutaneous DTH to sheep globulin
was prevented by anti-IFNy antibody treatment but circulating levels of
mouse anti-sheep globulin antibody (assayed by ELISA) were unaltered.
These results suggest that in Thi prone mice, IFNy plays a pivotal role in
the induction of severe glomerular injury and crescent formation.
Antibody independent glomerulonephritis and crescent formation in
chain deficient mice. S. Li, SR. Holdsworth and P. G. Tipping, Centre for
Inflammatory Diseases, Monash University Department of Medicine, Monash
Medical Centre, Clayton, Victoria, Australia. The prominent participation
of T cells, macrophages and fibrin suggests that crescent formation in
glomerulonephritis (GN) is a T cell dependent, delayed type hypersensi-
tivity (DTH)-like lesion, with no requirement for autologous antibody. To
address this hypothesis, GN was initiated by a planted glomerular antigen
(sheep immunoglobulin) in mice with deletion of the p. immunoglobulin
heavy chain gene (p. chain deficient mice). Homozygous p. chain deficient
mice have normal antigen recognition and normal DTH following cuta-
neous challenge with sheep globulin, but have rio circulating immunoglob-
ulin or antibody response to antigen challenge. GN was induced in
presensitized mice by a subnephritogenic dose of sheep anti-mouse GBM
globulin. Heterozygous mice (p. chain +/—) developed proliferative GN
with proteinuria (6.1 2.7mg/24 hr), renal impairment (serum creatinine
31 3.6 p.mol/liter) and crescents in 35 1.4% of glomeruli. They had
high serum titers of anti-sheep antibody and prominent glomerular
deposition of mouse immunoglobulin. Homozygous p. chain deficient mice
(—/—) also developed proliferative GN, histologically indistinguishable
from +/— mice. Proteinuria (6.3 2.5 mg/24 hr), renal impairment (30
1.2 p.mol/liter) and crescent formation (28 5%) were not statistically
different from +1— mice, despite the absence of detectable mouse
immunoglobulin in serum or glomeruli. These results demonstrate that
glomerular crescent formation can occur independent of a humoral
immune response to planted glomerular antigen and without glomenilar
deposition of autologous antibody. This strongly supports the hypothesis
that crescent formation is a manifestation of DTH.
Increased binding of polymeric A-IgA isolated from patients with IgA
nephropathy (IgAN) by cultured human mesangial cells. KN. Lai, WY
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To and J.C.K Leung, Department of Medicine, The Chinese University of
Hong Kong, Hong Kong. IgAN is characterized by raised plasma A-IgA1
and mesangial polymeric A-IgA1 deposits. It remains uncertain whether
the predominant glomerular A-IgA1 deposits represent a selective uptake
of polymeric IgA or a nonspecific uptake due to raised circulating A-IgA1.
In this study, we aim to study whether there is an increased binding of
monomeric IgA1 (mIgA1) or polymeric lgA1 (pIgA1) from patients with
IgAN to cultured human mesangial cells (HMC). Total IgA1 in plasma
from patients or healthy controls was isolated by jacalin-agarose column as
jacalin-bound proteins (JBP). mIgA1 and pIgA1 were distinctly separated
by FPLC. HMC were incubated with IgA preparations and IgA bound to
HMC was determined by flow cytometry analysis using standard curves
constructed by known concentrations of K-IgA or A-lgA1. In order to avoid
any increased binding of IgA to HMC due to elevated K- or A-IgA
concentrations in JBP samples from patients, JBP samples from patients
or controls were appropriately diluted to achieve comparable levels of
total IgA1. No difference in the total mIgA or plgA1 concentration,
percentage of mIgA1 or pIgA1, or the K/A ratio of mIgA1 or pIgA1 was
found between adjusted JBP samples from patients or healthy controls.
We found a sharp rise in percentage of plgA1 among lgA1 bound to HMC
(>50%) despite only 3% of the IgA1 in the adjusted JBP samples were
polymeric suggesting that pIgA1 had a higher affinity to HMC than mIgA1.
Furthermore, the K/A ratios of pIgA1 bound to HMC were significantly
lower than the K/A ratios of pIgA1 in adjusted JBP only with IgAN patients
but not healthy controls (P = 0.0026). Our data suggest a preferential
mesangial binding of polymeric A-IgA1 from patients with IgAN. These
"pathogenic" polymeric A-IgA are important in the pathogenesis of IgAN.
T cells direct changes in the glomerular expression of tissue factor
pathway inhibitor (TFPI) during the development of a rabbit model of
fibrin dependent crescentic glomerulonephritis (GN). J.H. Erlich, J.
Aposlolopoulos, P. G. Tipping, and S.R. Holdsworth, Centre for injiamma-
toiy Diseases, Monash University Department of Medicine, Monash Medical
Centre, Clayton, Victoria, Australia. TFPI, the major in viva inhibitor of
tissue factor (TF) mediated coagulation, is expressed in normal rabbit
glomeruli and is down-regulated during the development crescentic
glomerulonephritis and normal rabbits where glomerular TF activity and
T cell infiltration are prominent features. This suggests that TFPI may
potentially have an important role in vivo in inhibiting activation of
coagulation and reducing glomerular fibrin deposition. T cells have been
demonstrated to have a role in augmenting glomerular TF in this disease,
but their role in the regulation of TFPI expression is unknown. This
question was assessed in a model of crescentic GN, induced in presensi-
tized rabbits by i.v. injection of 25 mg/kg of horse anti-rabbit glomerular
basement membrane globulin, by in vivo T cell depletion. Rabbits were
treated with either a monoelonal anti-rabbit CD5 or an irrelevant mono-
clonal control antibody (50 mg/kg) one hour prior to anti-GBM globulin,
followed by a daily dose of 20 mg/kg. Depletion of circulating T cells was
assessed by flow cytometry of peripheral blood and tissue depletion was
assessed by immunostaining of the kidney and spleen. T cell accumulation
in glomeruli was prevented by treatment with anti-CDS antibody. On day
4 after anti-GBM globulin, glomerular TFPI antigen assessed by ELISA,
was significantly reduced (anti-CD5 treated 5.6 0.4 ng/103 glomeruli,
control 11.9 2.4 ng/103 glomeruli, P = 0.0027). Glomerular TFPI
mRNA expression (corrected for GAPDH) was also reduced by T cell
depletion (anti-CD5 treated 21.6 4, control 100 29.2, P = 0.0037).
Glomerular TF activity, antigen and mRNA were also decreased. This
data demonstrates that T cells are important in directing glomerular
expression of TFPt and provides the first demonstration in vivo of cellular
regulation of TFPI expression. The mechanism by which T cells direct
TFPI expression requires further study, and may involve direct effects of
T cells or intrinsic glomerular cells or effects mediated via macrophage
recruitment or activation.
Genetic linkage studies in thin basement membrane disease. J. Ellis, K.
Fairley, and J. Savige, University Department of Medicine, Austin and
Repatriation Medical Centre, Heidelberg, and Renal Unit, Epworth Hospital,
Richomond, Victoria, Australia. Patients with thin basement membrane
disease (TBMD) have hematuria, and sometimes proteinuria and hyper-
tension. In some families this condition has an autosomal dominant
inheritance. The diagnosis of TBMD is made when the glomerular
basement membrane (GBM) is less than 250 nm on ultrastructural
measurements. Thus mutations in one of the genes encoding a basement
membrane structural protein may be responsible for TBMD. We have
looked for linkage to these genes in several families with TBMD using
dinucleotide repeats. Candidate genes examined were those encoding
alpha 1-4 (IV) collagen chains, laminin A, B2 and fibronectin. DNA was
collected from effected and normal family members and amplified using
the primers for the appropriate repeats (one of each pair being radiola-
belIed) and Taq polymerase. The products were electrophoresed on
denaturing polyacrylamide sequencing gels, and the alleles examined for
evidence of segregation of one allele with the disease in each family.
Linkage studies in one of these families were consistent with X-linked
inheritance, and thus the diagnosis of Alport syndrome is likely. In another
family, the studies with markers for the alpha 3 or 4 (IV) collagen chains,
in which mutations occur in autosomal Alport syndrome, were uninfor-
mative. In the final family, linkage to the genes for the type IV collagen
chains, fibronectin and laminin B2 was excluded by recombination. These
results suggest that the TBMD has a heterogeneous genetic basis.
Studies in bull terrier hereditary nephritis: A model for autosomal
dominant Alport syndrome. G. Jennings, J. Savige, J. Hood, R. Sinclair, C.
Huxtable, and W. Robinson, University Department of Medicine and Depart-
ment of Pathology, Austin and Repatriation Medical Centre, Melbourne, and
School of Veterina,y Studies, Murdoch University, Perth, Australia. Bull
terrier hereditary nephritis is an autosomal dominantly-inherited disease
with a lamellated glomerular basement membrane (GBM) identical to
that seen in human X-linked Alport syndrome. The aims of this study were
to determine the protein abnormality responsible for Bull terrier heredi-
tary nephritis. Candidate proteins were the autosomally-inherited type IV
collagen chains (alpha 1—4 (IV)), laminin 1, Bi and B2 chains, fibronectin,
nidogen, and perleean. First, a difference in the distribution or amounts of
these proteins in affected and normal dog kidneys was examined using
immunohistochemistry and semiquantitative ELISAs. Unlike the X-linked
forms of Alport syndrome, the Goodpasture antigen was present in the
kidneys of Bull terriers with hereditary nephritis, and there was no
difference in the distribution or reduction in the amount of any of the
other proteins in affected compared with normal dog kidneys. Some
individuals with Alport syndrome, who are missing the Goodpasture
antigen from their GBM, will develop anti-GBM disease post-renal
transplant. Thus, 3 affected Bull terriers were immunized with normal dog
GBM to determine whether they would produce anti-GBM antibodies and
what the antibody target would be. The urinary protein excretion in-
creased in all the immunized affected animals, and one made anti-GBM
antibodies. However, these antibodies did not bind differently in Western
blots to normal and affected GBM and did not bind to GBM in normal dog
kidneys by indirect immunofluorescence. There were no histological
abnormalities consistent with anti-GBM disease in any of the kidneys of
the immunized animals. In Bull terrier hereditary nephritis, the amount of
the abnormal protein may he relatively normal because of the autosomal
dominant inheritance; the protein abnormality may still affect one of the
major constituents of the GBM.
Comparison of immunosuppressive drugs on cytokine mRNA profiles
in human MLC. G. Patrick, R. Krishnan, and G.R. Russ, Transplantation
Immunology Laboratory, Renal Unit, The Queen Elizabeth Hospital, Wood-
ville Road, Woodville, Australia. Mixed lymphocyte culture (MLC) is a
useful model in the study of the alloimmune response. This study
characterizes the early changes in T lymphocyte cytokine mRNA expres-
sion (IL-2, IFN7, IL-4 and IL-b) in unmodified and immunosuppressed
human MLC. Equal numbers of macrophage-deplete human peripheral
blood mononuclear cells (PBMNC) from two healthy volunteers were
co-cultured in the presence of various drugs at anti-proliferative concen-
trations: cyclosporine (CSA) 0.5 jsglml, FK 506 i0 rg/ml, rapamycin
(RAPA) I n, prostaglandin E2 (PGE2) iO M and pentoxi'lline (PTX)
100 zgIml. Cultures were harvested after 2, 4, 6 and 20 hours and total
RNA was quantitated and analyzed by RT-PCR. PCR products were
semi-quantitated by densitometric scanning of ethidium bromide stained
agarose gels and values were normalized to /3-actin. Up-regulation of
mRNA for IL-2, IFNy and IL-b was seen in unmodified MLC and was
maximal at 20 hours. Expression of IL-4 was low and changed little
throughout the time course. CSA, FK506, PTX and PGE2 markedly
down-regulated the expression of message for IL-2 and lFNy, but had a
lesser effect on IL-4. By contrast, when compared to unmodified MLC,
increased expression of IL-b mRNA was seen as early as 2 hours and
persisted to 20 hours. However, with RAPA only minor down-regulation
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of IL-2 and IFNy mRNA was seen. In addition there was no effect on IL-4
message and no up-regulation of IL-b message. In conclusion, despite
different modes of action, CSA, FK 506, prostaglandin E2 and pentoxifyl-
line have a similar influence on cytokine mRNA expression in human
MLC. Increased early expression of message for the immunosuppressive
cytokine IL-lO induced in vitro by these drugs suggests this cytokine may
play an important role in the inhibitory modification of the alloimmune
response. In contrast, rapamycin had little effect on early cytokine mRNA
expression, confirming a mode of action of this drug independent of gene
transcription for the cytokines studied.
B cell selection and apoptosis in the germinal center. KG. C. Smith,
TD. Hewitson, G.J. V Nossal, and D.M. Tarlinton, The Walter and Eliza
Hall Institute for Medical Research and Department of Nephrology, Royal
Melbourne Hospital, Victoria, Australia. The humoral immune response
results in the production of high affinity antibody-forming cells (AFCs)
and memory B cells. Both of these are products of the germinal center
(GC) and are critical for effective immune responses. In the GC prolifer-
ation, somatic hypermutation and apoptosis occur. Selection of mutants
with high affinity for antigen, with concomitant loss of low affinity cells, is
critical for the production of memory B cells and high affinity antibody-
forming cells (AFC5). To determine the importance of apoptosis in this
selection, we studied the roles of apoptotic pathways controlled by BCL-2
and FAS. Wild-type mice expressed high levels of FAS on GC cells, but lpr
mice, deficient in FAS, had no defect in selection or in AFC, GC, or
memory cell number. Mice expressing transgenic BCL-2 in their B cells
displayed increased recruitment of memory B cells and persistence of
AFC foci. Transgenic strains expressing high levels of BCL-2 had an
abnormally selected memory population, demonstrating the importance of
apoptosis in efficient development of immunological memory. Affinity
maturation was described over 30 years ago, yet the molecular basis of it
at the level of the AFC has not been described. We have achieved this by
isolating single antigen-specific bone marrow AFCs producing high affinity
antibody in the primary response and sequencing their V genes. The
mutational pattern of these genes indicated they arose early in the GC
reaction, before memory cells, and were highly selected on the basis of
affinity. They persisted at the expense of uiimutated cells, indicating that
passage through the GC confers longevity. The timing of their selection
results in a mutational pattern distinct from that of memory B cells, and
has implications for regulation of the immune response.
Extracellular matrix remodelling in a wound-like injury to the kidney.
K. Kelynack, C. Jones, J. Forbes, T Hewitson, and G. Becker, Department of
Nephrology, Royal Melbourne Hospital, Department of Nephrology, Royal
Children's Hospital, Victoria, Australia. The mechanisms of interstitial
extracellular matrix (ECM) remodelling in the kidney in viva are not fully
understood. ECM remodelling was studied in time course experiments in
a model of renal scarring. A wound-like injury was produced using a single
application of liquid nitrogen to the surface of the kidney. Animals were
sacrificed at 5 intervals up to 32 days post-injury (N = 7 at each time
point). Immunohistochemistry was used to localize collagen III, monocyte/
macrophage (Mo) and myofibroblast (MF) infiltration. Activity of matrix
degrading enzymes (MMPs 2 and 9) were assessed by zymography. Cell
proliferation was quantitated by bromodeoxyuridine (BrdU) incorpora-
tion. Initially, the injury consisted of an acute polymorph infiltration,
followed by a concurrent Mo and MF accumulation (P < 0.01 and P <
0.05, respectively; maximal at D4). Immunohistochemistry for BrdU
localized proliferation to MF and tubular epithelial cells, but not Mo.
Cellular infiltrate decreased from day 8. There was progressive collagen
III accumulation maximal at day 32, while the wound area became
sequentially smaller over time (P < 0.01 at D16). The zymographic activity
of MMPs 2 and 9 was consistently higher in the scarred region of injured
kidneys than in non-injured controls. In conclusion, this animal model
enabled the study of the tissue remodelling events of cell and matrix
removal and contraction following a "one-hit" injury to the kidney. This
model provides the potential to further investigate these cellular mecha-
nisms and their involvement in matrix turnover.
Fas, ice and autoimmunity in CrmA transgenic and lpr mice. KG.C.
Smith, A. Strasser, and DL. Vau.x. The Walter and Eliza Hall Institute of
Medical Research, Royal Melbourne Hospital, Victoria, Australia. lpr mice,
deficient in the apoptosis-signalling cell surface molecule Fas (CD 95),
develop an SLE-like illness and die of immune complex-mediated nephri-
tis. Interleukin ij3 converting enzyme (ICE), a cysteine protease that is a
homologue of the C. elegans cell death gene ced-3, has been implicated in
signalling downstream of Fas. The cowpox virus encodes a protein, CrniA,
that can inhibit the enzymatic activity of ICE. To examine the role of ICE
in Fas-mediated death and autoimmunity, we generated transgenic mice
expressing CrmA in their T lineage cells. Thymocytes from CrmA
transgenic mice remained susceptible to apoptosis induced by dexameth-
asone or y-irradiation, indicating that ICE is not required for cell death
triggered by these agents. Activated T cells and thymocytes from the
CrmA transgenics were, however, protected against apoptosis caused by
ligation of the Fas antigen, showing that, at least in T cells, Fas-triggered
apoptosis is mediated by ICE. CrmA expressing T cells are killed normally
by cytotoxic T cells, indicating that the apoptosis induced by CTL is not
dependent on Fas. lpr mice accumulate abnormal B220+ T cells, anti-
DNA antibodies and an SLE-like illness. Despite having no detectable Fas
killing of T cells, CrmA mice do not develop these features. Thus, the
action of ICE, or a homologue blocked by CrmA, is critical for Fas-
mediated cell death. Blocking this death is, however, insufficient to cause
the autoimmune phenotype seen in lpr mice suggesting the mechanism
responsible for SLE in lpr mice is due to more than inhibition of
Fas-mediated death alone.
The myoflbroblast in acute transplant rejection. E. Pedagogos, T.
Hewitson, K Nicholls, R. Walker, G. Becker, Department of Nephrology, The
Royal Melbourne Hospital, Victoria, Australia. Acute rejection is an impor-
tant predictor of the development of chronic rejection with interstitial
fibrosis. We studied the renal biopsies from patients with acute rejection
within one month post-transplantation (N = 10) to ascertain whether
myohbroblasts (MF) have a role in this process. MF are collagen
producing cells with morphological features of fibroblasts, and intracellu-
lar a smooth muscle actin (aSMA) as in smooth muscle cells. A control
group consisted of patients with routine three month biopsies and normal
renal function (N = 10). Immediate transplant biopsies taken at the time
of renal transplant anastomosis were also used for comparison within each
group. MF were identified by morphology and aSMA immunostaining. T
cells and macrophages (M4) were defined using a monoclonal antibody to
CD3 and CD68, respectively. Immunostaining was performed for collagen
III (Co113) using a goat monoclonal antibody. The Mann-Whitney U-test
was used for statistical analysis. With acute rejection there were significant
increases in interstitial fractional area (IFA) (median = 21.05 vs. 6.05, P <
0.001), aSMA staining (median = 9.25 vs. 3.55, P < 0.001), T cells(median = 1.8 vs. 0.0, P < 0.001) and M4 (median = 4.45 vs. 0.35, P <
0.001) as compared with the control group, However, there was not a
significant change in Coll3 (median = 1.85 vs. 2.1, P = 0.20). We conclude
that MF are present in acute transplant rejection. The absence of an
increase in Coll3 staining within one month post-transplant suggests that
in this early stage fibrosis may depend on persistence of MF with
stimulation to synthesise Coll3. Treatment aimed at decreasing MF
persistence and stimulation may reduce later tubulointerstitial fibrosis.
Arteriovenous access flstulae (AYE) exert significant demands on both
anaerobic threshold (AT) and cardiac output (CO)—A case for AVE
closure in stable renal transplant patients (RTx). J. W.M. Agar, T.J.
Jackson, J. Steinwedel, CF. Corke, andA.F. Appelbe, Departments of Renal
Medicine, Intensive Care, and Cardiology, Geelong Hospital, Geelong,
Victoria, Australia. The maintenance of a chronic AVF in RTx may be
viewed as "insurance" against subsequent graft failure and return to
chronic hemodialysis. However, in stable long-term RTx, a patent AVF
may exert a significant chronic increase in demand on left ventricular (LV)
work which, in turn, might be expected to adversely affect the prognosis of
patients already acknowledged to have increased cardiac risk. To assess
the effect of an AVF on LV work, 5 stable male RTx> 18 months post-Tx
(mean age = 49) had echocardiographic CO assessment with AVF open(AVFo) and AVF closed (AVFc), while AVFo and AVFc exercise
anaerobic thresholds (AT) were assessed by VCO2 versus VO2 uptake
curves using the Beaver method. Results were assessed by the paired t-test.
The resting AVFo CO measured 6.91 1.68 liter/mm (range 4.9—9.1)
which compared with a resting AVFc CO of 6.03 1.0 liter/mm (range
4.7—7.4), a mean increase of 113% (P = 0.027). The AVFo AT was
16.03 6.08 (range 10.16—26.0) which compared with the AVFc AT of
18.27 7.78 (range 11.8—31.25), a mean increase of 114% (P = 0.026).
The work required to reach the AT was assessed with AVFo at 68 27.5
watts and with AVFc at 81.6 36.9 watts (P = 0.049). Despite small
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numbers, this study clearly suggests that LV workload maybe significantly
and permanently increased by a patent AVF with an associated reduction
in exercise efficiency. AVF patency is ideal in RTx where graft function is
doubtful, but should long-term stable graft function be anticipated, the
adverse effects of AVF patency (persistently elevated LV workload and
reduced exercise capacity shown by elevated resting AVFo CO vs AVFc
CO and reduced AVFo AT vs AVFc AT) make a strong case for
considering AVF closure. The prognostic advantage for LV function may
outweigh AVF preservation in stable RTx.
Effect of cardiovascular screening on patient and graft survival in
elderly renal transplant recipients. A.P. Parnham, G.M. Hawley, J.J.B.
Petrie, P. Garrahy, G. Balderson, Ri. Rigby, M. C. Falk, D. Wall, D. Nicol,
and R. Hardie, Renal Transplant Unit, Princess Alexandra Hospital, Ipswich
Road, Woolloongabba, Queensland, Au. In 1989 analysis of results in our
elderly transplant recipients revealed a high cardiac mortality. This led to
a strict policy of cardiovascular screening instituted in 1990. All patients
had echocardiography. Patients over 50 years of age, or with any of the
following criteria, had dipyridamole thallium scanning with SPECT:
patients with renal disease secondary to diabetes or analgesic nephropa-
thy, >10 pack year smoking history, or severe hyperlipidemia. Coronary
angiography was performed in patients greater than 65 years old, past or
current history of ischemic heart disease, echocardiography showing
regional wall motion abnormalities or left ventricular ejection fraction <
40%, or a positive thallium scan. Patients with coronary artery disease
were considered to be unsuitable for transplantation unless they were
revascularized or their mortality was thought to be acceptable. Prior to
cardiac screening, both patient and graft survival were significantly worse
in patients aged over 60 years (N = 58) compared to those aged 30—50
years (N = 151; P < 0.0005 and P < 0.0005). Patient survival was 82.8%
versus 96% at 1 year and 58.4% versus 90.0% at 5 years, respectively.
Graft survival was 77.6% versus 9 1.3% at 1 year and 56.7% versus 78% at
5 years, respectively. After cardiac screening patient survival in elderly
patients (N = 62) was comparable with those aged 30—50 years (N = 179;P = NS). Patient survival was 98.3% versus 96.8% at 1 year, and 95.4%
versus 94.9% at 3 years, respectively. Graft survival was significantly better
in the elderly recipients, 98.3% versus 93.2% at one year and 95.3% versus
85.7% at 3 years, respectively (P < 0.05). With careful screening for
cardiovascular disease improved outcomes can be obtained in elderly
renal transplant recipients.
Triglycerides, glucose and the 4G/5G polymorphism of the PAll gene
determine levels of the thrombotic risk factor PAIl in renal transplant
recipients. A. Irish, F. Green, and P.J. Morris, Oxford Transplant Centre,
Oxford and The Department of Medicine, University College, London,
England, United Kingdom. Renal transplant recipients (RTR) suffer
increased thrombotic complications. Plasminogen activator inhibitor 1
activity (PAIl) is the major inhibitor of fibrinolysis and increased levels
are associated with venous and arterial thrombotic risk in the general
population. A polymorphism of the PAIl gene (4G/5G) is associated with
increased PAIl and interaction with triglycerides (Tg), glucose (Glue) and
insulin in carriers of the 4G allele, compared with the 5G allele. We
measured PAIl, Tg and fasting Glue in 203 stable RTR and, determined
their PAIl genotype. PAIl levels in patients did not differ according to
cyclosporine A or prednisolone use. PAl levels by genotype and correla-
tion with Tg and glucose are shown below.
Genotype 5G/5G (61) 4G/5G (91) 4G/4G (51)









"p <0.05, bp <0.01
PAT activity increased significantly in homozygotes for the 4G allele who
had the strongest correlation with Tg and Glue. This suggests that the
4G/5G genotype exacerbates or ameliorates the interaction between
environmental factors and PAIl in RTR to influence individual cardio-
vascular and thrombotic risk. Prospective evaluation of PAIl as a cardio-
vascular risk factor is required in RTR to determine the significance of this
finding, the effect of genotype, and the potential for population screening
and intervention studies.
Outcome of children born to renal transplant recipient mothers. FR.
Willis, Mi. Gorrie, CA. Findlay, AG. Wilkinson, M.A. Watson, iD. Briggs,
and T.J. Beattie, Renal Unit, Royal Hospital for Sick Children-Yorkhill, and
Renal Unit, Western Infirmaty, Glasgow, Scotland, United Kingdom. Objec-
tive: To assess the current physical status and neurodevelopmental
outcome of children born to mothers following renal transplantation.
Methodology: This was a cross-sectional prevalence survey of 48 children
born to 34 women transplanted at a single center from 1971—1992. Data on
maternal renal disease, immunosuppression, pregnancy, delivery and child
development were collected using hospital records and parental question-
naire. Children also underwent physical and developmental examination,
urinalysis and urinary tract ultrasound examination. Results: Maternal
renal failure was due to reflux nephropathy/chronic pyelonephritis (16),
chronic glomenulonephritis (8), and other causes (10). All mothers
received prednisolone immunosuppression, 1 as sole therapy, 1 as part of
triple therapy. Sixteen (47%) received azathioprine/prednisolone and 16
(47%) cyclosporin/prednisolone. Twenty-three girls and 25 boys aged 9
months to 18 years were studied. Twenty-seven/48 (56%) were born
prematurely, 21/48 (44%) with birth weight (BW) <2500g. Twenty-one/48(44%) were small for gestation (BW <10th centile). General health and
physical assessment were unremarkable in 45/48 (94%) and 41/43 (95%),
respectively. Development was considered normal in 47/48 (98%), and
4/40 (10%) children investigated by ultrasound had urinary tract abnor-
malities compared with 10/203 (5%) children presenting with a first
afebrile UTI (OR = 2.14, P = 0.18 NS). Conclusions: The outcome for
children of renal transplant recipient mothers is good. Urinary tract
ultrasound screening is worthwhile, given the heritable nature of some
maternal renal disease.
Upper gastrointestinal bleeding after renal transplantation. J. Katsoulis
and MB. Fraenkel, Renal Unit, Austin and Repatriation Medical Centre,
Heidelberg, Victoria, Australia. Between December 1994 and June 1995, 5
of the 14 renal transplants conducted at the Austin and Repatriation
Medical Centre were complicated by major upper G.I. hemorrhage. To
investigate possible precipitants for this unexpected cluster of adverse
events, a chart review of 28 consecutive cadaveric and live donor trans-
plants from June 1994 to 1995 was performed. Those patients with and
without G.I. hemorrhage were compared with respect to symptoms, use of
H2 antagonists, use of steroids for rejection, the timing of bleeding, extent
of lesions, presence of Helicobacter pylon and the presence of previously
reported risk factors for G.I. bleeding: NSAIDS, smoking, alcohol,
hyperparathyroidism and hypercalcemia. All 5 patients with hemorrhage
were previously asymptomatic, not on H2-antagonists, and had minimal
symptoms at the time of bleeding. All episodes occurred within one month
of transplantation. Endoscopy revealed multiple ulcers with negative rapid
urease tests, although 2 cases showed H. pylon on gastric biopsy. All cases
required  5 units blood transfusion. One case required laparotomy.
Three of 5 with hemorrhage (60%) had received pulse steroid therapy just
prior to hemorrhage: 13/23 without hemorrhage (57%) had received pulse
steroid therapy, and 6/23 non-bleeders were on ranitidine (5 of these
received pulse steroid therapy). Other risk factors were not significantly
different between the two groups. The literature suggests an 8% incidence
of upper G.I. hemorrhage after transplantation. Prophylactic use of H2
antagonists has been shown to prevent complications in previously asymp-
tomatic individuals, but this is not routine therapy in many units. This
retrospective study was not able to determine an explanation for the
cluster of G.I. hemorrhage post-transplantation, indicating that the timing
may have been fortuitous. We suggest that gastric biopsies as well as
urease tests should be performed to diagnose H. Pylon in patients with
G.I. bleeding in the post-transplant period. We have introduced routine
use of H2 antagonists in the post-transplant period and will establish
prospectively if the incidence of post-transplant bleeding complications is
reduced.
Hypercholesterolemia and transplantation: the A&RMC experience.
C.J. Holmes and MB. Fnaenkel, Renal Unit, Austin Campus, Austin and
Repatriation Medical Centre, Heidelberg, Victoria, Australia. Coronary
artery disease is a major cause of morbidity and mortality in renal
transplant recipients, and hypercholesterolemia has been established as an
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independent risk factor for coronary artery disease in the general popu
lation. A retrospective review of cholesterol levels, independent cardiac
risk factors and response to cholesterol lowering therapy in our transplant
recipients was performed. In accordance with new National Heart Foun-
dation (NHF) guidelines based on cardiac risk stratification, each patient
was assigned a target cholesterol. One hundred eighty-two patients with
functioning renal transplants were assessed. Sixteen patients (9%) had
established coronary artery disease and were assigned a target cholesterol
of 4.5 mmol/liter. Twenty-three (13%) had a target cholesterol of 5.0
mmol/liter, 134 (74%) a target of 5.5 mmol/liter and 9 (5%) a target of 6.5
mmol/liter. Analysis of serum cholesterol levels showed 32 patients (18%)
had never had their serum cholesterol checked. Forty-one patients (23%)
had a serum cholesterol within their target, 41 (23%) had an elevated
serum cholesterol which was being treated actively, and 68 (36%) had an
elevated serum cholesterol which was untreated. Patients treated with
chotestyramine generally had a poor response to therapy. Patients treated
with HMG coA reductase inhibitors had better lowering of serum
cholesterol, although only 4 of 26 patients had achieved their target
cholesterol. Nineteen of these 26 patients were prescribed 10 mg/day or
less of pravastatin or simvastatin. Of the patients with untreated hyper-
cholesterolemia, according to NHF guidelines, 36 (56%) should be
considered for drug therapy. Two possible side effects of cholesterol
lowering therapy were noted. The findings suggest a need for closer
monitoring, follow-up, and active treatment of hypercholesterolemia if
NHF guidelines are to be achieved. The question is raised whether
ANZData should collate and report serum cholesterol levels and HMG
coA reductase inhibitor use, in an attempt to determine if cholesterol
levels have an effect on excess cardiovascular mortality in transplant
recipients.
H transgenic mice show reduced expression of the major porcine
xenoantigen GaJa(l,3) Gal and reduced susceptibility to human antibody.
S.J. Cohney, MS. Sandrin, E. Mouhtouris, N. Osman, I.E. C. McKenzie,
Austin Research Institute, Austin Hospital, Heidelberg, Victoria, Australia.
The major obstacle to transplanting pig organs to humans is hyperacute
rejection, mediated by human natural antibodies directed against one
major xenoantigen on porcine tissues: the Gala(1,3) Gal epitope (Gal).
Elimination of this antigen from pig cells will prevent hyperacute rejection
when pig tissue is exposed to human serum. Constitutive removal of Gal
by knockout of the ni, 3 galactosyltransferase gene (the enzyme respon-
sible for Gal formation) while successfully performed in mice, is not
possible in pigs. An alternative strategy was considered in light of the
knowledge that al,3galactosyltransferase(a 1 ,3GT) and al ,2fucosyltrans-
ferase (al,2FT) use the same substrate (N-acetyl lactosamine); use by the
latter enzyme results in the formation of H substance. Competition
between these transferases was examined. Cos cells simultaneously trans-
fected with cDNA clones encoding the al,3GT and al,2FT show prefer-
ential expression of H substance with dramatic reduction in the produc-
tion of Gal, resulting in decreased human antibody binding and reduced
complement mediated cell lysis. Transgenic mice were produced by
injection of the cDNA encoding the al,2FT under the H2Kh promoter.
Serology showed high levels of expression of H substance on erythrocytes,
peripheral blood lymphocytes, splenocytes and thymocytes from trans-
genie mice in contrast to its absence on these cell types from non-
transgenic mice. Significantly, transgenic mice showed a 90% reduction in
surface expression of Gal compared to non-transgenic mice. Immunohis-
tochemistry showed heavy staining for H substance on liver, spleen, kidney
and heart, with a concomitant dramatic reduction in staining for Gal. The
potential of this transgene to offer protection in the context of xenotrans-
plantation was demonstrated by the finding of a 90% reduction in the
binding of human antibody to H transgenic cells and a 30 to 50% decrease
in complement mediated cell lysis. These findings have important impli-
cations in that al,2FT transgenic pigs could be produced as a source of
organs for humans.
Insulin-like growth factor-i (IGF-1) stimulates apical sodium-hydro-
gen exchange (NHE) in human proximal tubule cells (PTC). D. W.
Johnson, B.K Brew, P. Poronnik, Dl. Coo/c, M.J Field, A.Z. GyOiy, and
C.A. Pollock, Department of Medicine, University of Sydney at Royal North
Shore Hospital, Sydney, Australia. IGF-1 is considered to play an important
role in many physiological and pathological renal growth states, such as
compensatory hypertrophy and diabetic nephropathy. To define whether
such growth stimulation was potentially modulated by activation of apical
NHE, confluent primary cultures of human PTC were studied after 48
hours incubation in serum-free, hormonally-defined media in the presence
or absence of 100 ng/ml IGF-1. Resting intracellular pH (pH1) values in
IGF- 1-treated cells, measured by BCECF quantitative microspectrofluo-
rimetry, were significantly elevated compared with controls (7.52 0.08
vs. 7.30 0.06, N = 20, P < 0.05, respectively). NHE activity, defined as
Na -dependent, EIPA-inhibitable H effiux following an intracellullar
acid load, was markedly enhanced in the IGF-1 group (8.78 1.69
mM/mm vs. 3.03 0.72 mM/mm, N = 10, P < 0.01. EIPA-sensitive 22Na
uptake after 1 minute, expressed as counts per minute (cpm)/1000 cells or
as cpm/mg protein, was also stimulated to 277.7% 64.6% (N = 12, P =
0.01) and 370.3 116.9% (N = 12, P 0.004) of control values,
respectively. IC50 values in both IGF-l and control groups for EIPA (0.5
ILM and 1.1 !LM, respectively) and for the isoform-discriminative NHE
blocker, H0E694 (4.0 p.M and 10.0 tLM, respectively), were consistent with
predominant activation of apical, rather than basolateral, NHE activity.
Kinetic analysis revealed an increase in V,,, by IGF-1 (15.50 1.50
mM/mm vs. 7.26 3.07 mM/mm, N = 10, P < 0.05), without a significant
change in antiporter affinity for intracellular H or extracellular Nat The
results demonstrate that IGF-1 stimulates apical NHE in human PTC and,
hence, may serve to link Na transport workload and cell growth through
as yet undefined pathways.
The role of nitric oxide in iron-induced toxicity of proximal tubule cells
in primary culture. L. Chen, Y-C, Tay and D.C.H. Ha,ris, Department of
Renal Medicine, Westmead Hospital, Westmead, New South Wales, Austra-
lia. Both iron and nitric oxide play pivotal roles in various types of acute
and chronic renal disease. Iron is cytotoxic to proximal tubule cells via
lipid peroxidation, and previously we showed that the protective effects of
various scavengers of reactive oxygen species were not equivalent, sug-
gesting that the classical pathway of hydroxyl radical production may not
be the only explanation of iron-induced lipid peroxidation and cytotoxicity.
The present study was designed to investigate the possible role of nitric
oxide in iron-induced toxicity. Proximal tubule segments were isolated by
collagenase digestion of rat renal cortex, separated by Percoll density
gradient centrifugation, plated onto plastic culture dishes coated with
rat-tail collagen and grown to confluence in a mixture of Dulbecco's
Modified Eagle's medium and nutrient F-12 Ham (1:1). On day 5 cells
were treated with ferric ammonium citrate or ferric nitrilotriacetate.
N02/N03 production was measured by spectrophotometry, toxicity
assessed by LDH leakage and transmission electron microscopy, and
peroxidation by malondialdehyde (MDA) production. Both LDH leakage
and NO2/N05 production in iron-treated (400 p.m) cells were signifi-
cantly higher than control (LDH: 50.1 6.3% vs. 12.1 2.3, p. SD, P <
0.01; NO2/NO5 2.45 0.03 nmol/dish vs. 2.02 0.08, P < 0.05).
L-arginine also induced formation of NO2/N05 (5—50 mM) and LDH
leakage (10—50 mM) (LDH: 30.6 3.6 vs. 20.1 1.5, P < 0.01;
NO2/N03: 3.62 0.18 vs. 1.74 0.09, P < 0.01) and iron (200 p.M)
increased L-arginine-induced cytotoxicity and N02/N03 - production
(LDH: 41.3 2.9 vs. 22.0 1.5, P < 0.01; N02/NO3; 3.13 0.13 vs.
2.45 0.24, P < 0.05). The effects of iron and L-arginine appeared to be
synergistic. No effect was seen with D-arginine. In preliminary studies
L-arginine did not increase MDA production. It is hypothesized that nitric
oxide plays a role as one of the mediators of iron-induced toxicity in
proximal tubule cells, perhaps by the production of peroxynitrite, or
nitrosylation of enzymes.
HB-EGF in models of glomerulonephritis: Predominant expression by
glomerular epithelial cells. K Paizis, M. Polihronis, G. Kirkland, S. Osvath,
and D.A. Power, Immunology Research Centre, St. Vincent's Hospital,
Melbourne, Australia. Heparin-binding epidermal growth factor-like
growth factor (HB-EGF) is a potent mitogen for vascular smooth muscle
cells, keratinocytes and fibroblasts. Since HB-EGF mRNA is regulated as
an immediate early gene in cultured glomerular mesangial cells (MC), we
determined the presence of HB-EGF mRNA transcripts in the Thy 1.1
model of mesangial proliferative glomerulonephritis by in situ hybridiza-
tion. Although normal glomeruli were negative, HB-EGF mRNA tran-
scripts were identified in the glomerulus within 30 minutes of disease
induction. Levels increased until 4 days, corresponding to the most
proliferative phase of the model and declined thereafter. A role for
HB-EGF in the proliferative phase of this model was further suggested by
in vitro studies which showed that HB-EGF was mitogenic for rat
mesangial cells, with a potency equivalent to bFGF but less than that of
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PDGF. Sequential immunohistochemistry and in situ hybridization
showed, surprisingly, that although occasional MC and infiltrating macro-
phages expressed HB-EGF mRNA, the most prominent expression oc-
curred in visceral glomerular epithelial cells (GEC). Thy 1.1 glomerulo-
nephritis is produced by administration of antibodies against MC, so that
there must be some sort of rapid communication between injured MC and
normal GEC. The nature of this is unknown, but induction of HB-EGF
mRNA appears sensitive to anti-oxidants and the murine promoter
contains NF-KB sites (which are often dependent on oxidation for
signalling), so we are attempting to inhibit HB-EGF expression in this
model using anti-oxidants. In two models of GEC injury, the passive
Heymann nephritis (PHN) and acute puromycin aminonucleoside (PAN)
models, in situ hybridization and immunohistochemistry demonstrated the
presence of HB-EGF mRNA and increased protein in GEC, but not other
cell types. Semiquatitiative PCR showed a 3—5 X increase in the PAN
model but a smaller 1,5x change in the PHN model. In the PAN model,
the increase occurred at day 2 post-induction, prior to the onset of
proteinuria, whereas it was not until day 19—21 in the PHN model that
HB-EGF increased, about 2 weeks after the onset of proteinuria. These
studies show that HB-EGF is expressed in models of both MC and GEC
injury, predominantly by GEC. Although HB-EGF does not appear to be
important in the pathogenesis of proteinuria, because it was not increased
in the PHN model prior to its onset, it might prove to be important in the
proliferative phase of the Thy 1.1 model.
Glomerulonephritis in mice with genetic deficiencies of the plasmino-
gen/plasmin system. AR. Kitching, P. Carmeliet, S.R. Holdsworth, and P. G.
Tipping, Centre for Inflammatory Diseases, Monash University Department of
Medicine, Monash Medical Centre, Clayton, and Center for Transgene
Technology and Gene Therapy, Catholic University of Leuven, Leuven,
Belgium. Fibrin is an important mediator of injury in severe proliferative
crescentic glomerulonephritis (GN). The protective role of the fibrinolytic
system in GM was studied using mice deficient in genes coding for proteins
of the plasminogen/plasmin system. Accelerated autologous anti-glomer-
ular basement membrane GN was induced in mice deficient in urokinase-
type plasminogen activator (uPA—I--, N 9), the uPA receptor
(uPAR—/—, N 7), tissue-type PA (tPA—/—, N = 5), both tPA and uPA(N = 5), piasminogen (pig—I--, N = 8) and wild type mice (WT, N = 20).
Renal injury was studied ten days after initiation of disease. WT mice
developed proliferative GM with fibrin deposition, occasional crescent
formation and renal impairment. The pig—I— and the combined tPA—I—,
uPA—I— mice developed increased glomerular fibrin deposition com-
pared to WT, necrosis of glomerular tufts, and (for pig—I—) higher
percentages of crescentic glomeruli (19 3.5% vs. 4.8 1.9%, P = 0.014).
Renal function was significantly more impaired in pig—I-- mice (SCr
48.6 10.0 .rmol/liter vs. 13.5 3.2 WT, P = 0.03), and combined
tPA—/—, uPA—I— mice (36.4 8.3 vs. 18.6 2.9 WT, P = 0.04), The
uPA—!— mice also had more impaired renal function compared to WT
(37.4 2.8 vs. 26.1 4.5, P < 0.05). Mice deficient in tPA showed a trend
towards more severe renal impairment (36.5 12.7 vs. 26.1 4.5, NS).
The 5Cr of uPAR—I— mice (26.6 3.6) was no different to WT mice.
Those with deficiencies of tPA, uPA or uPAR did not have increased
glomerular hypercellularity or increased glomerular PAS positive material
compared to 'NT. Induction of GM in mice deficient in plasminogen or
both PAs results in severe disease, compared to WT. Mice deficient in
uPA or tPA (but not those who lack uPAR) have some evidence of
increased disease severity. These results provide evidence that the fibrino-
lytic system plays a major role in maintaining glomerular function in
proliferative forms of GM.
COIAA5 mutation screening in Alport syndrome (AS) using a simpli-
fied PCR-based chemical cleavage method (CCM) on skin fibroblast
cDNA. A. Chiysostomou, G.J. Becker, D. Chan, and IF. Bateman, Depart-
ment of Nephrology, The Royal Melbourne Hospital and Orthopaedic
Molecular Biology Research Unit, The Royal Children Hospital, Melbourne,
Australia. X-linked AS has been shown in up to 50% of cases to arise from
mutations in the COL4A5 gene. The lack of protein expression in readily
accessible cells has meant that all mutation screening to date has been
conducted at the genomic level using Southern DNA analysis and SSCP.
The large size of the gene (250 kb), poor rate of mutation detection using
Southerns (approximately 15%) and high rate of false positives (SSCP)
has meant that mutation screening is tedious and expensive. We describe
a method for screening for mutations at the eDNA level using a simplified
CCM. The principle of the CCM relies of the formation of heteroduplexes
between wild type and mutant DNA, a mutation results in a mismatch and
after treatment with chemicals the mismatched base(s) becomes chemi-
cally susceptible to cleavage with piperidine. The heteroduplexes are
end-labelled and the cleaved products are seen when run on a 6%
acrylamide gel allowing simultaneous detection and localization. Using
RNA extracted from skin fibroblasts of 9 AS patients and the principle of
illegitimate transcription, RT PCR was performed and 6 overlapping PCR
products encoding the entire COL4A5 were generated. The CCM has
been modified to allow heteroduplex formation during PCR, by limiting
the dilution of oligonucleotides and increasing the cycle number to favor
heteroduplex formation. Using this method we have identified mutations
in 2 of our patients. The advantages of using this modified method to
screen for COL4A5 mutations are that the entire gene can be screened
quickly, relatively easily and using only 6 pairs of oligonucleotides as
compared to 51 pairs if the same area were to be screened at the genomic
level. This is the first time the entire COL4A5 gene has been screened in
patients with X-linked AS. Given a mutation screening method with near
100% detection rate was used, the fact that we are still only detecting less
than 50% of mutations implicates the involvement of another gene other
than COL4A5 in the pathogenesis of up to 50% of X-linked AS.
Interleukin-lO enhances rat mesangial cell expression of MHC class II
and ICAM-1. S.J. Chadban, R.C. Atkins, and D.J. Nikolic-Paterson, Depart-
ment of Nephrology, Monash Medical Centre, Victoria, Australia. Macro-
phages are not only producers of the cytokine interleukin-lO (IL-b), but
are also regulated by this cytokine via paracrine and autocrine pathways.
IL-b is a potent inhibitor of many macrophage functions, including
surface expression of MHC class II and ICAM-1 molecules, which are
involved in antigen presentation. Since mesangial cells share many func-
tional characteristics with macrophages, this study examined: (a) whether
mesangial cells are capable of IL-b production, and (b) the effects of
exogenous IL-b on mesangial cell functions. A well-characterized rat
mesangial cell line (1097) cultured in RPMI/5% fetal calf serum in 5%
CO2 at 37°C was utilized. The presence of IL-lO mRNA in cultures of
unstimulated and LPS-stimulated mesangial cells was demonstrated by
RT-PCR. The addition of recombinant murine IL-b (2.5—20 nglml) to
mesangial cells did not directly induce class II expression, but did
significantly augment interferon-gamma (IFNy)-induced de novo surface
expression of MHC class II antigens in a dose dependent manner using
antibody staining and flow cytometry. This was shown by both an increase
in the percentage of cells expressing detectable class II antigens (25 —*
44%, P < 0.05) and an increase in the intensity of class II expression
(1' 54% in mean channel fluorescence, P < 0.05). The effect was abro-
gated by the addition of a neutralizing anti-IL-lO antibody. In parallel
experiments, IL-lO down-regulated constitutive MHC class II expression
on rat peritoneal macrophages. In addition, IL-lO up-regulated constitu-
tive ICAM- 1 expression by mesangial cells in a dose dependent fashion( 36% in mean channel fluorescence). Thus, it is concluded that mesan-
giai cells can produce IL-b. In contrast to the effects on macrophages,
however, IL-b increases MHC class H and ICAM-1 expression by
mesangial cells which may augment their capacity to present antigen.
Elimination of galactose t1,3-galactose (Gal), the major porcine xeno-
antigen: Protective effect in models of xenotransplantation. MJ. Tange,
R.G. Tearle, M. Katerelos, T Shinkel, M.J. Pearse, and A.J.F. d'Apice,
Immunology Research Centre, St. Vincent's Hospital, Melbourne, Victoria,
and Bresatec Ltd, Adelaide, SA, Australia. Xenotransplantation utilizing
genetically manipulated pigs as a source of organs is a possible solution to
the shortage of donor organs. However, pig to human xenotransplantation
is complicated by hyperacute rejection (HAR) due to preformed natural
xenoantibodies. Gal has been identified as the major xenoantigen on
porcine endothelial cells which is recognized by these xenoantihodies. As
a first step toward elimination of this xenoantigen in pigs, Gal-deficient
(Gal KO) mice were generated by targeting the alpha 1,3 galactosyltrans-
ferase gene to determine the feasibility and efficacy of this approach. Gal
KO mice are viable and breed normally; however, they invariably develop
nuclear cataracts within 4—6 weeks of birth. A detailed histological
examination did not identify any other abnormalities. The Gal epitope was
eliminated from leukocytes and tissues (kidney, liver, heart and lung) as
detected by 1B4 lectin and purified anti-Gal antibodies while wild-type
(WT) mice reacted strongly with both reagents. When reacted with a
range of concentrations of human serum, splenocytes from Gal KO mice
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show a 60% decrease in 1gM and lgG binding compared to WT controls
as detected by FACS analysis. Loss of the Gal epitope was shown to be
functionally protective as there was a 30—50% decrease in complement
activation measured by C3 binding. In addition, KO mouse hearts
perfused with human plasma on a Langendorif apparatus survived signif-
icantly longer than WT hearts (8.3 mm 1.3 mm vs. 26.6 9.3 mm). In
summary, deletion of the Gal epitope in mice is protective in both in vitro
and cx vivo assays which model aspects of HAR. These results provide a
firm basis for continued efforts to eliminate this xenoantigen in pigs in
which it is the dominant antigen recognized by human preformed xeno-
antibodies.
Genetic determinants of thrombosis in renal transplant recipients. A.
Irish, F. Green, D. Gray and P.J. Morris, Oxford Transplant Centre, Oxford
and Department of Medicine, University College, London, England, United
Kingdom. Renal transplant recipients (RTR) suffer from early allograft
vascular thrombosis and long-term risk of venous and arterial thrombosis,
especially myocardial infarction. We investigated whether resistance to
activated protein C due to a mutation in the factor V gene (FV Leiden),
or the 4G/5G polymorphism of the promoter region of the plasminogen
activator inhibitor type I (PAIl) gene may predipose patients to throm-
bosis. We studied 300 RTR of whom 77 had suffered a venous and/or
arterial thrombotic complication. Forty-two percent of those with throm-
bosis vs. 26% of those without, had a family history of cardiovascular
disease (P < 0.05). Eighteen patients (6%) were hetorozygous for the FV
Leiden mutation and 7 (39%) of those had suffered venous thrombosis
compared with 15% of the patients without the mutation (P < 0.05, Odds
ratio 3.695% CI 1.3 to 9.9). However, FV Leiden was not a risk factor for
arterial thrombosis and could only explain 14% of the venous thromboses.
Patients homo- or heterozygous for the PAIl 4G allele, who have higher
PAIl activity than 5G homozygotes, had an odds ratio for arterial and
venous thrombosis of 2.1 (P = 0.1, 95% CI 0.8 to 5.0). Carriers of the FV
Leiden mutation are at increased risk of venous thrombosis, and carriers
of the PAll 4G allele may be at increased risk of venous and arterial
thrombosis, confirming that genetic variation in the coagulant and fibrino-
lytic pathways contributes to the increased risk of venous and arterial
thrombosis in RTR. Genotyping of RTR may aid identification of high
risk groups for prophylactic interventions.
Suppression of crescentic glomerulonephritis cutaneous delayed type
hypersensitivity in rats by SK&F105685 treatment. X.R. Huang, SR.
Holdsworth, W. W Hancock, and P. G. Tipping, Centre for Inflammatory
Diseases, Monash University Department of Medicine, Monash Medical
Centre, Clayton, Victoria, Australia and Sandoz Centre for Immunobiology,
Harvard University, Boston, Massachusetts, USA. SK&F 105685 is a novel
azaspirane analog, with suppressor-cell inducing activity which has been
demonstrated to attenuate adjuvant arthritis and renal allograft rejection
in rats. The capacity of SK&F105685 to attenuate severe crescentic
glomerulonephritis (GN) was evaluated in rats. Glomerulonephritis (GN)
was induced in Wistar Kyoto rats by s.c. sensition with sheep globulin in
Freunds Complete Adjuvant followed by iv. injection of a subnephrito-
genie dose of sheep anti-rat GBM globulin, 5 days later. Ten days after
anti-GBM globulin, this protocol induced severe crescentic GN, with
crescents in 58 5.2% (mean SEM) of glomeruli, significant proteinuria
(108 10.2 mg/24 hr, normal 6.8 1.2 mg/24 hr) and impaired renal
function (serum creatinine 132 15.8 smol/liter, normal 38 3.9
.rmol/1iter). CD5+ve T cells [2.8 0.6 cell/glomerular cross section
(c/gcs), normal 0.01 0.001 c/gcs] and EDI +ve macrophages (18 8
c/gcs, normal 0.005 0.001 c/gcs) were present in glomeruli. Daily
treatment with SK&F105685 (20 mg/kg i.p.) from the time of administra-
tion of anti-GBM globulin resulted in significant suppression of renal
disease. Crescent formation (11 3.2% of glomeruli), proteinuria (58.3
7.5 mg/24 hr), serum creatinine (64.5 4.0 ,trmol/liter), and glomerular
infiltration of CD5+ve T cells (0.5 0.01 c/gcs) and ED1+ve macro-
phages (3.8 1.0 c/gcs) were reduced compared to untreated disease (P <
0.01 compared to untreated in each case). Treatment also prevented the
cutaneous DTH response to sheep globulin (skinfold thickness, treated
1.3 0.01 mm, untreated 3.0 0.1 mm, normal 1.2 0.1 mm).
SK&F105685 treatment did not effect circulating leukocyte numbers
(8.9 2.6 x io cells/liter, untreated 10.1 2.3 x iO cells/liter) or
circulating rat anti-sheep antibody titres (measured by ELISA). These
data demonstrate that SK&F105685 attenuates crescentic ON in rats and
suggest that this effect is via suppression of cell mediated effeetor
mechanisms rather than humoral immunity.
CD8 T-cell depletion impairs proteinuria in active Heymann nephri-
tis. M.J. Penny, R.A. Boyd, B.M. Hall, Department of Medicine, Liverpool
Hospital, Liverpool, NSW, Australia. Previous work by this group has
suggested that activated T-cells, including CD8 cytotoxic effector cells,
may be central to glomerular injury mechanisms in Heymann nephritis.
This study examined the effect of CD8 T-eell depletion in HN in Lewis
rats. A group permanently depleted of CD8 T-eells (CD8°) by a
combination of thymectomy and anti-C58 mAb treatment, was compared
to a group normal rats immunized to induce HN (HN). Both these groups
were immunized with RTA in CFA, and boosted at 2 weeks with RTA in
IFA. A control group (C) was immunized only with adjuvant. Disease
activity was assessed by: proteinuria and anti-RTA Ab's at 6, 9 and 12
weeks; and glomerular Ig/C3 deposition at 9 weeks. CDB depletion was
confirmed by 2-color FACS analysis of PBLs. Renal cortical leukocyte
infiltrates were examined by immunoperoxidase cytochemistry (IPx).
Semiquantitative PCR of cytokine mRNA expression of renal cortical
leukocyte subsets (Thi, Th2, CTL, macrophage) is in progress. CD8
depletion was maintained to 12 weeks with 0.6 0.1% of CD3 cells being
CD8, compared to 23.3 1.4% in HN and C groups (X P 0.001).
There was no significant difference in urine protein excretion between
groups at 6 weeks. Proteinuria in the CD8 group at 9 and 12 weeks was
significantly less than in HN, but was moderately increased compared to C,
(P 0.015. for all). Anti-Fx1A Ab titers in the HN and CD8 groups at 6,
9 and 12 weeks were significantly elevated compared to C (all P s 0.003).
Titers in CD8° were not significantly different to HN. At 9 weeks there was
marked glomerutar Ig and C3 deposition in HN, which was moderate in
the CD8 group. Nine week results are shown (><
Group Proteinuria' RTA Ab" Glom. Ig & C3
Control 6.4 1.8 2.2 0.7 —
HN 204.6 113.6 873.5 358.9 +++
CD8° 19.6 10.9 579.8 358.5 ++
mg/lOU g/24 hrs; "normal serum = 1.0
At 9 weeks, aPTCR, CD4, CD8, and macrophage (M) infiltrates
were demonstrated in HN. These were virtually absent in the CD8° group
with a small but significant increase in ai3TCR cells and Mçts, compared
to HN. There was a significant reduction of CD8 cells in the CD8° group
compared to C. P 0.020 for all comparisons between all groups
(excluding CD4). Nine week results are shown (cells/HPF X of 10
HPF) br IPx cell subgroups.
Group TCR (aTCR) CD4 (W3.25) CD8 (OX.8) M (EDI)
Control 3.9 0.9 + 3.5 0.6 3.3 0.9
HN 29.7 10.9 +++ 13.6 5.3 32.4 11.2
CDS" 6.7 3.0 + 1.7 0.5 5.4 1.7
Permanent CD8 T-cell depletion significantly attenuated the proteinuria
and leukocyte infiltrates of HN almost to baseline levels, with little
reduction of Fx1A Ab titers and glomerular Ig/C3 deposition. This study
suggests that CD8 cytotoxic effector mechanisms independent of antibody
and complement may be important in the evolution of HN.
Functional blocking of TNFa in rat crescentic glomerulonephritis and
comparison with IL-i blockade. H.Y Lan, Q. Song, D.J. Ni/colic-Paterson,
R. C. Atkins, Department of Nephrology, Monash Medical Centre, Clayton,
Victoria, Australia. Tumor necrosis factor-a (TNFa) is a major pro-
inflammatory cytokine which has many functions in common with inter-
Ieukin-1 (IL-i). Having demonstrated a functional role for IL-i in rat
crescent glomerulonephritis, we sought to determine whether TNFa may
play a similar functional role and if blockade of both cytokines would give
an additive effect on disease development. TNFa action was inhibited by
administration of a soluble dimeric form of the p55 chain of the human
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TNFa receptor (TNFbp), while IL-I activity was inhibited by administra-
tion of the IL-i receptor antagonist (IL-ira) Accelerated anti-GBM
glomerulonephritis was induced in primed rats by i.v. injection of rabbit
anti-rat GBM nephrotoxic serum (NTS). Groups of 6 animals were treated
from the time of NTS injection until being killed on day 10 with: (a)
TNFhp (1 mg/kg i.p. every second day; (b) IL-ira (0.5 jLg/hr via s.c. osmic
pump); (c) TNFbp plus IL-ira; (d) saline only (control). Saline-treated
animals developed severe proteinuria, a reduction in GFR, prominent
leukocytic infiltration and severe glomerular and tubulointerstitial injury
including 20 to 30% crescent formation. Treatment with TNFbp alone
caused a marked inhibition of disease with a 40 to 60% reduction in
proteinuria, maintenance of normal GFR, almost complete suppression of
glomerular and tubulointerstitial injury including leukocytic infiltration
and abrogation of glomerular crescert formation (0 to 4%). However, no
added benefit was apparent when treating animals with a combination of
TNFbp and IL-ira. In conclusion, this study demonstrates that TNFo
plays a major pathogenic role in rat crescentic glomerulonephritis. Fur-
thermore, IL-l and TNFa appear to operate through similar mechanisms
in mediating renal injury, since blockade of both molecules gave no added
benefit in this disease model.
Continuous veno-venous hemofiltration (CVVH) and continuous veno-
venous hemodialysis (CVVHD) in critically ill children. S. Alexander, P.
Glidden, J. Herrin, Division of Nephrology, Childrens' Hospital, Boston
Massachusetts, USA. CVVH and CVVHD are increasingly being used as
modalities for fluid removal and dialysis in patients who are too hemody-
namically unstable to tolerate routine hemodialysis and ultralfiltration.
We report on a retrospective review of 15 patients treated at the
Childrens' Hospital Boston with either CVVH or CVVHD from January
1992 to October 1995. There were 10 boys and 5 girls. 8 were less than 1
year old, 2 were aged between 2 and 5 years, 2 were aged between 10 and
15 years and 3 were aged between 16 and 20 years. All children had
pre-existing disease. Six children had underlying cardiac lesions including
2 cardiac transplants, 4 children had a previous malignancy including 1
child post-bone marrow transplant, and 2 children had been receiving
ECMO. Precipitating events were primarily postoperative renal insuffi-
ciency and sepsis. CVVH ranged from 1 hour up to 216 hours with
successful ultrafiltration in all cases. The major complications included
bleeding, hypothermia, sepsis, and hyponatremia. Six children survived, 3
on long term dialysis and 3 off dialysis. 9 children died, 7 on CVVH at the
time of death and 2 children who had discontinued CVVH at the time of
death. CVVH and CVVHD are useful modalities for removing fluid and
providing dialysis in children who are too hemodynamically unstable to
tolerate routine hemodialysis and ultrafiltration.
Multinational study of hemodialysis. P. TH. Coates, A.J. Bleyer, B.
Hylander, Y Nomoto, A. Borklund, E. de Ia Tony, J.M. Burkart, andA.P.S.
Disney, The Queen Elizabeth Hospital, Woodville, SA, Australia; Bowman
Grey School, Winston-Salem, North Carolina, USA; Karolinska Hospital,
Stockholm, Sweden; and Tokai University, Ischera City, Japan. A cross-
sectional study was undertaken to describe and compare the current state
of dialysis therapy internationally. Four different academic centers com-
prising 11 units and 791 patients participated. Between 3/95 and 5195 data
were, collected concerning dialysis dose (dialysis prescription, filter type,
urea clearance, reuse numbers, length of treatment, blood flow and weight
loss), hemodialysis access (type and position of first and current access)
and patient compliance (interdialysis weight gain, serum phosphate, serum
potassium and number of missed treatments). Kt/V was calculated using
the Daugirdas formula. Calculated Kt/V values for Australian units were
(N = 170) 1.21 0.3, Japanese units (N = 191) 1.26 0.3, Swedish units(N = 84) 1.30 0.3 and American units (N = 346) 1.29 0.2. Initial
access was a radial fistula (RF) in 100% of Japanese, 81.5% of Australian,
78.1% of Swedish and 58.9% of American patients. Current access was a
forearm gortex loop in 42% of American patients and an RF in 84% of
Japanese, 66% of Australians and 55% of Swedes. More patients in
America underwent operations for access repair than the other nations.
Interdialytic weight gains were not significantly different when adjusted for
patient body weight. Australian and North American patients had higher
serum phosphates than patients from Japan and Sweden. Potassium values
were similar across countries. American patients had a higher frequency of
missed treatments and early sign offs (>10 mm before prescribed times).
This study shows diminishing differences in international Kt/V values. In
addition, patient compliance may influence differences between pre-
scribed and delivered dialysis dose. A longitudinal study with increased
international participation has commenced.
Dose.finding, safety, and dialysis performance of low molecular weight
heparin.fraxiparine (CY216) in hemocydialysis. KN. Lai, A. Wang, K Ho
and A. Yu, Department of Medicine, The Chinese University of Hong Kong,
Hong Kong. In 10 ureinic patients undergoing temporary hemodialysis, we
investigated the lowest effective yet safe dosage of the low molecular
weight heparin (CY216) in comparison to unfractionated heparin (UFH).
Initial hemodialysis sessions were untaken with UFH in a loading dose
followed by continuous infusion maintaining the activated partial throm-
boplastin time (APTT) 2 to 2.5 times the baseline value. Hemodialysis
sessions (4-hours) were then undertaken with CY216 in a single bolus dose
(200 U aXa IC/kg, 175 U aXa IC/kg, 150 U aXa IC/kg, or 125 U aXa
IC/kg, twice for each dose). APTT and anti-Xa levels were monitored
hourly during dialysis. Dialyzer volume (Vol) and urea clearance (Cur)
were determined at the onset and at the completion of dialysis. There was
no clots in the bubble traps in any UFH or CY216 sessions. Small amount
of coagulated fibers in the dialyzer was observed in 12.5%, 56.2%, 62.5%,
75%, 18.8% of dialysis sessions with CY216 200 U/kg, CY216 175 U/kg,
CY216 150 U/kg, CY216 125 U/kg, and UFH, respectively(X2 19.8,P <
0.001). A 35% rise of APY1' above baseline value was observed one hour
after CY216 bolus in all dialysis sessions with CY216 but then the APTT
fell rapidly. APIT time curve was constructed and hence area under the
APTT time curve (AUC) was determined for each dialysis. The APTT
AUC for UFH was 6-fold that of CY216 (P < 0.001). The anti-Xa levels
exceeded 0.4 lU/mi for CY216 treatment irrespective of the dosage (mean
0.63). The anti-Xa AUC for CY216 was 10-fold that of UFH (P < 0.001).
No significant reduction of Cur was found in dialysis with either CY216 or
UFH and the percentage change of C. were comparable in all dialysis
sessions. No significant reduction of Vol was observed in dialysis with
either CY216 or UFH. A small but significant reduction of volume (3.5%)
was observed in dialysis with CY216 125 U/kg. We conclude that the use
of CY2I 6 for hemodialysis is safe and effective as compared with UFH.
The lowest effective dosage can be reduced to 125 U aXa IC/kg.
A cross-sectional analysis of urea reduction ratios and albumin levels
in Australian hemodialysis patients. PG. Kerr, A.P.S. Disney for the
ANZDATA Registry, Australia. The mortality rate of Australian dialysis
patients is considerably lower than in the USA, being i2% per annum
(iO.5% for HD). This could be on the basis of a lower average age of
patients (median 56, mean 54 years), fewer diabetic patients (16% of new
patients, 20.3% of existing patients), and fewer black or indigenous
patients. Recent evidence has suggested that both the urea reduction ratio
(URR) and the serum albumin (Alb) correlate with mortality in dialysis
patients. Urea kinetic modelling and the application of techniques derived
from this have not been extensively practiced in Australia; however, most
(85%) hemodialysis patients in Australia receive at least 12 hours of
dialysis per week. Further, most patients are dialyzed using cellulose based
membranes (96%). We surveyed 7 renal units throughout the country (in
conjunction with the 6 monthly ANZDATA registry survey) asking these
units to record the most recent URR (as a percentage) and pre-dialysis
Alb results for their HD patients. Results were based on a mid-week
dialysis session. Post dialysis bloods were drawn 2 minutes after cessation
of the blood pump. A total of 519 patients were included in the survey
(21% of all Australian HD patients). The mean SD URR was 59.3
16.3% (range 53.4 to 64.1 for individual units)—this equates to a Kt/V of
approximately 1.0. The Alb result was 38.5 4.6 g/l Cur (range 36.5
4i.5). While these results would suggest "adequate' dialysis, this cross
sectional analysis does not explain a major survival advantage (cf. the
USA). It is intended to now follow these, and further additional patients,
into the future. However, the number of dialysis hours per week may be
the more pertinent factor.
Intradialytic parenteral nutrition (IDPN) in malnourished hemodialy-
sis patients. BA. Cooper, R.J. Caterson, P. Elliott, CA. Pollocl/, Department
of Renal Medicine, Royal North Shore Hospital NSW 2065, Australia. It is
known that malnutrition is associated with a poor prognosis in end-stage
renal failure. However, often oral supplementation is either not tolerated
or fails to improve the patient's nutritional state. In 5 patients unable to
tolerate enteral feeding, the efficacy of IDPN in improving the nutritional
status was assessed. Prior to IDPN all patients were judged to be severely
malnourished as determined by: body mass index (range 16.7—21.6), serum
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albumin (25—36 g/dl), total lymphocyte Count (0,4-1 )< 1000/j.d), total body
nitrogen (68.2—83.9% of predicted normal), insulin-like growth factor-i
(IGF-i) (0.87—319 pjml), prealbumin (263—367 mg/mI), transferrin (1.9—
2.3 g/liter) and anthropometric measurements. Amino acid (AA) balance
was calculated by subtracting the estimated AA losses in the dialysate
effluent from the known amount of AA given (assuming first order
kinetics). Plasma AA profiles were also measured. One liter of IDPN was
administered over 4—6 hours and contained 470—1000k calories and 8.3—9
grams of nitrogen. Prior to IDPN, dialysis results in a net negative balance
of all AA. Initially IDPN appeared to promote catabolism in the most
malnourished patients (increased net negative AA balance). However,
with continued treatment anabolism was evident with individual AA
retention rates averaging between 40% and 85%. Despite this, no change
in IGF-1, transferrin and pre-albumin occurred. We conclude that initia-
tion of IDPN may initially promote catabolism in the more severly
malnourished patient, but a positive nitrogen balance may be achieved
that is not reflected in traditional nutritional markers. Whether this has a
positive effect on morbidity and mortality remains to be determined.
Thoratec'' arteriovenous fistulae. R. Auwardt, J. Snider, D. Francis, D.
Vellar, B. Muiphy, Department of Nephrology, St Vincent's Hospital, Fitroy,
Victoria, Australia. Polyterafluoroethylene (PTFE) grafts have been com-
monly used in patients whose native veins are inadequate for vascular
access surgery without grafting. Lately a new material thoratec' has
become available with the advantage that it can be used immediately
without waiting the 6 to 8 weeks needed for PTFE grafts. This obviates the
need for temporary venous lines with their attendant complications. This
study was undertaken to determine what the survival rate is with the use
of thoratec'' in our unit. All patients who had Thoratec ' arteriovenous
fistulac created were included in the study. Forty-two fistulae in 34
patients were created between April 1993 and May 1995. Six patients had
2 thoratec access devices created and 1 patient had 3. Patients were
followed for 83 to 500 days (median 345 days). There were a total of 58
access complications which occurred in 23 access devices in 17 patients.
Sixteen of these grafts were abandoned. Ten access devices had multiple
complications (all thromboses) ranging from 2 to 9 with a median of 3. Of
the 10, 8 were abandoned within the period of the study. The cummulative
survival (life table method) of fistulae until the first complication (throm-
bosis or sepsis) was 37.3% at 12 months. The cummulative survival of
fistulae until abandonment was 57.12% at 12 months. Published survival
rates of PTFE fistulae range from 62.4% to 85%. Our 12-month survival
rate of 57% with Thoratec although lower, is not out of keeping with the
published rates above. It is very difficult to compare any of these results
given the potential differences in patient populations such as age, inci-
dence of diabetes mellitus, vascular disease, vein size and previous access
surgery. Overall our results suggest that Thoratec' arteriovenous fistulae
have a survival rate similar to that of PTFE and with the immediate
benefits mentioned earlier justify its continued preferential use in our unit.
However, the survival rates are low and new vascular access solutions and
approaches are urgently needed. Thoratec" is a proprietary polyurethane,
manufactured by Thoratec Lab. Corp.
Peritoneal dialysis and its effect on host defence mechanisms in the
peritoneal cavity. T. Miller and G. Findon, Department of Medicine,
University of Auckland, Auckland, New Zealand. Peritoneal dialysis in the
management of ESRF is not without its risks. One common complication
of dialysis is the peritonitis that is thought to accompany accidental touch
contamination of the connecting devices during bag exchange. We have
used an experimental model of peritoneal dialysis to explore the effect of
dialysis on the clearance of several pathogens commonly introduced into
the peritoneal cavity at the time of bag exchange. Contrary to expecta-
tions, the experiments showed that the ability of host defence mechanisms
to clear a bolus challenge remains largely intact despite a considerable
dialysis associated change to the peritoneal milieu. In retrospect, the use
retrospect, the use of a bolus challenge of up to i0 microorganisms,
together with the selection of human pathogens for use in an animal
model were probably not wise decisions. In the course of further experi-
ments, we determined the microbiological spectrum of naturally occurring
touch contamination in the experimental host. In contrast to the previous
experiments, peritonitis was readily established within a few days when
touch contaminated catheters were used to introduce dialysis fluid into the
peritoneal cavity. Susceptibility to peritonitis was not enhanced in subjects
undergoing dialysis. One additional finding of considerable interest was
that the microorganism isolated from the peritoncal fluid in all the cases
of peritonitis was very much a minor component of the host skin flora used
to contaminate the catheter. We have concluded that the host defence
status of the peritoneal cavity in subjects undergoing dialysis presents
something of a paradox. Despite dialysis, host defences in the peritoneal
cavity cope with both high and low level challenges with a wide spectrum
of pathogens. However, it remains exquisitely susceptible to infection with
individual microbial strains with the characteristics that allow establish-
ment and persistence in the peritoneal milieu. The observations have
implications for the way in which CAPD-associated peritonitis might be
prevented.
Low density lipoprotein (LDL) subfraction profiles in chronic hemodi-
alysis (HD) and peritoneal dialysis (PD) patients. A. Bofinger, J. West-
huyzen, D. Saltissi, C. Morgan, H. Healy, Departments of Renal Medicine
and Pathology, Royal Brisbane Hospital, Herston, Queensland, Australia.
Uremic dyslipidemia is a major risk factor for cardiovascular disease in
end-stage renal failure patients. In normals, predominance of small dense
LDL particles correlates with hypertriglyceridemia, glucose intolerance
and increased risk of coronary heart disease. Three LDL phenotypes can
be identified according to peak particle diameter (A,I,B), B being most
atherogenic. To assess the prevalence of LDL phenotypes in our dialysis
population, all consenting patients not on lipid-lowering medication were
studied. LDL subfraction profiles were determined using 3 to 13%
polyacrylamide gradient gel electrophoresis and correlated with lipid
profiles and indices of glucose tolerance. Results are expressed as mean
(sEM), except age, triglyceride, VLDL and fasting glucose expressed as
median (range).
HD (N = 30) PD (N = 17)
M:F 12:18 6:11
Age years 64 (23—83) 65 (26—83)
LDL diameter n 24.8 (0.1) 24.4 (0.1)'
LDL phenotype A:I:B 1:7:22 0:0:17
Total chol rnmol/liter 4.9 (0.2) 6.0 (0.3)'
Trig mrnol/liter 2.15 (0.51—6.42) 2.29 (0.60—3.86)
HDL Chol mmol/liter 1.0 (0.1) 1.2 (0.1)
LDL Chol rnmol/liter 2.9 (0.2) 3.6 (0.3)a
VLDL Chol rnmol/liter 0.95 (0.05—2.00) 1.00 (0.30—1.80)
BMI kg/rn2 24.8 (0.8) 26.5 (1.5)
Glycated Hb 0.083 (0.002) 0.091 (0.003)
Glucose mmol/liter 5.0 (3.3—7.9) 6.0 (4.5—11.5)
P < 0.05 for comparison with HD
A significant inverse correlation was found between LDL diameter and
triglyceride and a positive one between LDL diameter and HDL choles-
terol for both HD (r =
—0.82, r = 0.68, respectively) and PD (r = —0.74,
r = 0.67, respectively). Both groups (particularly PD) predominantly
exhibit the atherogenic phenotype B.
Initial experience with a disconnect/discard CAPD system and assess-
ment of CAPD system and assessment of CAPD adequacy. W.F. Heale,
S.L. Julian, APP. Cheung, KG. Tan, Renal Unit, Austin & Repatriation
Medical Centre, Heidelberg, Victoria, Australia. For many years peritonitis
has been the major complication limiting the long-term application of
CAPD. With improvement in technology the incidence of peritonitis has
declined, more attention has been focused on the efficacy of the technique
per se as a factor limiting long-term use of cAPD. This study aimed to
assess the incidence of peritonitis in patients using a disconnect discard
system, and the efficacy of dialysis assessed by urea and creatinine
clearance. Over a 30 month period the incidence of peritonitis was 14
episodes in 1140 patient months (1 episode/81 patient months) with a
disconnect/discard system. Eight were recurrent episodes in 4 patients,
and in 3 of 4 were due to G-organisms where diverticular disease was
suspected. This compared to 28 episodes in 466 patient months (1/17
patient months) with previous disconnect systems. Thirty current patients
on CAPD for a mean of 22 months had their dialysis efficacy measured
using the Adequest (Baxter) peritoneal dialysate clearance test combined
with a 24-hour urine creatinine clearance. Twenty-six (87%) of the
patients were using 8 liter exchanges/day. The mean combined dialysate
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and residual renal Kt/V urea was 1.8 0.38 and the mean creatinine
clearance 59 20 liter/week. 10 (33%) had a Kt/V < 1.70, and 11(37%)
had a ereatinine clearance < 50 liter/week. Residual renal function
contributed 8% of the mean Kt/V for urea and 19% of the mean
creatininc clearance. The mean urine output was 300 mI/day and 17 (56%)
of patients had a urine output of < 100 mI/day. This study suggests
peritonitis may be receding as a major problem with CAPD. Studies are
beginning to show a relationship between dialysis CAPD efficacy and
outcomes, though it is uncertain whether this reflects clearance of uremie
substances or control of fluid balance with better dialysis. Regular reviews
of CAPD efficacy and prescriptions may make a useful contribution to
therapy as residual renal function declines over time.
Fusidic acid concentrations in the dialysate of patients undergoing
CAPD following oral administration. J.F. Collins, T Miller, 1. Dittmer, S.
Moult,ie, J. Leaiy, G. Findon, Department of Medicine, Auckland Hospital,
Auckland, New Zealand. Staphylococeal peritonitis is a well recognized
complication of continuous ambulatory peritoneal dialysis (CAPD).
Staphyloeoccal infection currently accounts for 60 to 75% of reported
eases of peritonitis and of these, about one third are caused by Staphylo-
coccus aureus. Despite the widespread use of agents such as vancomycin,
flueloxacillin, cephlosporins and rifampicin, there remains a significant
incidence of treatment failure for S. aureus peritonitis and relapse of S.
epidermidis peritonitis. There is therefore a need for further, more
effective antimicrobials. Fusidic acid is one such agent that is highly active
against staphylococci and is well absorbed after oral administration.
Studies using an animal model of CAPD have shown that fusidic acid
reaches bactericidal levels in the dialysate once therapeutic serum levels
have been achieved, hut the situation in humans is unclear. In this study,
ten well CAPD patients, free of peritonitis, received a single oral dose of
500 mg fusidic acid and, at a later time, repeated doses of 500 mg TDS
over three days. Serum and dialysate was sampled at frequent intervals
and fusidic acid levels were determined by bioassay. The single 500 mg
dose of fusidic acid gave peak serum levels averaging 17 j.rg/ml and values
above the MIC for S. aureus (0.05 zg/ml) in the dialysate in about 50% of
patients. Multiple 500 mg doses gave fusidie acid levels in the serum
ranging from 50 to 180 jzg/ml and in the dialysate from 1.8 to 7.8 zg/ml,
that is, from 30 to 156 times the MIC for S. aureus. The results have
established that oral fusidie acid achieves high systemic and peritoneal
fluid levels in patients undergoing CAPD, and suggests a useful role for
the agent in the management of dialysis associated peritonitis.
Sclerosing peritonitis in Australia. R. Righy, Department of Nephrology,
Princess Alexandra Hospital, Brisbane, Australia. The aim was to determine
the clinical severity, outcome and etiological factors in severe scierosing
peritonitis (SP). All 33 adult dialysis units were surveyed retrospectively.
Patients were included if there was surgical or radiological evidence of
sclerosing encapsulating peritonitis (SEP) or small bowel obstruction with
tanned or thickened peritoneum in the absence of other causes (presumed
mural fibrosis). All Units responded. Fifty-eight patients were reported
from 17 units. Seven were excluded. The mean age was 48 17 years and
F:M was 2:1. The mean duration of CAPD was 57 30 months, range 11
to 150 months. Eleven eases were diagnosed from 1982 to 1988, and 40
eases from 1989 to 1994 inclusive. The mean annual rate of 1989—1994 was
6.6 per 1000 patients on CAPD. Twenty-two (55%) had been on CAPD 
4 years. Peritonitis was associated with SP in 23 (45%) cases. Hemoperi-
toneum in 3 cases. Small bowel obstruction occurred in 47 (92%) cases.
Encapsulated peritoneum was found in 39 (76%) cases. The CAPD system
was spike (32%), leurlock (24%), "0" Set (14%) and other disconnect
systems (30%). The mean number of peritonitis episodes was 5 4, being
staphiococcus aureus in 34%, pseudomonas 11% and fungal 13%. Immu-
nosuppression was used in 5 patients with relief of bowel obstruction in 2
and hemoperitoneum in 1. Mortality was ascribed to SP in 29 (57%)
patients including withdrawal from dialysis in 9 patients. Severe SP
remains a problem in CAPD patients especially with long duration of
treatment. Treatment with immunosuppression may be successful.
Influence of low calcium dialysate on blood pressure and calcium
metabolism in continuous ambulatory peritoneal dialysis patients. G.J.
Mangos, MA. Brown, ML. Buddle, L. Kress, W YL. Chan, J.J. Kelly,
Department of Renal Medicine, St. George Hospital and Department of
Medicine, St. George Hospital Clinical School, University of NSW Kogarah,
NSW 2217, Australia. Low calcium dialysate is being used with increasing
frequency across Australia. Its effect on ionised calcium (Cai) and
parathyroid hormone concentration (PTH) is variable, and its effect on
blood pressure (BP) unknown. A putative substance, parathyroid hyper-
tensive factor (PHF) has been implicated in the development of hyper-
tension in states of increased PTH production. The objectives of this study
were to determine whether low calcium dialysate increases blood pressure,
PTH and PHF. Stable CAPD patients using normal (1.75 mmol/liter)
calcium dialysate began a 4 week 'run-in' phase (Ph.!) where Ca/P04
balance and BP were 'optimized' (BP 160/90 mm Hg, [Ca] 2.2—2.6
mmol/liter, [PU4] 1—2 mmol/liter). At the end of this phase, ambulatory
blood pressure monitoring (ABPM), plasma electrolytes, creatinine, Ca,
P04, Cat, PTH, LFTs, PHF, Hb and Het and dialysate creatinine clearance
(Ccr) were performed. Dialysate was then changed to low calcium (1.25
mmol/liter) for a period of 8 weeks, during which no change to BP or
Ca/P04 medications occurred (Ph.2). At the end of this phase, the above
parameters were reassessed. Thirteen patients were initially enrolled. Five
patients were excluded (2 peritonitis, 3 other illnesses). Of the remaining
8 patients, the results are currently available for 5. Neither daytime,
nightime nor 24 hour BP or Ca altered from Ph.1 to Ph.2 despite a rise in
PTH from 7 (5,17) to 19 (18,28) pmol/litcr (P < 0.05), [median (inter-
quartile range)]. P04 increased from 1.5 0.5 to 2.0 0.9 mmol/liter
(mean SD), P = 0.051. Weight, Car, Hb, Het and albumin were
unchanged. PHF assays are in progress. This preliminary report has
demonstrated that low calcium dialysate does not affect blood pressure
despite the associated rise in PTH. A larger cohort may be required to
demonstrate small changes in blood pressure.
Clinical and cost benefits of laparoscopic tenckhoff catheter insertion
for continuous ambulatory peritoneal dialysis (CAPD). KM. Bannister, D.
Watson, T. Pearce and D. Paterson, Renal Unit, Internal Medicine Service
and University Department of Surgery, Royal Adelaide Hospital, Adelaide,
Australia. Tenekhoff catheter insertion for CAPD has now been per-
formed solely by laparoscopic technique at the Royal Adelaide Hospital
for the last 19 months. Thirty-three operations have been performed
largely by an experienced laparoscopist (D.W). The average operating
time was 38 mm (range 17—90 mm) and mean length of hospital stay was
3.2 days (range 1—10 days). Patients were trained in CAPD technique 2
weeks post-operatively as out-patients. All catheters were sutured in place
in the pelvis and there were no instances of obstruction by omentum. Few
significant complications were encountered: 2 post-operative bleeds caus-
ing catheter blockage (one evacuated laparoscopically and one requiring
open laparotomy), 1 subcutaneous wound hematoma and one exit site leak
with a port site hernia in the same patient. Three catheters migrated
(comparable to open insertion technique) but were easily repositioned
laparoseopically. Specific costing of medical, nursing, pathology, radiology
and pharmacy of the last 4 patients realised an average cost of $3,201 per
patient. This compares with a retrospective cost analysis of open laparot-
omy for catheter insertion of $5,418 (average length of stay = 10.5 days)
AJ'4-DRG 240 (South Aust. cost weights) reimburses $7,821 for a length of
stay 2.9 to 26.3 days. Laparoscopic insertion therefore realised an average
saving per patient of $4,520 on current AN-DRG service weights, results
in shorter hospital admissions and comparable or fewer complications
than open catheter insertion.
Surgical aspects of peritoneal dialysis (CAPD) access. JR. Hardie,
Department of Surgery, University of Queensland, Princess Alexandra Hos-
pital, Brisbane, Australia. Successful CAPD depends on safe, reliable
peritoneal access, but technical problems and catheter sepsis prevent this
in many patients. A standardized surgical technique based on 15 years
experience has been used in a personal series of 53 catheters in 50 patients
between May 1990 and January 1995 (Group 1). Principles include:
aseptic, atraumatic technique; antibiotic cover (reinsertions + obesity);
accurate placement deep in the pelvis; secure fixation of both cuffs (outer
cuff 1 to 2 cm deep to skin); flushing in theater to confirm good flow in
both directions: fixation of catheter to skin, closed absorbent dressing, for
7 to 10 days. CAPD began at 3 weeks, after cuff healing, using intermittent
dialysis if required or weekly flush/heparin lock to keep it clear. Long-term
skin fixation stopped movement at the exit site, and the exit site was kept
clean and dry. Results were compared to 577 catheter insertions in 354
patients at a major hospital unit with many surgeons, and 30% of catheters
inserted by a surgical trainee operating alone (Group 2). There were 5
early complications (9.4%) in Group 1, and 509 problems in 367 catheters
(63.6% of catheters) in Group 2, the most common being dialysate leak
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(1.9% vs. 13.6%), exit site problems (1.9% vs. 13.9%), catheter migration(1.9% vs. 5.9%) and poor drainage (0% vs 5.4%). There were no late
problems in 31(60%) of Group I catheters, and 221 (40%) in Group 2.
The major long-term problem was exit site infection (Group 1: 0.2/
catheter vs. Group 2: 0.97/catheter). Catheter failure and removal oc-
curred in 10 (19%) of Group 1 and 282 (49%) of Group 2, the major
reasons being peritonitis (30%, 43% of failures), and exit site sepsis (50%,
43%). This comparison confirms the need for competent surgical tech-
nique by an experienced surgeon, followed by high standards of catheter
care and dialysis technique.
Pitfalls of dual energy x-ray absorptiometry in dialysis: Beware the
lumbar spine. MS. Stein, D.K. Packham, P.R. Ebeling, J.D. Wark, and G.J.
Becker, Departments of Medicine and Nephrology. The Royal Melbourne
Hcmpital, Parkville, Victoria 3050. Dual energy x-ray absorptiometry(DXA) is a rapid and precise technique used to record bone mineral
density (BMD) at multiple skeletal sites. We report our experience in the
use of DXA with 250 dialysis patients. BMD was measured at the lumbar
spine (LS), femoral neck (FN) and ultradistal radius (UD) using Hologic
QDRI000W (N = 77) and QDR2000plus (N = 173) densitometers. BMD
was expressed as Z-scores (standard deviations from age- and sex-matched
healthy reference population). We were able to record BMD at all three
skeletal Sites in 87% of the 250 patients. There were large intra-individual
differences in BMD between Sites scanned, particularly between LS and
FN or UD. LS minus FN, median difference in Z-scores = 0.91, P <
0.0001. LS minus UD, median difference = 1.2, P < 0.0001. Differences
between FN and UD were less marked. FN minus UD median differ-
ence = 0.29, P = 0.0013. X-rays of the lumbar spine were examined in a
subset of 47 patients. These were identified as having, or were at risk of
having, scan artifacts because they had: an LS Z-score different from FN
or UD Z-score by more than 0.5 (N = 25), LS Z-score worse than —2 or
greater than 2 (N = 13), or uninterpretable LS DXA (N = 9). Twenty-five
x-rays showed marked aortie calcification, 11 had rugger-jersey spine, 9
had seoliosis and 5 had fracture. These data highlight the pitfalls of
assessing bone density in dialysis patients from AP lumbar spine DXA
alone. Lateral DXA may overcome some of these problems.
Randomized comparison of basic Y (BY) and freeline solo (FS) fluid
transfer systems for CAPD. D.C.H. Harris, E. Yuill, J. Connolly, C. Hunt,
Department Renal Medicine, Westmead and Blacktown Hospitals, West-
mead, NSW 2145, Australia. To compare the efficacy and cost-benefit of a
single- (BY) versus twin-bag (FS) disconnect system for reducing catheter-
related infections in CAPD patients, a randomized, single-center study is
near completion in 3 groups of independent adult dialysis patients: Group
A, new patients (N 40); B, existing patients with 1—3 separate infective
episodes in the past 12 months (9); C, existing patients with no infections
in the past 12 months, or new catheters (24). The length of training in new
patients (A) was no different between BY and FS (3.4 1.3d vs. 3.2 1.7,
.r + SD). Time to first infection was (21 13 weeks (BY) vs. 11 11 weeks
(FS), P = NS). Total follow-up time at this analysis is 722 Pt. mon.
Separate episodes of pertonitis were more frequent with BY than FS (A
6 vs. 3; B 3 vs. 3; C 15 vs. 5). Among all patients, rates of peritonitis were
higher with BY than FS (1:14.3 pt. mon vs. 1:33.2, P < 0.02) due to a
higher rate in C-BY than C-FS (1:9.0 vs. 1:27.6, P < 0.02), with a similar
trend in A-BY vs. A-FS (1:24.1 vs. 1:63.1). A total of 56% of infections
with BY were due to staph, 40% with FS (P = ns); in group C there were
10 exit site infections in 5 patients with BY, and 1 with FS. The protective
effect of FS against peritonitis and exit site infection appeared to be
independent. Rates of hospitalization for all reasons were similar between
BY and FS, whereas hospitalization for catheter-related infection oc-
curred 10 times in 6 patients with BY, vs. 6 times in 3 with FS. In group
C total catheter infection-related hospitalization was 31 vs. 3d for BY vs.
FS. The difference in true costs of treatment with BY vs. FS are being
calculated. In conclusion, the twin-bag disconnect system (FS) is superior
to the single-bag system (BY) in terms of rates of peritonitis, exit site
infection and catheter infection-related hospitalization, and these benefits
may offset the increased cost of consumables for FS.
Sodium modelling and ultrafiltration profiling in maintenance hemo-
dialysis (HD). D. Parsons, E. Yuill, M. Llapitan, D.C.H. Harris, Department
of Renal Medicine, Westmead and Blacktown Hospitals, New South Wales,
Australia. It has been claimed that sodium modelling reduces intradialytic
hypotension and symptoms (especially cramps, headache, nausea) without
altering interdialytic blood pressure (BP) or weight gain of young patients
on conventional HD and older patients on high-flux HD in comparison to
constant sodium (140 or 138 mmol/liter) HD. To assess whether a
combination of sodium modelling and ultrafiltration profiling could
improve these parameters, the following study nears completion in 12 (6
female) patients aged 60.2 (range 45—72) years. Patients received HD(conventional 11, high-flux 1) by 4 regimens in random order for 3 weeks
(1 week washout) each: (a) sodium modelling (exponential decline from
150 to 140 mmol/liter) + conventional (linear) ultrafiltration (150C); (b)
sodium modelling + profiled (removal of 65% of target loss in first 2
hours) ultrafiltration (150P); (c) constant sodium (143 mmol/liter) +
conventional ultrafiltration (143C); or (d) constant sodium + profiled
ultrafiltration (143P). By the time of this analysis, all patients had
completed 3 arms, and 4 patients had completed 4 arms of the trial.
Predialysis BP was no different between the 4 regimens (156 16/83 8,
SD, 150C; 156 19/83 10, 150P; 157 19/85 8, 143C; 153
17/83 11, 143P), nor was weight gain (2.78 0.82 kg, 150C; 262 0.89,
150P; 2.74 0.74, 143C, 2.81 0.08, 143P). Neither sodium modelling
nor ultrafiltration profiling had any effect on incidence of interdialytic
hypotension or intra- and inter-dialytic symptoms (nausea, lethargy,
headache, cramps; scored semiquantitatively). An apparent improvement
in interdialytic thirst with sodium modelling requires trial completion for
confirmation. In conclusion, the added expense of modelling and profiling
technology is not justified by the criteria of cardiovascular symptoms, salt
and water balance and symptoms alone.
Evaluation of the Biostat urea monitor—Accuracy of 'V'. P. G. Kerr, J.
Howard, 0. McGee, and R. C. Atkins, Department of Nephrology, Monash
Medical Center, Clayton, Victoria, Australia. Dialysate based assessment of
the delivered dose of dialysis offers several advantages over blood
sampling methods. Apart from quantitating the actual amount of urea
removed, this approach remains accurate in the face of fistula recircula-
tion, urea rebound, variable blood flow, and incorrect treatment time.
Kt/V is calculated from the slope of the decline in urea concentration in
the dialysate over the course of the treatment. By equilibrating dialysate
with blood at the initiation of the treatment, an estimate of pre-dialysis
blood urea (Cb) and the volume of distribution for urea ('V') can be
obtained. We performed Kt/V assessments on 20 in-center HD patients
using the Baxter Biostat® dialysate urea monitor and compared the results
with urea reduction ratios (URR) and KtIV calculated by the formula of
Basile. In addition, in 11 of these patients, V (and Cb) was derived and
compared to total body water estimates using D20. The mean Kt/V by
Biostat was 1.11 0.23 and by formula was 1.23 0.16 (P < 0.005,
Student's paired t-test). The mean URR was 0.66 0.07. The lab
pre-dialysis urea was 24.4 6.2 mmol/liter compared to the Biostat result
of 23.9 5.9 (when corrected for plasma water), with the mean difference
of the techniques being—0.53 mmol/l (95% CI —0.36 to 1.42). For V, the
D20 result was 34.0 12.3 liters, compared to the Biostat result of 38.6
8.6. Thus, the mean difference of the techniques (or bias of the Biostat)
was 1.2 liters (95% Cl —0.9 to 3.3) and the limits of agreement were —5.2
to 7.6 liters. Thus, the Biostat gives a reasonable assessment of V, tending
to overestimate this value, thus potentially underestimating Kt/V. The V
value, however, does not greatly influence the other results obtained with
the Biostat machine.
Site specific risk factors for osteopenia in dialysis patients. MS. Stein,
D.K Packham, P.R. Ebeling, J.D. Wark, and G.J. Becker, Departments of
Medicine and Nephrology, The Royal Melbourne Hospital, Parkville, Victo-
ria, Australia. Two hundred fifty dialysis patients were studied to deter-
mine the prevalence and distribution of osteopenia and the effect of risk
factors for bone loss on different skeletal sites. One hundred forty-five
(58%) were men. The median age, height and weight were: 57 years, 170
cm, 70 kg for men and 56 years, 156 cm and 58 kg for women. Bone
mineral density (BMD) was recorded at the lumbar spine (LS), femoral
neck (FN) and ultradistal radius (UD) by dual energy x-ray absorptiom-
dry using Hologic QDRI000W and QDR2000plus densitometers. Results
were expressed as Z-scores (standard deviations from age- and sex-
matched healthy reference populations). Osteopenia was defined as a
Z-seore worse than —2. The prevalence of osteopenia at LS, FN and UD
was 8%, 13% and 20%, respectively. Previous transplantation was associ-
ated with a lower Z-seore at FN and UD. The Mann-Whitney analyses,
transplanted versus not transplanted, were at FN: —1.5 versus —0.53, P =
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0.0069 and at UD: —1.44 vs. —0.82, P = 0.0011. Previous parathyroidec-
tomy was associated with higher BMD at LS (2.34 vs. 0.13, P = 0.001) and
FN (—0.35 vs. —1.47, P = 0.0017) but no difference at UD. A history of
secondary amenorrhea (> 6 months before age 40 years) was associated
with lower BMD at FN (—1.34 vs. —0.32, P = 0.0047) but no significant
differences at LS nor UD. In hemodialysis patients with no history of the
above risk factors, BMD was not correlated with duration of dialysis at any
site. At LS, FN and UD, BMD was related to alkaline phosphatase (r =
—0.50, P < 0.001, r = —0.33, P = 0.012 and r —0.29, P = 0.034). BMD
correlated with PTH at LS only (r =
—0.31, P = 0.023). Weight correlated
with BMD at all sites; LS: r = 0.26,P = 0.002; FN r = 0.31, P = 0.009 and
even at the non-weight bearing site of UD; r = 0.47, P < 0.001. We
conclude that osteopenia is common in dialysis. Large changes in BMD
are found in association with past transplantation, parathyroidectomy and
amenorrhea, but these changes vary between skeletal sites. Knowledge of
these risk factors may enable preservation of bone during chronic renal
failure.
Evaluation of a peracetic acid dialyzer re-use program by an on-line
urea monitor system (Biostat 1000"). J. W.M. Agar, and CA. Somerville,
Department of Renal Medicine, Geelong Hospital, Geelong, Victoria, Aus-
tralia. A Baxter Healthcare Biostat 1000" on-line urea monitor (OLUM)
was used to evaluate solute clearance and dialysis "adequacy" (DA) in a
sequential peracetic acid sterilized hemophane membrane dialyzer re-use
(DR) program. Ten randomly selected bicarbonate HDx patients (M:F =
8:2) were studied with a mean DR of 7.8 re-uses (range = 4—10).
OLUM-calculated Kt/V protein catabolic rate (PCR), normalized PCR
(nPCR), total urea removal (TUR) and % reduction urea (PRU) were
derived. A standard laboratory pre/post dialysis single pool blood urea
reduction ratio (URR) was measured to contrast the PRU. Dialysate flow
rate was 600 mI/mm mean dialysis time was 241.7 6.36 mm (range
228—271) Q8 (mI/mm) = 250 (9 pts) or 275 (1 pt) and dialyzer surface
area = 1.2 m2 (7 pts) or 1.0 m2 (3 pts). Mean OLUM-calculated Kt/V =
1.03 0.16 (range 0.7—1.4), PCR = 67.22 10.74 (range 50—97), nPCR
0.99 .17 (range 0.7—1.4), TUR = 22262 4071 mg/dialysis (range
16009 35182), PRU = 58.3 5.0% (range 47—68), while laboratory
measured URR = 64.25 4.91% (range 54—73). No significant changes
were seen during DR. Single pool URR invariably exceeded PRU,
suggesting that the URR may overestimate DA when used as a routine
DA assessment tool. TUR and PRU were standardized for dialysis time.
Mean PRUs (%/min) did not alter during DR (P = NS). TURs, greatest
after a 72 hour interdialytic break (Uses 1, 4, 7, 10 (see Table)I, did
sequentially decline with DR, though not significantly and without change
in the PRUs.
Use 1 2 3 4 5 6 7 8 9 10 P
TURs 107.9 90.1 83.2 102.6 85.2 85.9 97.3 82 79.8 98 NS
PRUs 0.24 0.25 0.24 0.24 0.24 0.24 0.24 0.25 0.25 0.25 NS
It is concluded that, despite unresolved DR issues of safety and nursing
time TUR and DA are not adversely affected by DR. The OLUM is useful
in providing information on DA while the Kt/V and PRU results thus
obtained have led to a re-evaluation of the dialysis prescription. In
particular, dialyzer surface area and time on dialysis have been re-assessed
with a clear resultant trend towards lengthening dialysis time.
Scavenging reactive chemical species of glucose degradation from
peritoneal dialysis solutions (PDS) with thiol compounds. G.E. Lash, S.D.
Bird, M. Legge, and Ri. Walker, Departments of Medicine and Biochemistry,
Otago Medical Schoo4 Dunedin, New Zealand. During the commercial
PDS (CPDS) heat sterilization procedure, D-glucose is degraded, giving
rise to cytotoxic reactive chemical species including low molecular weight
aldehydes. Colorimetric determination of formaldehyde (HCHO) in spent
(10 patients, dwell times: 4—12 hr) and unspent CPDS was performed by
means of the Nash reaction with the absorbance of 3,5-diacetyl-1:4-
dihydrolutidine measured at 400 nm. HCHO was measured in thiol (table)
treated unspent CPDS and compared to autoclaved and control (filtered)
laboratory made (LM) PDS. L-cysteine (Cys) and HCHO reaction kinetics








Untreated PDS 10.5 0.48 22.9 0.28
PDS + Cys 3.6 0.02 10.3 0.47
PDS + GSSG 6.7 0.91 27.1 0.44
PDS + NACy5 4.4 0.47 12.8 0.44
PDS + DTT 2.9 0.37 6.1 0.67
PDs + ProCys 10.9 0.26 —
Triplicate determinations (mean SE) from 5 independent PDS
batches. DTT = Dithiothreitol. GSSG = oxidized glutathione, NACys =
N-acetyl-L-cysteine.
HCHO was not detected in control (filtered) LMPDS but was present in
unspent CPDS and autoclaved LMPDS. This was reduced with the
addition of thiols. Notably thiol compounds with the free sulfhydryl group
(—SH) were the most efficient HCHO scavengers (bold in table). The
formation of the non-enzymatic thiol-HCHO reaction product was veri-
fied by proton NMR spectroscopy:
There were lower levels of HCHO in spent CPDS compared to unspent
CPDS, indicative of HCHO adsorption/absorption at the peritoneal
membrane surface. Thiols may benefit the peritoneum by removing
aldehydes and other reactive chemical species and provide a supply of
extra glutathione precursors required during oxidative stress.
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